Jobs Simply - Other Vitae Pharmaceuticals Resources

Other Vitae Pharmaceuticals Resources

Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Pipeline - Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Vitae Pharmaceuticals, Inc. company research & investing information. Find executives and the latest company news.
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing of the active pharmaceutical ingredient ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... News for Medical Sales & Marketing professionals and Independent Sales Representatives: Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
Vitae Pharmaceuticals | Atlas Venture Vitae Pharmaceuticals is leveraging a proprietary drug discovery platform to develop therapies in cardiovascular, neurological and metabolic diseases. ...
Boehringer Ingelheim Corporation Vitae - News, Search Jobs ... var addthis_pub="bdwyer"; FORT WASHINGTON, Pa. & INGELHEIM, Germany----Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they
Vitae Pharmaceuticals Inc to Reacquire Full Rights - News ... Fort Washington, Pennsylvania – October 21, 2008 –Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
Companies: Vitae Pharmaceuticals Vitae Pharmaceuticals: In January 2005, Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, announced its new corporate branding to clearly ...
Pennsylvania Bio - Vitae Pharmaceuticals Secures $13 Million ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
Vitae's Debt Financing: Crucial Lifeline in a Tightening ... Start-Up -- Roughly one week after GlaxoSmithKline gave Vitae Pharmaceuticals back rights to its renin inhibitor, the biotech signed a $13 million ...
Steve Lotesta | LinkedIn View Steve Lotesta's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Steve Lotesta discover inside ...
Kerri Lipinski | LinkedIn Vitae Pharmaceuticals. Privately Held; Pharmaceuticals industry ... Company; 10,001+ employees; PFE; Pharmaceuticals industry. October 2000 – January 2010 (9 ...
positions offered - PIPLA In-house Patent Attorney - Vitae Pharmaceuticals. posted May 19, 2011 7:15 PM by Bill ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
PHARMA : SARB PHARMACEUTICALS Curabitur tortor ante, condimentum vitae molestie eu, sollicitudin a orci. ... "Our vision is to be a leading pharmaceutical company in India and to become a ...
Oxford Finance LLC - Press Releases Vitae Pharmaceuticals Secures $13 Million in Debt Financing. 9/16/08. Oxford Finance ... Somaxon Pharmaceuticals Secures up to $65 Million in Financing ...
VITAE - Vitae Pharmaceuticals VITAE company profile in Netherland. VITAE provides services related to Personnel ... VITAE provides services related to Vitae Pharmaceuticals, Personnel Services, Recruitment ...
Creative and Changing Deal Structures | Pennsylvania Bio Mr. Hatfield is the president and chief executive officer of Vitae Pharmaceuticals, Inc. ... Prior to joining Vitae, Mr. Hatfield spent nearly 20 years at Bristol ...
Prospect Venture Partners :: News Archives 2009 Vitae Pharmaceuticals. June 15, 2009 - Boehringer Ingelheim and Vitae Pharmaceuticals ... February 12, 2009 - Portola Pharmaceuticals Enters Worldwide License Agreement for ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced the company’s novel, clinical-stage renin inhi
Vitae earns $14M milestone payment from Boehringer Ingelheim Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone ...
Boehringer Ingelheim: Privacy Has its Virtues - IN VIVO BI and Vitae partner on 11beta-HSD1 inhibitors for diabetes, Deal 10/1/2007 ... European Pharmaceutical Companies Patent Expirations Pharmaceutical Profits R&D ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Pharmaceuticals, Inc., an integrated discovery and development company, announced that it has initiated a Phase 1 clinical trial of its novel ...
June | 2010 | Silico Research Vitae Pharmaceuticals has announced that it has earned a $14 million ... GW Pharmaceuticals has announced that it has signed a three year extension to ...
Vitae begins hypertension drug study | Philadelphia Business ... Vitae Pharmaceuticals Inc. initiated a phase-I clinical trial Monday ... Vitae's phase-I study will evaluate the safety of the drug in a small group of health ...
In-house Patent Attorney - Vitae Pharmaceuticals - PIPLA Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that ...
Vitae Pharmaceuticals | Neurology Sites: CardiologyOncologyRespiratoryEndocrineNeurologyGastroenterology featured_supplier: not featured supplierSupplier Type: Pharmaceutical ...
Venrock Vitae Pharmaceuticals. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient ...
PharmaLive: Vitae Reports Positive Clinical Data in Chronic ... Vitae Reports Positive Clinical Data in Chronic Kidney Disease ... Vitae Pharmaceuticals is financed by leading corporate and venture capital investors; its ...
Vitae Pharmaceuticals is new name of Concurrent ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals is new name of Concurrent ...
Novartis' Christine Brennan joins Vitae | InPharm US biopharmaceutical company Vitae Pharmaceuticals has appointed Christine Brennan chief business officer. ... Vitae's chief executive Jeffrey Hatfield commented: "We are very ...
Direct Renin Inhibition and the Kidney - Full Text View ... Further study details as provided by Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals, Inc. ( Richard Gregg, MD, Chief Scientific Officer ) ...
Oligopeptides - Data on oligopeptides described by ... Data on oligopeptides described by researchers at Vitae Pharmaceuticals ... For additional information, contact G. Wu, Vitae Pharmaceuticals, 502 West Office Center Drive, Fort ...
Anchen Pharmaceuticals, Inc - Irvine, California (CA ... Anchen Pharmaceuticals, Inc company profile in Irvine, CA. Our free company profile report for Anchen Pharmaceuticals, Inc includes business information ...
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Symlin News - Healthcare Industry Today Symlin News is an EIN News Service for health professionals. ... Vitae Pharmaceuticals Inc., ... Preventing Diabetes Damage: Zinc's Effects on a Kinky, Two-Faced Cohort ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Boehringer, Vitae ink $242 mln Alzheimer's deal | Reuters Boehringer, Vitae ink $242 mln Alzheimer's deal. Tweet. Share this ... biotech company Vitae Pharmaceuticals to research and develop new Alzheimer's drugs, the ...
CiNii Article - Cloning, Characterization and Site-Directed ... Department of Discovery Biology, Vitae Pharmaceuticals Inc. ... Vitae Pharmaceuticals Inc. PANEMANGALORE Reshma. Department of Discovery Biology, Vitae ...
Pramlintide News - Healthcare Industry Today Pramlintide News is an EIN News Service for health professionals. Constantly updated news ... Vitae Pharmaceuticals Inc., ... Symlin Delivered via Insulin Pump Reduces Symptoms ...
Related Business News - Boehringer, Vitae partner on ... German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the potential to slow or even ...
Business Directory | Neurology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Pipeline - Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Vitae Pharmaceuticals, Inc. company research & investing information. Find executives and the latest company news.
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing of the active pharmaceutical ingredient ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... News for Medical Sales & Marketing professionals and Independent Sales Representatives: Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
Vitae Pharmaceuticals | Atlas Venture Vitae Pharmaceuticals is leveraging a proprietary drug discovery platform to develop therapies in cardiovascular, neurological and metabolic diseases. ...
Boehringer Ingelheim Corporation Vitae - News, Search Jobs ... var addthis_pub="bdwyer"; FORT WASHINGTON, Pa. & INGELHEIM, Germany----Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they
Vitae Pharmaceuticals Inc to Reacquire Full Rights - News ... Fort Washington, Pennsylvania – October 21, 2008 –Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Companies: Vitae Pharmaceuticals Vitae Pharmaceuticals: In January 2005, Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, announced its new corporate branding to clearly ...
Pennsylvania Bio - Vitae Pharmaceuticals Secures $13 Million ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
Vitae's Debt Financing: Crucial Lifeline in a Tightening ... Start-Up -- Roughly one week after GlaxoSmithKline gave Vitae Pharmaceuticals back rights to its renin inhibitor, the biotech signed a $13 million ...
NuRx Pharmaceuticals, Inc: Private Company Information ... NuRx Pharmaceuticals, Inc company research & investing information. Find executives and the latest company news. ... It has a license agreement with Vitae Pharmaceuticals, Inc. ...
Steve Lotesta | LinkedIn View Steve Lotesta's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Steve Lotesta discover inside ...
Kerri Lipinski | LinkedIn Vitae Pharmaceuticals. Privately Held; Pharmaceuticals industry ... Company; 10,001+ employees; PFE; Pharmaceuticals industry. October 2000 – January 2010 (9 ...
positions offered - PIPLA In-house Patent Attorney - Vitae Pharmaceuticals. posted May 19, 2011 7:15 PM by Bill ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a ...
VITAE - Vitae Pharmaceuticals VITAE company profile in Netherland. VITAE provides services related to Personnel ... VITAE provides services related to Vitae Pharmaceuticals, Personnel Services, Recruitment ...
PHARMA : SARB PHARMACEUTICALS Curabitur tortor ante, condimentum vitae molestie eu, sollicitudin a orci. ... "Our vision is to be a leading pharmaceutical company in India and to become a ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Oxford Finance LLC - Press Releases Vitae Pharmaceuticals Secures $13 Million in Debt Financing. 9/16/08. Oxford Finance ... Somaxon Pharmaceuticals Secures up to $65 Million in Financing ...
Creative and Changing Deal Structures | Pennsylvania Bio Mr. Hatfield is the president and chief executive officer of Vitae Pharmaceuticals, Inc. ... Prior to joining Vitae, Mr. Hatfield spent nearly 20 years at Bristol ...
Prospect Venture Partners :: News Archives 2009 Vitae Pharmaceuticals. June 15, 2009 - Boehringer Ingelheim and Vitae Pharmaceuticals ... February 12, 2009 - Portola Pharmaceuticals Enters Worldwide License Agreement for ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced the company’s novel, clinical-stage renin inhi
ACE Inhibitors News - Healthcare Industry Today ACE Inhibitors News is an EIN News Service for health professionals. Constantly updated news and information ... FORT WASHINGTON, Pa. - (BUSINESS WIRE) - Vitae Pharmaceuticals ...
Direct Renin Inhibition and the Kidney - Full Text View ... Verified on June 2011 by Vitae Pharmaceuticals, Inc. First Received on October 6, 2010. ... Further study details as provided by Vitae Pharmaceuticals, Inc. ...
Boehringer Ingelheim: Privacy Has its Virtues - IN VIVO BI and Vitae partner on 11beta-HSD1 inhibitors for diabetes, Deal 10/1/2007 ... European Pharmaceutical Companies Patent Expirations Pharmaceutical Profits R&D ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Pharmaceuticals, Inc., an integrated discovery and development company, announced that it has initiated a Phase 1 clinical trial of its novel ...
June | 2010 | Silico Research Vitae Pharmaceuticals has announced that it has earned a $14 million ... GW Pharmaceuticals has announced that it has signed a three year extension to ...
PharmaLive: Vitae Reports Positive Clinical Data in Chronic ... Vitae Reports Positive Clinical Data in Chronic Kidney Disease ... Vitae Pharmaceuticals is financed by leading corporate and venture capital investors; its ...
Vitae Pharmaceuticals is new name of Concurrent ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals is new name of Concurrent ...
Venrock Vitae Pharmaceuticals. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient ...
Oligopeptides - Data on oligopeptides described by ... Data on oligopeptides described by researchers at Vitae Pharmaceuticals ... For additional information, contact G. Wu, Vitae Pharmaceuticals, 502 West Office Center Drive, Fort ...
Anchen Pharmaceuticals, Inc - Irvine, California (CA ... Anchen Pharmaceuticals, Inc company profile in Irvine, CA. Our free company profile report for Anchen Pharmaceuticals, Inc includes business information ...
Vitae Pharmaceuticals | Neurology Sites: CardiologyOncologyRespiratoryEndocrineNeurologyGastroenterology featured_supplier: not featured supplierSupplier Type: Pharmaceutical ...
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
Community Bank of Northern Wisconsin :: News, Sports, Weather ... Vitae Pharmaceuticals today announced results of a Phase I clinical ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company discovering ...
Symlin News - Healthcare Industry Today Symlin News is an EIN News Service for health professionals. ... Vitae Pharmaceuticals Inc., ... Preventing Diabetes Damage: Zinc's Effects on a Kinky, Two-Faced Cohort ...
Vitae begins hypertension drug study | Philadelphia Business ... Vitae Pharmaceuticals Inc. initiated a phase-I clinical trial Monday ... Vitae's phase-I study will evaluate the safety of the drug in a small group of health ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
Novartis' Christine Brennan joins Vitae | InPharm US biopharmaceutical company Vitae Pharmaceuticals has appointed Christine Brennan chief business officer. ... Vitae's chief executive Jeffrey Hatfield commented: "We are very ...
CiNii Article - Cloning, Characterization and Site-Directed ... Department of Discovery Biology, Vitae Pharmaceuticals Inc. ... Vitae Pharmaceuticals Inc. PANEMANGALORE Reshma. Department of Discovery Biology, Vitae ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... Vitae Pharmaceuticals Receives $14 Million Milestone Payment as Boehringer Ingelheim Advances Lead Compound into Phase I Clinical Trials ...
Diabetes Vitae Pharmaceuticals Receives $14 Million Milesto... Servier : Launch of IMIDIA, an ... said, "We are delighted to invest in Diartis Pharmaceuticals Pharmaceuticals. ...
Company Presentations | Biotech 2010: Imagine. Collaborate ... Boryung Pharmaceuticals is a division of the Boryung Group that is ... Vitae Pharmaceuticals, Inc. Vitae is a clinical-stage biopharmaceutical company building ...
Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Pipeline - Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Vitae Pharmaceuticals, Inc. company research & investing information. Find executives and the latest company news.
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing of the active pharmaceutical ingredient ...
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
boehringer-ingelheim-corporation-vitae - News, Search Jobs ... var addthis_pub="bdwyer"; FORT WASHINGTON, Pa & INGELHEIM, Germany----Boehringer Ingelheim and Vitae Pharmaceuticals, Inc , announced
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... News for Medical Sales & Marketing professionals and Independent Sales Representatives: Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
vitae-pharmaceuticals-inc-to-reacquire-full-rights - News ... Fort Washington, Pennsylvania – October 21, 2008 –Vitae Pharmaceuticals, Inc , an emerging pharmaceutical company dedicated to the discovery and
Vitae Pharmaceuticals | Atlas Venture Vitae Pharmaceuticals is leveraging a proprietary drug discovery platform to develop therapies in cardiovascular, neurological and metabolic diseases. ...
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Pennsylvania Bio - Vitae Pharmaceuticals Secures $13 Million ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
VITAE - Vitae Pharmaceuticals VITAE company profile in Netherland. VITAE provides services related to Personnel ... VITAE provides services related to Vitae Pharmaceuticals, Personnel Services, Recruitment ...
Companies: Vitae Pharmaceuticals Vitae Pharmaceuticals: In January 2005, Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, announced its new corporate branding to clearly ...
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
Vitae's Debt Financing: Crucial Lifeline in a Tightening ... Start-Up -- Roughly one week after GlaxoSmithKline gave Vitae Pharmaceuticals back rights to its renin inhibitor, the biotech signed a $13 million ...
Catherine Bryson | LinkedIn Vitae Pharmaceuticals. Privately Held; Pharmaceuticals industry. January 2009 – Present (2 ... Public Company; 10,001+ employees; BMY; Pharmaceuticals industry ...
Steve Lotesta | LinkedIn View Steve Lotesta's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Steve Lotesta discover inside ...
PHARMA : SARB PHARMACEUTICALS Curabitur tortor ante, condimentum vitae molestie eu, sollicitudin a orci. ... "Our vision is to be a leading pharmaceutical company in India and to become a ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced the company’s novel, clinical-stage renin inhi
NuRx Pharmaceuticals, Inc: Private Company Information ... NuRx Pharmaceuticals, Inc company research & investing information. Find executives and the latest company news. ... It has a license agreement with Vitae Pharmaceuticals, Inc. ...
Oxford Finance LLC - Press Releases Vitae Pharmaceuticals Secures $13 Million in Debt Financing. 9/16/08. Oxford Finance ... Somaxon Pharmaceuticals Secures up to $65 Million in Financing ...
Creative and Changing Deal Structures | Pennsylvania Bio Mr. Hatfield is the president and chief executive officer of Vitae Pharmaceuticals, Inc. ... Prior to joining Vitae, Mr. Hatfield spent nearly 20 years at Bristol ...
Prospect Venture Partners :: News Archives 2009 Vitae Pharmaceuticals. June 15, 2009 - Boehringer Ingelheim and Vitae Pharmaceuticals ... February 12, 2009 - Portola Pharmaceuticals Enters Worldwide License Agreement for ...
Vitae Pharmaceuticals | Neurology Sites: CardiologyOncologyRespiratoryEndocrineNeurologyGastroenterology featured_supplier: not featured supplierSupplier Type: Pharmaceutical ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Pharmaceuticals, Inc., an integrated discovery and development company, announced that it has initiated a Phase 1 clinical trial of its novel ...
Vitae receives 11Beta-HSD-1 program milestone payment from ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned an $8 million milestone payment from ...
Direct Renin Inhibition and the Kidney - Full Text View ... Verified on June 2011 by Vitae Pharmaceuticals, Inc. First Received on October 6, 2010. ... Further study details as provided by Vitae Pharmaceuticals, Inc. ...
Boehringer Ingelheim: Privacy Has its Virtues - IN VIVO BI and Vitae partner on 11beta-HSD1 inhibitors for diabetes, Deal 10/1/2007 ... European Pharmaceutical Companies Patent Expirations Pharmaceutical Profits R&D ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
June | 2010 | Silico Research Vitae Pharmaceuticals has announced that it has earned a $14 million ... GW Pharmaceuticals has announced that it has signed a three year extension to ...
Anchen Pharmaceuticals, Inc - Irvine, California (CA ... Anchen Pharmaceuticals, Inc company profile in Irvine, CA. Our free company profile report for Anchen Pharmaceuticals, Inc includes business information ...
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Vitae Pharmaceuticals is new name of Concurrent ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals is new name of Concurrent ...
Oligopeptides - Data on oligopeptides described by ... Data on oligopeptides described by researchers at Vitae Pharmaceuticals ... For additional information, contact G. Wu, Vitae Pharmaceuticals, 502 West Office Center Drive, Fort ...
Venrock Vitae Pharmaceuticals. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient ...
Boehringer, Vitae ink $242 mln Alzheimer's deal | Reuters Boehringer, Vitae ink $242 mln Alzheimer's deal. Tweet. Share this ... biotech company Vitae Pharmaceuticals to research and develop new Alzheimer's drugs, the ...
Vitae Pharma | Lowongan kerja | Bursa cari pekerjaan Vitae Pharmaceuticals is a clinical stage biopharmaceutical company ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio ...
VITAE REPORTS POSITIVE CLINICAL DATA IN CHRONIC KIDNEY ... Vitae Pharmaceuticals today announced results of a Phase I clinical study in healthy volunteers demonstrating the Company s lead compound VTP 27999 ...
positions offered - PIPLA In-house Patent Attorney - Vitae Pharmaceuticals. posted May 19, 2011 7:15 PM by Bill ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a ...
Vitae begins hypertension drug study | Philadelphia Business ... Vitae Pharmaceuticals Inc. initiated a phase-I clinical trial Monday ... Vitae's phase-I study will evaluate the safety of the drug in a small group of health ...
In-house Patent Attorney - Vitae Pharmaceuticals - PIPLA Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
CiNii Article - Cloning, Characterization and Site-Directed ... Department of Discovery Biology, Vitae Pharmaceuticals Inc. ... Vitae Pharmaceuticals Inc. PANEMANGALORE Reshma. Department of Discovery Biology, Vitae ...
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Business Directory | Neurology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Related Business News - Boehringer, Vitae partner on ... German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the potential to slow or even ...
Novartis' Christine Brennan joins Vitae | InPharm US biopharmaceutical company Vitae Pharmaceuticals has appointed Christine Brennan chief business officer. ... Vitae's chief executive Jeffrey Hatfield commented: "We are very ...
Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Pipeline - Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Vitae Pharmaceuticals, Inc. company research & investing information. Find executives and the latest company news.
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing of the active pharmaceutical ingredient ...
Vitae Pharmaceuticals | Atlas Venture Vitae Pharmaceuticals is leveraging a proprietary drug discovery platform to develop therapies in cardiovascular, neurological and metabolic diseases. ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... News for Medical Sales & Marketing professionals and Independent Sales Representatives: Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
Pennsylvania Bio - Vitae Pharmaceuticals Secures $13 Million ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
PHARMA : SARB PHARMACEUTICALS Curabitur tortor ante, condimentum vitae molestie eu, sollicitudin a orci. ... "Our vision is to be a leading pharmaceutical company in India and to become a ...
Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ... Vitae Pharmaceuticals is an emerging pharmaceutical company with a ...
Companies: Vitae Pharmaceuticals Vitae Pharmaceuticals: In January 2005, Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, announced its new corporate branding to clearly ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced the company’s novel, clinical-stage renin inhi
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
Vitae's Debt Financing: Crucial Lifeline in a Tightening ... Start-Up -- Roughly one week after GlaxoSmithKline gave Vitae Pharmaceuticals back rights to its renin inhibitor, the biotech signed a $13 million ...
Catherine Bryson | LinkedIn Vitae Pharmaceuticals. Privately Held; Pharmaceuticals industry. January 2009 – Present (2 ... Public Company; 10,001+ employees; BMY; Pharmaceuticals industry ...
Vitae receives 11Beta-HSD-1 program milestone payment from ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned an $8 million milestone payment from ...
NuRx Pharmaceuticals, Inc: Private Company Information ... NuRx Pharmaceuticals, Inc company research & investing information. Find executives and the latest company news. ... It has a license agreement with Vitae Pharmaceuticals, Inc. ...
Steve Lotesta | LinkedIn View Steve Lotesta's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Steve Lotesta discover inside ...
Oxford Finance LLC - Press Releases Vitae Pharmaceuticals Secures $13 Million in Debt Financing. 9/16/08. Oxford Finance ... Somaxon Pharmaceuticals Secures up to $65 Million in Financing ...
Boehringer Ingelheim And Vitae Pharmaceuticals Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have entered into a significant worldwide collaboration to research and develop beta ...
Prospect Venture Partners :: News Archives 2009 Vitae Pharmaceuticals. June 15, 2009 - Boehringer Ingelheim and Vitae Pharmaceuticals ... February 12, 2009 - Portola Pharmaceuticals Enters Worldwide License Agreement for ...
Creative and Changing Deal Structures | Pennsylvania Bio Mr. Hatfield is the president and chief executive officer of Vitae Pharmaceuticals, Inc. ... Prior to joining Vitae, Mr. Hatfield spent nearly 20 years at Bristol ...
Vitae Pharma | Lowongan kerja | Bursa cari pekerjaan Vitae Pharmaceuticals is a clinical stage biopharmaceutical company ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio ...
Vitae Pharmaceuticals | Neurology Sites: CardiologyOncologyRespiratoryEndocrineNeurologyGastroenterology featured_supplier: not featured supplierSupplier Type: Pharmaceutical ...
Vitae Pharmaceuticals gets $13M in financing | Philadelphia ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals gets $13M in financing ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
June | 2010 | Silico Research Vitae Pharmaceuticals has announced that it has earned a $14 million ... GW Pharmaceuticals has announced that it has signed a three year extension to ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Direct Renin Inhibition and the Kidney - Full Text View ... Verified on October 2010 by Vitae Pharmaceuticals, Inc. First Received on October 6, 2010. ... Further study details as provided by Vitae Pharmaceuticals, Inc. ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Pharmaceuticals, Inc., an integrated discovery and development company, announced that it has initiated a Phase 1 clinical trial of its novel ...
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Second Collaboration With Boehringer Provides Extended Cash ... Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae on The Pink Sheet DAILY, Jun-15-2009
Anchen Pharmaceuticals, Inc - Irvine, California (CA ... Anchen Pharmaceuticals, Inc company profile in Irvine, CA. Our free company profile report for Anchen Pharmaceuticals, Inc includes business information ...
Venrock Vitae Pharmaceuticals. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient ...
Vitae Pharmaceuticals is new name of Concurrent ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals is new name of Concurrent ...
connectingSF™ - Helping the life science community to meet in ... ActiveSite Pharmaceuticals, Inc. United States. CEO. Addison Whitney. United States ... Vitae Pharmaceuticals. United States. Chief Business Officer. Vivozon ...
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
positions offered - PIPLA In-house Patent Attorney - Vitae Pharmaceuticals. posted May 19, 2011 7:15 PM by Bill ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a ...
Oligopeptides - Data on oligopeptides described by ... Data on oligopeptides described by researchers at Vitae Pharmaceuticals ... For additional information, contact G. Wu, Vitae Pharmaceuticals, 502 West Office Center Drive, Fort ...
In-house Patent Attorney - Vitae Pharmaceuticals - PIPLA Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
CiNii Article - Cloning, Characterization and Site-Directed ... Department of Discovery Biology, Vitae Pharmaceuticals Inc. ... Vitae Pharmaceuticals Inc. PANEMANGALORE Reshma. Department of Discovery Biology, Vitae ...
Boehringer, Vitae ink $242 mln Alzheimer's deal | Reuters Boehringer, Vitae ink $242 mln Alzheimer's deal. Tweet. Share this ... biotech company Vitae Pharmaceuticals to research and develop new Alzheimer's drugs, the ...
Novartis' Christine Brennan joins Vitae | InPharm US biopharmaceutical company Vitae Pharmaceuticals has appointed Christine Brennan chief business officer. ... Vitae's chief executive Jeffrey Hatfield commented: "We are very ...
Diabetes Vitae Pharmaceuticals Receives $14 Million Milesto... Servier : Launch of IMIDIA, an ... said, "We are delighted to invest in Diartis Pharmaceuticals Pharmaceuticals. ...
Business Directory | Neurology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Pipeline - Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Vitae Pharmaceuticals, Inc. company research & investing information. Find executives and the latest company news.
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
Vitae Pharmaceuticals | LinkedIn Welcome to the company profile of Vitae Pharmaceuticals on LinkedIn. Vitae Pharmaceuticals, Inc., a pharmaceutical company, engages in discovering, developing, and...
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing of the active pharmaceutical ingredient ...
Vitae Pharmaceuticals | Atlas Venture Vitae Pharmaceuticals is leveraging a proprietary drug discovery platform to develop therapies in cardiovascular, neurological and metabolic diseases. ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... News for Medical Sales & Marketing professionals and Independent Sales Representatives: Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Pennsylvania Bio - Vitae Pharmaceuticals Secures $13 Million ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
PHARMA : SARB PHARMACEUTICALS Curabitur tortor ante, condimentum vitae molestie eu, sollicitudin a orci. ... "Our vision is to be a leading pharmaceutical company in India and to become a ...
Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ... Vitae Pharmaceuticals is an emerging pharmaceutical company with a ...
Companies: Vitae Pharmaceuticals Vitae Pharmaceuticals: In January 2005, Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, announced its new corporate branding to clearly ...
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
Vitae's Debt Financing: Crucial Lifeline in a Tightening ... Start-Up -- Roughly one week after GlaxoSmithKline gave Vitae Pharmaceuticals back rights to its renin inhibitor, the biotech signed a $13 million ...
German drugmaker Boehringer to partner with Vitae to develop ... TRENTON, N.J. — German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the ...
NuRx Pharmaceuticals, Inc: Private Company Information ... NuRx Pharmaceuticals, Inc company research & investing information. Find executives and the latest company news. ... It has a license agreement with Vitae Pharmaceuticals, Inc. ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Pharmaceuticals, Inc., an integrated discovery and development company, announced that it has initiated a Phase 1 clinical trial of its novel ...
Steve Lotesta | LinkedIn View Steve Lotesta's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Steve Lotesta discover inside ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced the company’s novel, clinical-stage renin inhi
Oxford Finance LLC - Press Releases Vitae Pharmaceuticals Secures $13 Million in Debt Financing. 9/16/08. Oxford Finance ... Somaxon Pharmaceuticals Secures up to $65 Million in Financing ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
Vitae Pharmaceuticals | Neurology Sites: CardiologyOncologyRespiratoryEndocrineNeurologyGastroenterology featured_supplier: not featured supplierSupplier Type: Pharmaceutical ...
Creative and Changing Deal Structures | Pennsylvania Bio Mr. Hatfield is the president and chief executive officer of Vitae Pharmaceuticals, Inc. ... Prior to joining Vitae, Mr. Hatfield spent nearly 20 years at Bristol ...
Vitae Pharmaceuticals gets $13M in financing | Philadelphia ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals gets $13M in financing ...
Vitae receives 11Beta-HSD-1 program milestone payment from ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned an $8 million milestone payment from ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Direct Renin Inhibition and the Kidney - Full Text View ... Verified on October 2010 by Vitae Pharmaceuticals, Inc. First Received on October 6, 2010. ... Further study details as provided by Vitae Pharmaceuticals, Inc. ...
Boehringer, Vitae ink $242 mln Alzheimer's deal | Reuters Boehringer, Vitae ink $242 mln Alzheimer's deal. Tweet. Share this ... biotech company Vitae Pharmaceuticals to research and develop new Alzheimer's drugs, the ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Second Collaboration With Boehringer Provides Extended Cash ... Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae on The Pink Sheet DAILY, Jun-15-2009
Vitae Pharmaceuticals is new name of Concurrent ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals is new name of Concurrent ...
Anchen Pharmaceuticals, Inc - Irvine, California (CA ... Anchen Pharmaceuticals, Inc company profile in Irvine, CA. Our free company profile report for Anchen Pharmaceuticals, Inc includes business information ...
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
June | 2010 | Silico Research Vitae Pharmaceuticals has announced that it has earned a $14 million ... GW Pharmaceuticals has announced that it has signed a three year extension to ...
Venrock Vitae Pharmaceuticals. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient ...
Vitae Ph Search Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer. ... Vitae Pharmaceuticals, Inc. ( formerly Concurrent Pharmaceuticals)-Detailed Product ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Oligopeptides - Data on oligopeptides described by ... Data on oligopeptides described by researchers at Vitae Pharmaceuticals ... For additional information, contact G. Wu, Vitae Pharmaceuticals, 502 West Office Center Drive, Fort ...
CiNii Article - Cloning, Characterization and Site-Directed ... Department of Discovery Biology, Vitae Pharmaceuticals Inc. ... Vitae Pharmaceuticals Inc. PANEMANGALORE Reshma. Department of Discovery Biology, Vitae ...
Vertex Pharmaceuticals Inc (VRTX.O) People | Reuters.com Business news & Financial news from Reuters.com. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Boehringer Ingelheim and Vitae Pharmaceuticals announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to research and develop novel treatments for Alzheimer`s disease. Tweet ...
Related Business News - Boehringer, Vitae partner on ... German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the potential to slow or even ...
Jan. 5, 2005 Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, has announced its ... Nereus Pharmaceuticals, a pioneer in drug discovery and development from marine ...
All Headlines - Alzheimer's News - Eqentia Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Vitae Pharmaceuticals, ... ( Vitae Pharmaceuticals) is a development stage pharmaceutical company ...
Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Pipeline - Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Vitae Pharmaceuticals, Inc. company research & investing information. Find executives and the latest company news.
Vitae Pharmaceuticals | LinkedIn Welcome to the company profile of Vitae Pharmaceuticals on LinkedIn. Vitae Pharmaceuticals, Inc., a pharmaceutical company, engages in discovering, developing, and...
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing of the active pharmaceutical ingredient ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... News for Medical Sales & Marketing professionals and Independent Sales Representatives: Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
Vitae Pharmaceuticals | Atlas Venture Vitae Pharmaceuticals is leveraging a proprietary drug discovery platform to develop therapies in cardiovascular, neurological and metabolic diseases. ...
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Pennsylvania Bio - Vitae Pharmaceuticals Secures $13 Million ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ... Vitae Pharmaceuticals is an emerging pharmaceutical company with a ...
Companies: Vitae Pharmaceuticals Vitae Pharmaceuticals: In January 2005, Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, announced its new corporate branding to clearly ...
Vitae's Debt Financing: Crucial Lifeline in a Tightening ... Start-Up -- Roughly one week after GlaxoSmithKline gave Vitae Pharmaceuticals back rights to its renin inhibitor, the biotech signed a $13 million ...
German drugmaker Boehringer to partner with Vitae to develop ... TRENTON, N.J. — German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the ...
Oxford Finance Corporation - Press Releases Vitae Pharmaceuticals Secures $13 Million in Debt Financing. 9/16/08. Oxford Finance ... Somaxon Pharmaceuticals Secures up to $65 Million in Financing ...
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Pharmaceuticals, Inc., an integrated discovery and development company, announced that it has initiated a Phase 1 clinical trial of its novel ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced the company’s novel, clinical-stage renin inhi
Vitae Pharmaceuticals | Neurology Sites: CardiologyOncologyRespiratoryEndocrineNeurologyGastroenterology featured_supplier: not featured supplierSupplier Type: Pharmaceutical ...
PHARMA : SARB PHARMACEUTICALS Curabitur tortor ante, condimentum vitae molestie eu, sollicitudin a orci. ... "Our vision is to be a leading pharmaceutical company in India and to become a ...
Vitae receives 11Beta-HSD-1 program milestone payment from ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned an $8 million milestone payment from ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
Creative and Changing Deal Structures | Pennsylvania Bio Mr. Hatfield is the president and chief executive officer of Vitae Pharmaceuticals, Inc. ... Prior to joining Vitae, Mr. Hatfield spent nearly 20 years at Bristol ...
Vitae Pharmaceuticals gets $13M in financing | Philadelphia ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals gets $13M in financing ...
NuRx Pharmaceuticals, Inc: Private Company Information ... NuRx Pharmaceuticals, Inc company research & investing information. Find executives and the latest company news. ... It has a license agreement with Vitae Pharmaceuticals, Inc. ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Healthcare Sales & Marketing Network: AlloCure Appoints Kevin ... News for Medical Sales & Marketing professionals and Independent Sales Representatives: AlloCure Appoints Kevin J. Heyeck as Chief Business Officer
Direct Renin Inhibition and the Kidney - Full Text View ... Verified on October 2010 by Vitae Pharmaceuticals, Inc. First Received on October 6, 2010. ... Further study details as provided by Vitae Pharmaceuticals, Inc. ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Second Collaboration With Boehringer Provides Extended Cash ... Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae on The Pink Sheet DAILY, Jun-15-2009
Vitae Ph Search { Businesswire via BioPortfolio} Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer ...
Vitae Pharmaceuticals is new name of Concurrent ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals is new name of Concurrent ...
June | 2010 | Silico Research Vitae Pharmaceuticals has announced that it has earned a $14 million ... GW Pharmaceuticals has announced that it has signed a three year extension to ...
Venrock Vitae Pharmaceuticals. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient ...
Titan Pharmaceuticals Inc - Executive and Business Contacts ... Contacts at Titan Pharmaceuticals Inc, part of Biotechnology industry in South San Francisco, CA
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Alex Howarth | LinkedIn Chief Business Officer at Vitae Pharmaceuticals. Head, Venture Partnerships, Worldwide ... Extensive network in pharmaceutical industry across big pharma, mid-size pharma, spec ...
Oligopeptides - Data on oligopeptides described by ... Data on oligopeptides described by researchers at Vitae Pharmaceuticals ... For additional information, contact G. Wu, Vitae Pharmaceuticals, 502 West Office Center Drive, Fort ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
Anchen Pharmaceuticals, Inc - Irvine, California (CA ... Anchen Pharmaceuticals, Inc company profile in Irvine, CA. Our free company profile report for Anchen Pharmaceuticals, Inc includes business information ...
Boehringer, Vitae ink $242 mln Alzheimer's deal | Reuters Boehringer, Vitae ink $242 mln Alzheimer's deal. Tweet. Share this ... biotech company Vitae Pharmaceuticals to research and develop new Alzheimer's drugs, the ...
CiNii Article - Cloning, Characterization and Site-Directed ... Department of Discovery Biology, Vitae Pharmaceuticals Inc. ... Vitae Pharmaceuticals Inc. PANEMANGALORE Reshma. Department of Discovery Biology, Vitae ...
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Boehringer Ingelheim and Vitae Pharmaceuticals announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to research and develop novel treatments for Alzheimer`s disease. Tweet ...
Vertex Pharmaceuticals Inc (VRTX.O) People | Reuters.com Dr. Cordes was the Chairman of Vitae Pharmaceuticals, Inc. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy ...
Business Directory | Neurology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Pipeline - Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Vitae Pharmaceuticals, Inc. company research & investing information. Find executives and the latest company news.
Vitae Pharmaceuticals | LinkedIn Welcome to the company profile of Vitae Pharmaceuticals on LinkedIn. Vitae Pharmaceuticals, Inc., a pharmaceutical company, engages in discovering, developing, and...
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... News for Medical Sales & Marketing professionals and Independent Sales Representatives: Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing of the active pharmaceutical ingredient ...
Vitae Pharmaceuticals | Atlas Venture Vitae Pharmaceuticals is leveraging a proprietary drug discovery platform to develop therapies in cardiovascular, neurological and metabolic diseases. ...
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Pennsylvania Bio - Vitae Pharmaceuticals Secures $13 Million ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ... Vitae Pharmaceuticals is an emerging pharmaceutical company with a ...
Companies: Vitae Pharmaceuticals Vitae Pharmaceuticals: In January 2005, Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, announced its new corporate branding to clearly ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced the company’s novel, clinical-stage renin inhi
Vitae's Debt Financing: Crucial Lifeline in a Tightening ... Start-Up -- Roughly one week after GlaxoSmithKline gave Vitae Pharmaceuticals back rights to its renin inhibitor, the biotech signed a $13 million ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
PHARMA : SARB PHARMACEUTICALS Curabitur tortor ante, condimentum vitae molestie eu, sollicitudin a orci. ... "Our vision is to be a leading pharmaceutical company in India and to become a ...
NuRx Pharmaceuticals, Inc: Private Company Information ... NuRx Pharmaceuticals, Inc company research & investing information. Find executives and the latest company news. ... It has a license agreement with Vitae Pharmaceuticals, Inc. ...
Boehringer, Vitae ink $242 mln Alzheimer's deal | Reuters Boehringer, Vitae ink $242 mln Alzheimer's deal. Tweet. Share this ... biotech company Vitae Pharmaceuticals to research and develop new Alzheimer's drugs, the ...
Catherine Bryson | LinkedIn Vitae Pharmaceuticals. Privately Held; Pharmaceuticals industry. January 2009 – Present (2 ... Public Company; 10,001+ employees; BMY; Pharmaceuticals industry ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Pharmaceuticals, Inc., an integrated discovery and development company, announced that it has initiated a Phase 1 clinical trial of its novel ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
Creative and Changing Deal Structures | Pennsylvania Bio Mr. Hatfield is the president and chief executive officer of Vitae Pharmaceuticals, Inc. ... Prior to joining Vitae, Mr. Hatfield spent nearly 20 years at Bristol ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Vitae earns $14M milestone payment from Boehringer Ingelheim Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone ...
Direct Renin Inhibition and the Kidney - Full Text View ... Verified on October 2010 by Vitae Pharmaceuticals, Inc. First Received on October 6, 2010. ... Further study details as provided by Vitae Pharmaceuticals, Inc. ...
Vitae Pharmaceuticals | Neurology Sites: CardiologyOncologyRespiratoryEndocrineNeurologyGastroenterology featured_supplier: not featured supplierSupplier Type: Pharmaceutical ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Second Collaboration With Boehringer Provides Extended Cash ... Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae on The Pink Sheet DAILY, Jun-15-2009
Vitae Pharmaceuticals is new name of Concurrent ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals is new name of Concurrent ...
Venrock Vitae Pharmaceuticals. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient ...
June | 2010 | Silico Research Vitae Pharmaceuticals has announced that it has earned a $14 million ... GW Pharmaceuticals has announced that it has signed a three year extension to ...
Titan Pharmaceuticals Inc - Executive and Business Contacts ... Contacts at Titan Pharmaceuticals Inc, part of Biotechnology industry in South San Francisco, CA
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Vitae Ph Search { Businesswire via BioPortfolio} Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company with two compounds ...
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Oligopeptides - Data on oligopeptides described by ... Data on oligopeptides described by researchers at Vitae Pharmaceuticals ... For additional information, contact G. Wu, Vitae Pharmaceuticals, 502 West Office Center Drive, Fort ...
Vitae begins hypertension drug study | Philadelphia Business ... Vitae Pharmaceuticals Inc. initiated a phase-I clinical trial Monday ... Vitae's phase-I study will evaluate the safety of the drug in a small group of health ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
Anchen Pharmaceuticals, Inc - Irvine, California (CA ... Anchen Pharmaceuticals, Inc company profile in Irvine, CA. Our free company profile report for Anchen Pharmaceuticals, Inc includes business information ...
Boehringer Ingelheim and Vitae Pharmaceuticals announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to research and develop novel treatments for Alzheimer`s disease. Tweet ...
A Healthy Dose of Funding for Pharma, Biotech - Seeking Alpha Watson Pharmaceuticals (WPI) entered into a definitive agreement to acquire ... diabetes and metabolic syndrome, Vitae Pharmaceuticals entered into a worldwide ...
ADERIS Pharmaceuticals Inc - Executive and Business Contacts ... Contacts at ADERIS Pharmaceuticals Inc, part of Biotechnology industry in Hopkinton, MA
Novartis' Christine Brennan joins Vitae | InPharm US biopharmaceutical company Vitae Pharmaceuticals has appointed Christine Brennan chief business officer. ... Vitae's chief executive Jeffrey Hatfield commented: "We are very ...
CiNii Article - Cloning, Characterization and Site-Directed ... Department of Discovery Biology, Vitae Pharmaceuticals Inc. ... Vitae Pharmaceuticals Inc. PANEMANGALORE Reshma. Department of Discovery Biology, Vitae ...
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Related Business News - Boehringer, Vitae partner on ... German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the potential to slow or even ...
Vitae Pharmaceuticals And Boehringer Ingelheim Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
Jan. 5, 2005 Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, has announced its ... Nereus Pharmaceuticals, a pioneer in drug discovery and development from marine ...
Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Pipeline - Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Vitae Pharmaceuticals, Inc. company research & investing information. Find executives and the latest company news.
Vitae Pharmaceuticals | LinkedIn Welcome to the company profile of Vitae Pharmaceuticals on LinkedIn. Vitae Pharmaceuticals, Inc., a pharmaceutical company, engages in discovering, developing, and...
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Vitae Pharmaceuticals | Atlas Venture Vitae Pharmaceuticals is leveraging a proprietary drug discovery platform to develop therapies in cardiovascular, neurological and metabolic diseases. ...
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing of the active pharmaceutical ingredient ...
Pennsylvania Bio - Vitae Pharmaceuticals Secures $13 Million ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ... Vitae Pharmaceuticals is an emerging pharmaceutical company with a ...
Companies: Vitae Pharmaceuticals Vitae Pharmaceuticals: In January 2005, Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, announced its new corporate branding to clearly ...
Vitae's Debt Financing: Crucial Lifeline in a Tightening ... Start-Up -- Roughly one week after GlaxoSmithKline gave Vitae Pharmaceuticals back rights to its renin inhibitor, the biotech signed a $13 million ...
German drugmaker Boehringer to partner with Vitae to develop ... TRENTON, N.J. — German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the ...
Vitae Pharmaceuticals gets $13M in financing | Philadelphia ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals gets $13M in financing ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Pharmaceuticals, Inc., an integrated discovery and development company, announced that it has initiated a Phase 1 clinical trial of its novel ...
Vitae receives 11Beta-HSD-1 program milestone payment from ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned an $8 million milestone payment from ...
Healthcare Sales & Marketing Network: AlloCure Appoints Kevin ... AlloCure Appoints Kevin J. Heyeck as Chief Business Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Boehringer, Vitae ink $242 mln Alzheimer's deal | Reuters * $42 mln upfront, $200 mln pre-commercial milestones * Collaboration covers beta-secretase inhibitors LONDON, June 15 (Reuters) - Germany's Boehringer Ingelheimhas ...
PHARMA : SARB PHARMACEUTICALS Curabitur tortor ante, condimentum vitae molestie eu, sollicitudin a orci. ... "Our vision is to be a leading pharmaceutical company in India and to become a ...
NuRx Pharmaceuticals, Inc: Private Company Information ... NuRx Pharmaceuticals, Inc company research & investing information. Find executives and the latest company news. ... It has a license agreement with Vitae Pharmaceuticals, Inc. ...
Ya-jun Zheng | LinkedIn View Ya-jun Zheng's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Ya-jun Zheng discover inside ...
Vitae earns $14M milestone payment from Boehringer Ingelheim Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone ...
Creative and Changing Deal Structures | Pennsylvania Bio Mr. Hatfield is the president and chief executive officer of Vitae Pharmaceuticals, Inc. ... Prior to joining Vitae, Mr. Hatfield spent nearly 20 years at Bristol ...
Direct Renin Inhibition and the Kidney - Full Text View ... Verified on October 2010 by Vitae Pharmaceuticals, Inc. First Received on October 6, 2010. ... Further study details as provided by Vitae Pharmaceuticals, Inc. ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Vitae Pharmaceuticals | Neurology Sites: CardiologyOncologyRespiratoryEndocrineNeurologyGastroenterology featured_supplier: not featured supplierSupplier Type: Pharmaceutical ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Second Collaboration With Boehringer Provides Extended Cash ... Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae on The Pink Sheet DAILY, Jun-15-2009
Venrock Vitae Pharmaceuticals. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient ...
June | 2010 | Silico Research Vitae Pharmaceuticals has announced that it has earned a $14 million ... GW Pharmaceuticals has announced that it has signed a three year extension to ...
Vitae Pharmaceuticals is new name of Concurrent ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals is new name of Concurrent ...
Titan Pharmaceuticals Inc - Executive and Business Contacts ... Contacts at Titan Pharmaceuticals Inc, part of Biotechnology industry in South San Francisco, CA
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Vitae Ph Search { Businesswire via BioPortfolio} Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company with two compounds ...
Oligopeptides - Data on oligopeptides described by ... Data on oligopeptides described by researchers at Vitae Pharmaceuticals ... For additional information, contact G. Wu, Vitae Pharmaceuticals, 502 West Office Center Drive, Fort ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
Anchen Pharmaceuticals, Inc - Irvine, California (CA ... Anchen Pharmaceuticals, Inc company profile in Irvine, CA. Our free company profile report for Anchen Pharmaceuticals, Inc includes business information ...
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Boehringer Ingelheim and Vitae Pharmaceuticals announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to research and develop novel treatments for Alzheimer`s disease. Tweet ...
ADERIS Pharmaceuticals Inc - Executive and Business Contacts ... Contacts at ADERIS Pharmaceuticals Inc, part of Biotechnology industry in Hopkinton, MA
AlacraStore.com - BEXIMCO PHARMACEUTICALS Beximco Pharmaceuticals Limited is a manufacturer of pharmaceutical formulations and ... Vitae Pharmaceuticals, Inc. ( formerly Concurrent Pharmaceuticals) ...
Novartis' Christine Brennan joins Vitae | InPharm US biopharmaceutical company Vitae Pharmaceuticals has appointed Christine Brennan chief business officer. ... Vitae's chief executive Jeffrey Hatfield commented: "We are very ...
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
at Thomson West Current board memberships include Amicus Therapeutics (NASDAQ: FOLD), Intarcia, ... with 23andMe, Trine Pharmaceuticals, Liquidia, and Vitae Pharmaceuticals. ...
Related Business News - Boehringer, Vitae partner on ... German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the potential to slow or even ...
Vitae Pharmaceuticals And Boehringer Ingelheim Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Pipeline - Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Vitae Pharmaceuticals, Inc. company research & investing information. Find executives and the latest company news.
VITAE - Vitae Pharmaceuticals Vitae pharmaceuticals, inc. is a private company and located in PA, United States. Address: 502 w office center dr, PA, 190343260, Fort washington United States ...
Vitae Pharmaceuticals | LinkedIn Welcome to the company profile of Vitae Pharmaceuticals on LinkedIn. Vitae Pharmaceuticals, Inc., a pharmaceutical company, engages in discovering, developing, and...
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Vitae Pharmaceuticals | Atlas Venture Vitae Pharmaceuticals is leveraging a proprietary drug discovery platform to develop therapies in cardiovascular, neurological and metabolic diseases. ...
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing of the active pharmaceutical ingredient ...
Pennsylvania Bio - Vitae Pharmaceuticals Secures $13 Million ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ... Vitae Pharmaceuticals is an emerging pharmaceutical company with a ...
Companies: Vitae Pharmaceuticals Vitae Pharmaceuticals: In January 2005, Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, announced its new corporate branding to clearly ...
Vitae's Debt Financing: Crucial Lifeline in a Tightening ... Start-Up -- Roughly one week after GlaxoSmithKline gave Vitae Pharmaceuticals back rights to its renin inhibitor, the biotech signed a $13 million ...
Vitae receives 11Beta-HSD-1 program milestone payment from ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned an $8 million milestone payment from ...
Vitae Pharmaceuticals gets $13M in financing | Philadelphia ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals gets $13M in financing ...
German drugmaker Boehringer to partner with Vitae to develop ... TRENTON, N.J. — German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the ...
PHARMA : SARB PHARMACEUTICALS Curabitur tortor ante, condimentum vitae molestie eu, sollicitudin a orci. ... "Our vision is to be a leading pharmaceutical company in India and to become a ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Kerri Lipinski | LinkedIn View Kerri Lipinski's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Kerri Lipinski discover inside ...
NuRx Pharmaceuticals, Inc: Private Company Information ... NuRx Pharmaceuticals, Inc company research & investing information. Find executives and the latest company news. ... It has a license agreement with Vitae Pharmaceuticals, Inc. ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Pharmaceuticals, Inc., an integrated discovery and development company, announced that it has initiated a Phase 1 clinical trial of its novel ...
vitae pharma | Lowongan kerja | Bursa cari pekerjaan Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have entered into a significant worldwide collaboration to research ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced the company’s novel, clinical-stage renin inhi
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... FORT WASHINGTON, Pa. - (Business Wire) Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned ...
Creative and Changing Deal Structures | Pennsylvania Bio Mr. Hatfield is the president and chief executive officer of Vitae Pharmaceuticals, Inc. ... Prior to joining Vitae, Mr. Hatfield spent nearly 20 years at Bristol ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Vitae earns $14M milestone payment from Boehringer Ingelheim Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone ...
Direct Renin Inhibition and the Kidney - Full Text View ... Further study details as provided by Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals, Inc. ( Richard Gregg, MD, Chief Scientific Officer ) ...
Biotechnology - AlloCure Appoints Kevin J. Heyeck as Chief ... NewsRx is the leading source of news and information on Biotechnology ... led business development efforts at Vitae Pharmaceuticals, and before that, Pharmacopeia. ...
Vitae Pharmaceuticals | Neurology Sites: CardiologyOncologyRespiratoryEndocrineNeurologyGastroenterology featured_supplier: not featured supplierSupplier Type: Pharmaceutical ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Second Collaboration With Boehringer Provides Extended Cash ... Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae on The Pink Sheet DAILY, Jun-15-2009
Vitae Pharmaceuticals is new name of Concurrent ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals is new name of Concurrent ...
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Boehringer, Vitae ink $242 mln Alzheimer's deal | Reuters * $42 mln upfront, $200 mln pre-commercial milestones * Collaboration covers beta-secretase inhibitors LONDON, June 15 (Reuters) - Germany's Boehringer Ingelheimhas ...
June | 2010 | Silico Research Vitae Pharmaceuticals has announced that it has earned a $14 million ... GW Pharmaceuticals has announced that it has signed a three year extension to ...
Venrock Vitae Pharmaceuticals. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient ...
Titan Pharmaceuticals Inc - Executive and Business Contacts ... Contacts at Titan Pharmaceuticals Inc, part of Biotechnology industry in South San Francisco, CA
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Anchen Pharmaceuticals, Inc - Irvine, California (CA ... Anchen Pharmaceuticals, Inc company profile in Irvine, CA. Our free company profile report for Anchen Pharmaceuticals, Inc includes business information ...
AlloCure Appoints Kevin J. Heyeck as Chief Business Officer ... AlloCure Inc., a biotechnology company developing innovative therapies for the treatment of kidney disease, today announced the appointment of Kevin J
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
Related Business News - Boehringer, Vitae partner on ... German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the potential to slow or even ...
Boehringer Ingelheim and Vitae Pharmaceuticals announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to research and develop novel treatments for Alzheimer`s disease. Tweet ...
Oligopeptides - Data on oligopeptides described by ... Data on oligopeptides described by researchers at Vitae Pharmaceuticals ... For additional information, contact G. Wu, Vitae Pharmaceuticals, 502 West Office Center Drive, Fort ...
Novartis' Christine Brennan joins Vitae | InPharm US biopharmaceutical company Vitae Pharmaceuticals has appointed Christine Brennan chief business officer. ... Vitae's chief executive Jeffrey Hatfield commented: "We are very ...
at Thomson West Current board memberships include Amicus Therapeutics (NASDAQ: FOLD), Intarcia, ... with 23andMe, Trine Pharmaceuticals, Liquidia, and Vitae Pharmaceuticals. ...
Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Pipeline - Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Vitae Pharmaceuticals, Inc. company research & investing information. Find executives and the latest company news.
VITAE - Vitae Pharmaceuticals Vitae pharmaceuticals, inc. is a private company and located in PA, United States. Address: 502 w office center dr, PA, 190343260, Fort washington United States ...
Vitae Pharmaceuticals | LinkedIn Welcome to the company profile of Vitae Pharmaceuticals on LinkedIn. Vitae Pharmaceuticals, Inc., a pharmaceutical company, engages in discovering, developing, and...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Vitae Pharmaceuticals | Atlas Venture Vitae Pharmaceuticals is leveraging a proprietary drug discovery platform to develop therapies in cardiovascular, neurological and metabolic diseases. ...
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing of the active pharmaceutical ingredient ...
Pennsylvania Bio - Vitae Pharmaceuticals Secures $13 Million ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ... Vitae Pharmaceuticals is an emerging pharmaceutical company with a ...
Companies: Vitae Pharmaceuticals Vitae Pharmaceuticals: In January 2005, Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, announced its new corporate branding to clearly ...
NuRx Pharmaceuticals, Inc: Private Company Information ... NuRx Pharmaceuticals, Inc company research & investing information. Find executives and the latest company news. ... It has a license agreement with Vitae Pharmaceuticals, Inc. ...
Vitae's Debt Financing: Crucial Lifeline in a Tightening ... Start-Up -- Roughly one week after GlaxoSmithKline gave Vitae Pharmaceuticals back rights to its renin inhibitor, the biotech signed a $13 million ...
Vitae Pharmaceuticals gets $13M in financing | Philadelphia ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals gets $13M in financing ...
vitae pharma | Lowongan kerja | Bursa cari pekerjaan vitae pharma ... There must be thousands of people out there connected with the pharmaceutical industry who are interested in starting a blog about pharmaceutical consulting. ...
PHARMA : SARB PHARMACEUTICALS Curabitur tortor ante, condimentum vitae molestie eu, sollicitudin a orci. ... "Our vision is to be a leading pharmaceutical company in India and to become a ...
Healthcare Sales & Marketing Network: AlloCure Appoints Kevin ... AlloCure Appoints Kevin J. Heyeck as Chief Business Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Pharmaceuticals, Inc., an integrated discovery and development company, announced that it has initiated a Phase 1 clinical trial of its novel ...
Kerri Lipinski | LinkedIn View Kerri Lipinski's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Kerri Lipinski discover inside ...
Vitae earns $14M milestone payment from Boehringer Ingelheim Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone ...
Vitae receives 11Beta-HSD-1 program milestone payment from ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned an $8 million milestone payment from ...
Vitae Pharmaceuticals | Neurology Sites: CardiologyOncologyRespiratoryEndocrineNeurologyGastroenterology featured_supplier: not featured supplierSupplier Type: Pharmaceutical ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced the company’s novel, clinical-stage renin inhi
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... FORT WASHINGTON, Pa. - (Business Wire) Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned ...
Creative and Changing Deal Structures | Pennsylvania Bio Mr. Hatfield is the president and chief executive officer of Vitae Pharmaceuticals, Inc. ... Prior to joining Vitae, Mr. Hatfield spent nearly 20 years at Bristol ...
Direct Renin Inhibition and the Kidney - Full Text View ... Further study details as provided by Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals, Inc. ( Richard Gregg, MD, Chief Scientific Officer ) ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Boehringer, Vitae ink $242 mln Alzheimer's deal | Reuters * $42 mln upfront, $200 mln pre-commercial milestones * Collaboration covers beta-secretase inhibitors LONDON, June 15 (Reuters) - Germany's Boehringer Ingelheimhas ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Second Collaboration With Boehringer Provides Extended Cash ... Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae on The Pink Sheet DAILY, Jun-15-2009
Vitae Pharmaceuticals is new name of Concurrent ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals is new name of Concurrent ...
Nereus Pharmaceuticals, Inc. - Executive and Business ... Contacts at Nereus Pharmaceuticals, Inc., part of Biotechnology industry in San Diego, CA
June | 2010 | Silico Research Vitae Pharmaceuticals has announced that it has earned a $14 million ... GW Pharmaceuticals has announced that it has signed a three year extension to ...
Venrock Vitae Pharmaceuticals. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient ...
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Anchen Pharmaceuticals, Inc - Irvine, California (CA ... Anchen Pharmaceuticals, Inc company profile in Irvine, CA. Our free company profile report for Anchen Pharmaceuticals, Inc includes business information ...
Oligopeptides - Data on oligopeptides described by ... Data on oligopeptides described by researchers at Vitae Pharmaceuticals ... For additional information, contact G. Wu, Vitae Pharmaceuticals, 502 West Office Center Drive, Fort ...
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
AlloCure Appoints Kevin J. Heyeck as Chief Business Officer ... AlloCure Inc., a biotechnology company developing innovative therapies for the treatment of kidney disease, today announced the appointment of Kevin J
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
Idera Pharmaceuticals, Inc. - Executive and Business Contacts ... Contacts at Idera Pharmaceuticals, Inc., part of Biotechnology industry in Cambridge, MA
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Boehringer Ingelheim and Vitae Pharmaceuticals announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to research and develop novel treatments for Alzheimer`s disease. Tweet ...
Boehringer Ingelheim And Vitae Pharmaceuticals Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have entered into a significant worldwide collaboration to research and develop beta ...
Novartis' Christine Brennan joins Vitae | InPharm US biopharmaceutical company Vitae Pharmaceuticals has appointed Christine Brennan chief business officer. ... Vitae's chief executive Jeffrey Hatfield commented: "We are very ...
Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Pipeline - Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Vitae Pharmaceuticals, Inc. company research & investing information. Find executives and the latest company news.
VITAE - Vitae Pharmaceuticals Vitae pharmaceuticals, inc. is a private company and located in PA, United States. Address: 502 w office center dr, PA, 190343260, Fort washington United States ...
Vitae Pharmaceuticals | LinkedIn Welcome to the company profile of Vitae Pharmaceuticals on LinkedIn. Vitae Pharmaceuticals, Inc., a pharmaceutical company, engages in discovering, developing, and...
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Vitae Pharmaceuticals | Atlas Venture Vitae Pharmaceuticals is leveraging a proprietary drug discovery platform to develop therapies in cardiovascular, neurological and metabolic diseases. ...
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Pennsylvania Bio - Vitae Pharmaceuticals Secures $13 Million ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing of the active pharmaceutical ingredient ...
Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ... Vitae Pharmaceuticals is an emerging pharmaceutical company with a ...
Companies: Vitae Pharmaceuticals Vitae Pharmaceuticals: In January 2005, Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, announced its new corporate branding to clearly ...
Vitae's Debt Financing: Crucial Lifeline in a Tightening ... Start-Up -- Roughly one week after GlaxoSmithKline gave Vitae Pharmaceuticals back rights to its renin inhibitor, the biotech signed a $13 million ...
Vitae Pharmaceuticals gets $13M in financing | Philadelphia ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals gets $13M in financing ...
Vitae Pharmaceuticals | Neurology Sites: CardiologyOncologyRespiratoryEndocrineNeurologyGastroenterology featured_supplier: not featured supplierSupplier Type: Pharmaceutical ...
Healthcare Sales & Marketing Network: AlloCure Appoints Kevin ... AlloCure Appoints Kevin J. Heyeck as Chief Business Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
NuRx Pharmaceuticals, Inc: Private Company Information ... NuRx Pharmaceuticals, Inc company research & investing information. Find executives and the latest company news. ... It has a license agreement with Vitae Pharmaceuticals, Inc. ...
Kerri Lipinski | LinkedIn View Kerri Lipinski's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Kerri Lipinski discover inside ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... FORT WASHINGTON, Pa. - (Business Wire) Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned ...
Creative and Changing Deal Structures | Pennsylvania Bio Mr. Hatfield is the president and chief executive officer of Vitae Pharmaceuticals, Inc. ... Prior to joining Vitae, Mr. Hatfield spent nearly 20 years at Bristol ...
Boehringer, Vitae ink $242 mln Alzheimer's deal | Reuters * $42 mln upfront, $200 mln pre-commercial milestones * Collaboration covers beta-secretase inhibitors LONDON, June 15 (Reuters) - Germany's Boehringer Ingelheimhas ...
Direct Renin Inhibition and the Kidney - Full Text View ... Further study details as provided by Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals, Inc. ( Richard Gregg, MD, Chief Scientific Officer ) ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Vitae earns $14M milestone payment from Boehringer Ingelheim Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced the company’s novel, clinical-stage renin inhi
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Second Collaboration With Boehringer Provides Extended Cash ... Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae on The Pink Sheet DAILY, Jun-15-2009
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Vitae Pharmaceuticals is new name of Concurrent ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals is new name of Concurrent ...
June | 2010 | Silico Research Vitae Pharmaceuticals has announced that it has earned a $14 million ... GW Pharmaceuticals has announced that it has signed a three year extension to ...
Venrock Vitae Pharmaceuticals. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient ...
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Anchen Pharmaceuticals, Inc - Irvine, California (CA ... Anchen Pharmaceuticals, Inc company profile in Irvine, CA. Our free company profile report for Anchen Pharmaceuticals, Inc includes business information ...
AlloCure Appoints Kevin J. Heyeck as Chief Business Officer ... AlloCure Inc., a biotechnology company developing innovative therapies for the treatment of kidney disease, today announced the appointment of Kevin J
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
RXi Pharmaceuticals - Executive and Business Contacts, Sales ... Contacts at RXi Pharmaceuticals ... Vitae Pharmaceuticals, Inc. Nirvana Pharmaceuticals Inc. Gloucester Pharmaceuticals, Inc. FAMILY FIRST PHARMACEUTICALS, INC ...
Oligopeptides - Data on oligopeptides described by ... Data on oligopeptides described by researchers at Vitae Pharmaceuticals ... For additional information, contact G. Wu, Vitae Pharmaceuticals, 502 West Office Center Drive, Fort ...
Vertex Pharmaceuticals Inc (VRTX.O) People | Reuters.com Business news & Financial news from Reuters.com. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Related Business News - Boehringer, Vitae partner on ... German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the potential to slow or even ...
Boehringer Ingelheim and Vitae Pharmaceuticals announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to research and develop novel treatments for Alzheimer`s disease. Tweet ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
Drug Companies Join Forces Against Alzheimer's | Attorney At Law Boehringer Ingelheim, a German company, and Vitae Pharmaceuticals of Fort Washington, Pa. ... Experiments on laboratory mice have shown that deleting the enzyme can prevent the ...
Novartis' Christine Brennan joins Vitae | InPharm US biopharmaceutical company Vitae Pharmaceuticals has appointed Christine Brennan chief business officer. ... Vitae's chief executive Jeffrey Hatfield commented: "We are very ...
at Thomson West Current board memberships include Amicus Therapeutics (NASDAQ: FOLD), Intarcia, ... with 23andMe, Trine Pharmaceuticals, Liquidia, and Vitae Pharmaceuticals. ...
Diabetes: November 2007 Johnson & Johnson Pharmaceutical Research & Develo... Novo Nordisk : ... Vitae Pharmaceuticals Receives $14 Million Milesto... Servier : Launch of IMIDIA, an ...
Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Pipeline - Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Vitae Pharmaceuticals, Inc. company research & investing information. Find executives and the latest company news.
Vitae Pharmaceuticals | LinkedIn Welcome to the company profile of Vitae Pharmaceuticals on LinkedIn. Vitae Pharmaceuticals, Inc., a pharmaceutical company, engages in discovering, developing, and...
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing of the active pharmaceutical ingredient ...
Vitae Pharmaceuticals | Atlas Venture Vitae Pharmaceuticals is leveraging a proprietary drug discovery platform to develop therapies in cardiovascular, neurological and metabolic diseases. ...
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Pennsylvania Bio - Vitae Pharmaceuticals Secures $13 Million ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ... Vitae Pharmaceuticals is an emerging pharmaceutical company with a ...
Companies: Vitae Pharmaceuticals Vitae Pharmaceuticals: In January 2005, Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, announced its new corporate branding to clearly ...
Vitae Pharmaceuticals | Neurology Sites: CardiologyOncologyRespiratoryEndocrineNeurologyGastroenterology featured_supplier: not featured supplierSupplier Type: Pharmaceutical ...
Vitae's Debt Financing: Crucial Lifeline in a Tightening ... Start-Up -- Roughly one week after GlaxoSmithKline gave Vitae Pharmaceuticals back rights to its renin inhibitor, the biotech signed a $13 million ...
Vitae Pharmaceuticals gets $13M in financing | Philadelphia ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals gets $13M in financing ...
Healthcare Sales & Marketing Network: AlloCure Appoints Kevin ... AlloCure Appoints Kevin J. Heyeck as Chief Business Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
German drugmaker Boehringer to partner with Vitae to develop ... TRENTON, N.J. — German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the ...
NuRx Pharmaceuticals, Inc: Private Company Information ... NuRx Pharmaceuticals, Inc company research & investing information. Find executives and the latest company news. ... It has a license agreement with Vitae Pharmaceuticals, Inc. ...
vitae pharma | Lowongan kerja | Bursa cari pekerjaan Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have ... Vitae Pharmaceuticals, Ft. Washington, borrows $13 million from ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Pharmaceuticals, Inc., an integrated discovery and development company, announced that it has initiated a Phase 1 clinical trial of its novel ...
Kerri Lipinski | LinkedIn View Kerri Lipinski's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Kerri Lipinski discover inside ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... FORT WASHINGTON, Pa. - (Business Wire) Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced the company’s novel, clinical-stage renin inhi
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Creative and Changing Deal Structures | Pennsylvania Bio Mr. Hatfield is the president and chief executive officer of Vitae Pharmaceuticals, Inc. ... Prior to joining Vitae, Mr. Hatfield spent nearly 20 years at Bristol ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Boehringer, Vitae ink $242 mln Alzheimer's deal | Reuters * $42 mln upfront, $200 mln pre-commercial milestones * Collaboration covers beta-secretase inhibitors LONDON, June 15 (Reuters) - Germany's Boehringer Ingelheimhas ...
Direct Renin Inhibition and the Kidney - Full Text View ... Further study details as provided by Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals, Inc. ( Richard Gregg, MD, Chief Scientific Officer ) ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Second Collaboration With Boehringer Provides Extended Cash ... Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae on The Pink Sheet DAILY, Jun-15-2009
Vitae Pharmaceuticals is new name of Concurrent ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals is new name of Concurrent ...
June | 2010 | Silico Research Vitae Pharmaceuticals has announced that it has earned a $14 million ... GW Pharmaceuticals has announced that it has signed a three year extension to ...
Venrock Vitae Pharmaceuticals. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient ...
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Anchen Pharmaceuticals, Inc - Irvine, California (CA ... Anchen Pharmaceuticals, Inc company profile in Irvine, CA. Our free company profile report for Anchen Pharmaceuticals, Inc includes business information ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
Oligopeptides - Data on oligopeptides described by ... Data on oligopeptides described by researchers at Vitae Pharmaceuticals ... For additional information, contact G. Wu, Vitae Pharmaceuticals, 502 West Office Center Drive, Fort ...
AlloCure Appoints Kevin J. Heyeck as Chief Business Officer ... AlloCure Inc., a biotechnology company developing innovative therapies for the treatment of kidney disease, today announced the appointment of Kevin J
Vertex Pharmaceuticals Inc (VRTX.O) People | Reuters.com Business news & Financial news from Reuters.com. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Boehringer Ingelheim and Vitae Pharmaceuticals announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to research and develop novel treatments for Alzheimer`s disease. Tweet ...
Novartis' Christine Brennan joins Vitae | InPharm US biopharmaceutical company Vitae Pharmaceuticals has appointed Christine Brennan chief business officer. ... Vitae's chief executive Jeffrey Hatfield commented: "We are very ...
Related Business News - Boehringer, Vitae partner on ... German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the potential to slow or even ...
at Thomson West Current board memberships include Amicus Therapeutics (NASDAQ: FOLD), Intarcia, ... with 23andMe, Trine Pharmaceuticals, Liquidia, and Vitae Pharmaceuticals. ...
Diabetes: November 2007 Johnson & Johnson Pharmaceutical Research & Develo... Novo Nordisk : ... Vitae Pharmaceuticals Receives $14 Million Milesto... Servier : Launch of IMIDIA, an ...
Boehringer Ingelheim And Vitae Pharmaceuticals Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have entered into a significant worldwide collaboration to research and develop beta ...
Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Pipeline - Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
VITAE - Vitae Pharmaceuticals Vitae pharmaceuticals, inc. is a private company and located in PA, United States. Address: 502 w office center dr, PA, 190343260, Fort washington United States ...
Vitae Pharmaceuticals - Company Profile | LinkedIn View the Vitae Pharmaceuticals company profile on LinkedIn. See recent hires and promotions, competitors and how you're connected to Vitae Pharmaceuticals.
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
Pennsylvania Bio - Vitae Pharmaceuticals Secures $13 Million ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ... Vitae Pharmaceuticals is an emerging pharmaceutical company with a ...
Vitae's Debt Financing: Crucial Lifeline in a Tightening ... Start-Up -- Roughly one week after GlaxoSmithKline gave Vitae Pharmaceuticals back rights to its renin inhibitor, the biotech signed a $13 million ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing of the active pharmaceutical ingredient ...
Summary of NURX PHARMACEUTICALS, INC. - Yahoo! Finance Vitae"), pursuant to which we acquired an exclusive, worldwide ... payments made pursuant to the license Agreement with Vitae Pharmaceuticals, Inc. ...
NuRx Pharmaceuticals, Inc: Private Company Information ... Get NuRx Pharmaceuticals, Inc company research & investing information. Find executive management and the ... It has a license agreement with Vitae Pharmaceuticals, Inc. ...
Boehringer, Vitae ink $242 mln Alzheimer's deal | Reuters 31 Jan 2011. Boehringer, Vitae ink $242 mln Alzheimer's deal. Tweet ... biotech company Vitae Pharmaceuticals to research and develop new Alzheimer's drugs, the ...
Ya-jun Zheng - LinkedIn View Ya-jun Zheng's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Ya-jun Zheng discover inside ...
Vitae earns $14M milestone payment from Boehringer Ingelheim Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... FORT WASHINGTON, Pa. - (Business Wire) Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned ...
Creative and Changing Deal Structures | Pennsylvania Bio Mr. Hatfield is the president and chief executive officer of Vitae Pharmaceuticals, Inc. ... Prior to joining Vitae, Mr. Hatfield spent nearly 20 years at Bristol ...
Direct Renin Inhibition and the Kidney - Full Text View ... Further study details as provided by Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals, Inc. ( Richard Gregg, MD, Chief Scientific Officer ) ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
Vitae Pharmaceuticals | Neurology Sites: CardiologyOncologyRespiratoryEndocrineNeurologyGastroenterology featured_supplier: not featured supplierSupplier Type: Pharmaceutical ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced the company’s novel, clinical-stage renin inhi
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Second Collaboration With Boehringer Provides Extended Cash ... Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae on The Pink Sheet DAILY, Jun-15-2009
Vitae Pharmaceuticals is new name of Concurrent ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals is new name of Concurrent ...
June | 2010 | Silico Research Vitae Pharmaceuticals has announced that it has earned a $14 million ... GW Pharmaceuticals has announced that it has signed a three year extension to ...
Venrock Vitae Pharmaceuticals. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient ...
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Anchen Pharmaceuticals, Inc - Irvine, California (CA ... Anchen Pharmaceuticals, Inc company profile in Irvine, CA. Our free company profile report for Anchen Pharmaceuticals, Inc includes business information ...
GlaxoSmithKline and Vitae Pharmaceuticals Establish Strategic ... GlaxoSmithKline and Vitae Pharmaceuticals Establish Strategic Alliance to Develop and Commercialize Novel Hypertension Treatment. Companies to Advance Renin ...
Oligopeptides - Data on oligopeptides described by ... Data on oligopeptides described by researchers at Vitae Pharmaceuticals ... For additional information, contact G. Wu, Vitae Pharmaceuticals, 502 West Office Center Drive, Fort ...
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Novartis' Christine Brennan joins Vitae | InPharm US biopharmaceutical company Vitae Pharmaceuticals has appointed Christine Brennan chief business officer. ... Vitae's chief executive Jeffrey Hatfield commented: "We are very ...
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Vitae Pharmaceuticals And Boehringer Ingelheim Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
CiNii Article - Cloning, Characterization and Site-Directed ... Department of Discovery Biology, Vitae Pharmaceuticals Inc. ... Vitae Pharmaceuticals Inc. PANEMANGALORE Reshma. Department of Discovery Biology, Vitae ...
Vertex Pharmaceuticals Incorporated (VRTX.O) People | Reuters.com Business news & Financial news from Reuters.com. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Kinex Pharmaceuticals LLC - Executive and Business Contacts ... Contacts at Kinex Pharmaceuticals LLC, part of Biotechnology industry in Buffalo, NY
Boehringer Ingelheim and Vitae Pharmaceuticals announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to research and develop novel treatments for Alzheimer`s disease. Tweet ...
Vitae Pharmaceuticals gets $13M in financing | Philadelphia ... Philadelphia, PA News - View Daily Local Business News, Resources & more in Philadelphia, Pennsylvania. ... Vitae Pharmaceuticals gets $13M in financing ...
at Thomson West Current board memberships include Amicus Therapeutics (NASDAQ: FOLD), Intarcia, ... with 23andMe, Trine Pharmaceuticals, Liquidia, and Vitae Pharmaceuticals. ...
Diabetes: November 2007 Johnson & Johnson Pharmaceutical Research & Develo... Novo Nordisk : ... Vitae Pharmaceuticals Receives $14 Million Milesto... Servier : Launch of IMIDIA, an ...
Company Presentations | Biotech 2010: Imagine. Collaborate ... Boryung Pharmaceuticals is a division of the Boryung Group that is ... Vitae Pharmaceuticals, Inc. Vitae is a clinical-stage biopharmaceutical company building ...
Peter Barrett, PhD - Autism Consortium The Autism Consortium is an innovative collaboration of scientific and clinical leaders working with families to change the research paradigm and accelerate the ...
Jan. 5, 2005 Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, has announced its ... Nereus Pharmaceuticals, a pioneer in drug discovery and development from marine ...
Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Pipeline - Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Vitae Pharmaceuticals, Inc. Receives $14 Million Milestone ... Vitae Pharmaceuticals, Inc. Receives $14 Million Milestone Payment as Boehringer Ingelheim Corporation Advances Lead Compound into Phase I Clinical Trials ...
Vitae Pharmaceuticals - Company Profile | LinkedIn View the Vitae Pharmaceuticals company profile on LinkedIn. See recent hires and promotions, competitors and how you're connected to Vitae Pharmaceuticals.
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer FORT WASHINGTON, Pa., Jul 14, 2010 (BUSINESS WIRE) -- Vitae Pharmaceuticals, Inc. ...
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... Vitae Pharmaceuticals Receives $14 Million Milestone Payment as Boehringer Ingelheim Advances Lead Compound into Phase I Clinical Trials
Atlas Venture News Vitae Pharmaceuticals is a development-stage biopharmaceutical company building a ... Vitae Pharmaceuticals is financed by leading corporate and venture ...
Pennsylvania Bio - Vitae Pharmaceuticals Secures $13 Million ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
Vitae Pharmaceuticals Secures $13 Million in Debt Financing ... Vitae Pharmaceuticals Secures $13 Million in Debt Financing October 28, 2008--FORT ... Vitae Pharmaceuticals is financed by leading venture capital and corporate investors and ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing of the active pharmaceutical ingredient ...
Vitae Pharmaceuticals Appoints Richard Gregg, M.D. as Chief ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... FORT WASHINGTON, Pa. - (Business Wire) Vitae Pharmaceuticals, Inc., announced today the appointment of Dr. Christine Brennan as Chief Business Officer. ...
Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ... Vitae Pharmaceuticals is an emerging pharmaceutical company with a ...
Vitae Pharma Names New Chief Business Officer ... Vitae Pharmaceuticals has appointed Christine Brennan as a new chief business officer. Earlier, she served as an executive director and head of strate
Boehringer Ingelheim and Vitae Pharmaceuticals Announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have entered into a significant worldwide collaboration to research an
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... Vitae Pharmaceuticals Appoints Industry Veteran, Donald Hayden, as Chairman (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Vitae's Debt Financing: Crucial Lifeline in a Tightening ... Start-Up -- Roughly one week after GlaxoSmithKline gave Vitae Pharmaceuticals back rights to its renin inhibitor, the biotech signed a $13 million ...
Vitae earns $14M milestone payment from Boehringer Ingelheim Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Pharmaceuticals, Inc., an integrated discovery and development company, announced that it has initiated a Phase 1 clinical trial of its novel ...
Vitae Pharmaceuticals is new name of Concurrent ... Vitae Pharmaceuticals is new name of Concurrent. Philadelphia Business Journal ... Vitae has raised a total of $75 million in equity capital to date. ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Vitae Pharmaceuticals, Inc. (formerly Concurrent ... Vitae Pharmaceuticals, Inc. (formerly Concurrent Pharmaceuticals)-Detailed Product Pipeline Vitae Pharmaceuticals, Inc. (formerly Concurrent Pharmaceuticals) ...
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... TradingMarkets News for Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
Vitae receives 11Beta-HSD-1 program milestone payment from ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned an $8 million milestone payment from ...
VITAE INITIATES CLINICAL TRIALS FOR PSORIASIS AND CANCER ... Vitae Pharmaceuticals has initiated Phase II clinical studies with VTP-201227 for the treatment of psoriasis and VTP-195183 to enhance immune cell ...
Zhongren Wu - LinkedIn Vitae Pharmaceuticals (Privately Held; Pharmaceuticals industry) January 2003 — Present ... EC member of Sino-American Pharmaceutical Association-Philadelphia ...
Diabetes Johnson & Johnson Pharmaceutical Research & Develo... Novo Nordisk : ... Vitae Pharmaceuticals Receives $14 Million Milesto... Servier : Launch of IMIDIA, an ...
Creative and Changing Deal Structures | Pennsylvania Bio Mr. Hatfield is the president and chief executive officer of Vitae Pharmaceuticals, Inc. ... Prior to joining Vitae, Mr. Hatfield spent nearly 20 years at Bristol ...
June | 2010 | Silico Research Vitae Pharmaceuticals has announced that it has earned a $14 million ... GW Pharmaceuticals has announced that it has signed a three year extension to ...
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Vitae Pharmaceuticals | Neurology Sites: CardiologyOncologyRespiratoryEndocrineNeurologyGastroenterology featured_supplier: not featured supplierSupplier Type: Pharmaceutical ...
Vitae to get at least $42M in Boehringer Ingelheim ... Vitae Pharmaceuticals will receive $42 million in upfront and near-term payments under ... Vitae will be eligible to receive $200 million in pre-commercial ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Locus Pharmaceuticals Inc - Executive and Business Contacts ... Contacts at Locus Pharmaceuticals Inc, part of Biotechnology industry in Blue Bell, PA
GlaxoSmithKline and Vitae Pharmaceuticals Establish Strategic ... GlaxoSmithKline and Vitae Pharmaceuticals Establish Strategic Alliance to Develop and Commercialize Novel Hypertension Treatment. Companies to Advance Renin ...
Second Collaboration With Boehringer Provides Extended Cash ... Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae on The Pink Sheet DAILY, Jun-15-2009
Venrock Vitae Pharmaceuticals. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient ...
DFB Pharmaceuticals, Inc. - Executive and Business Contacts ... Contacts at DFB Pharmaceuticals, Inc., part of Pharmaceuticals industry in Fort Worth, TX
GLAXOSMITHKLINE AND VITAE ESTABLISH STRATEGIC ALLIANCE GlaxoSmithKline and Vitae Pharmaceuticals have formed an exclusive worldwide strategic alliance to develop and commercialize novel drug compounds for ...
vitae pharma | Lowongan kerja | Bursa cari pekerjaan vitae pharma ... Our company, a key player in the Pharmaceutical Industry with head office in Lagos, require for immediate employment, result driven personnel to fill up the. ...
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Business Directory | Neurology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Vertex Pharmaceuticals Incorporated (VRTX.O) People | Reuters.com Business news & Financial news from Reuters.com. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Vitae Pharmaceuticals And Boehringer Ingelheim Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Pipeline - Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the discovery and development of ... Vitae is uniquely able to discover innovative compounds by ...
Vitae Pharmaceuticals - Company Profile | LinkedIn View the Vitae Pharmaceuticals company profile on LinkedIn. See recent hires and promotions, competitors and how you're connected to Vitae Pharmaceuticals.
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer FORT WASHINGTON, Pa., Jul 14, 2010 (BUSINESS WIRE) -- Vitae Pharmaceuticals, Inc. ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... Vitae Pharmaceuticals Receives $14 Million Milestone Payment as Boehringer Ingelheim Advances Lead Compound into Phase I Clinical Trials
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... Program Targets 11beta-HSD-1 for the Treatment of Diabetes and Other Metabolic Syndrome Disorders FORT WASHINGTON, Pa.--(BUSINESS WIRE)-- Vitae Pharmaceuticals, Inc. ...
Atlas Venture News Vitae Pharmaceuticals is a development-stage biopharmaceutical company building a ... Vitae Pharmaceuticals is financed by leading corporate and venture ...
Pennsylvania Bio - Vitae Pharmaceuticals Secures $13 Million ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
Vitae Pharmaceuticals related content - Philadelphia Business ... Topic Result: News articles and analysis about Vitae Pharmaceuticals from bizjournals and from around the web < sign in to watch Vitae Pharmaceuticals ...
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ... Vitae Pharmaceuticals is an emerging pharmaceutical company with a ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... Vitae Pharmaceuticals Appoints Richard Gregg, M.D. as Chief Scientific Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Boehringer Ingelheim and Vitae Pharmaceuticals Announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have entered into a significant worldwide collaboration to research an
Vitae's Debt Financing: Crucial Lifeline in a Tightening ... Start-Up -- Roughly one week after GlaxoSmithKline gave Vitae Pharmaceuticals back rights to its renin inhibitor, the biotech signed a $13 million ...
Creative and Changing Deal Structures | Pennsylvania Bio Mr. Hatfield is the president and chief executive officer of Vitae Pharmaceuticals, Inc. ... Prior to joining Vitae, Mr. Hatfield spent nearly 20 years at Bristol ...
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
Vitae receives 11Beta-HSD-1 program milestone payment from ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned an $8 million milestone payment from ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Martin Freed | LinkedIn Principal at Pharmaceutical/Biotech Development Consulting ... Chief Medical Officer at Vitae Pharmaceuticals. Vice President, Clinical Development at ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... FORT WASHINGTON, Pa. - (Business Wire) Vitae Pharmaceuticals, Inc., announced today the appointment of Dr. Christine Brennan as Chief Business Officer. ...
Vitae Pharmaceuticals is new name of Concurrent ... Vitae Pharmaceuticals is new name of Concurrent. Philadelphia Business Journal ... Vitae has raised a total of $75 million in equity capital to date. ...
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... TradingMarkets News for Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
VITAE INITIATES CLINICAL TRIALS FOR PSORIASIS AND CANCER ... Vitae Pharmaceuticals has initiated Phase II clinical studies with VTP-201227 for the treatment of psoriasis and VTP-195183 to enhance immune cell ...
Vitae Pharmaceuticals Appoints Richard Gregg, M.D. as Chief ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
vitae pharma | Lowongan kerja | Bursa cari pekerjaan Vitamin D What The Pharmaceutical Industry Doesn t Want You to Know http pindz blogspot ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have ...
June | 2010 | Silico Research Vitae Pharmaceuticals has announced that it has earned a $14 million ... GW Pharmaceuticals has announced that it has signed a three year extension to ...
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... announce GMP manufacturing agreement , : Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing ...
Diabetes Johnson & Johnson Pharmaceutical Research & Develo... Novo Nordisk : ... Vitae Pharmaceuticals Receives $14 Million Milesto... Servier : Launch of IMIDIA, an ...
Vitae Pharmaceuticals, Inc. (formerly Concurrent ... Vitae Pharmaceuticals, Inc. (formerly Concurrent Pharmaceuticals)-Detailed Product Pipeline Vitae Pharmaceuticals, Inc. (formerly Concurrent Pharmaceuticals) ...
Cumberland Pharmaceuticals Inc. - Executive and Business ... Contacts at Cumberland Pharmaceuticals Inc., part of Pharmaceuticals industry in Nashville, TN
Vertex Pharmaceuticals Incorporated (VRTX.O) People | Reuters.com In 1999, he joined Merck KGaA and established EMD Pharmaceuticals, Inc. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Results from the BLOSSOM trial announced by Arena Pharmaceuticals Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) reported today positive, highly significant top-line results from the BLOSSOM (Behavioral modification and LOrcaserin ...
Second Collaboration With Boehringer Provides Extended Cash ... Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae on The Pink Sheet DAILY, Jun-15-2009
Vitae Pharmaceuticals | Neurology Sites: CardiologyOncologyRespiratoryEndocrineNeurologyGastroenterology featured_supplier: not featured supplierSupplier Type: Pharmaceutical ...
Venrock Vitae Pharmaceuticals. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient ...
Vitae Pharma Names New Chief Business Officer - News - Drug ... Vitae Pharmaceuticals has appointed Christine Brennan as a new chief business officer. Earlier, she served as an executive director and head of strategy ...
GLAXOSMITHKLINE AND VITAE ESTABLISH STRATEGIC ALLIANCE GlaxoSmithKline and Vitae Pharmaceuticals have formed an exclusive worldwide strategic alliance to develop and commercialize novel drug compounds for ...
Business Directory | Neurology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Boehringer, Vitae ink $242 mln Alzheimer's deal | Reuters Boehringer, Vitae ink $242 mln Alzheimer's deal. Tweet This. Share on ... biotech company Vitae Pharmaceuticals to research and develop new Alzheimer's drugs, the ...
Business & Technology | Boehringer, Vitae partner on ... German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop ... to Vitae, a small, development-stage pharmaceutical company based ...
Business Directory | Gastroenterology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies. W L ...
Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Pipeline - Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the discovery and development of ... Vitae is uniquely able to discover innovative compounds by ...
Vitae Pharmaceuticals - Company Profile | LinkedIn View the Vitae Pharmaceuticals company profile on LinkedIn. See recent hires and promotions, competitors and how you're connected to Vitae Pharmaceuticals.
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer FORT WASHINGTON, Pa., Jul 14, 2010 (BUSINESS WIRE) -- Vitae Pharmaceuticals, Inc. ...
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Atlas Venture News Vitae Pharmaceuticals is a development-stage biopharmaceutical company building a ... Vitae Pharmaceuticals is financed by leading corporate and venture ...
Pennsylvania Bio - Vitae Pharmaceuticals Secures $13 Million ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
Vitae Pharmaceuticals related content - Philadelphia Business ... Topic Result: News articles and analysis about Vitae Pharmaceuticals from bizjournals and from around the web < sign in to watch Vitae Pharmaceuticals ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... Vitae Pharmaceuticals Receives $14 Million Milestone Payment as Boehringer Ingelheim Advances Lead Compound into Phase I Clinical Trials
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... Vitae Pharmaceuticals Appoints Richard Gregg, M.D. as Chief Scientific Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Vitae Pharmaceuticals Appoints Richard Gregg, M.D. as Chief ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... Program Targets 11beta-HSD-1 for the Treatment of Diabetes and Other Metabolic Syndrome Disorders FORT WASHINGTON, Pa.--(Business Wire)-- Vitae Pharmaceuticals, Inc. ...
Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ... Vitae Pharmaceuticals is an emerging pharmaceutical company with a ...
Boehringer Ingelheim and Vitae Pharmaceuticals Announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have entered into a significant worldwide collaboration to research an
Vitae's Debt Financing: Crucial Lifeline in a Tightening ... Start-Up -- Roughly one week after GlaxoSmithKline gave Vitae Pharmaceuticals back rights to its renin inhibitor, the biotech signed a $13 million ...
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
Diabetes Johnson & Johnson Pharmaceutical Research & Develo... Novo Nordisk : ... Vitae Pharmaceuticals Receives $14 Million Milesto... Servier : Launch of IMIDIA, an ...
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... FORT WASHINGTON, Pa. - (Business Wire) Vitae Pharmaceuticals, Inc., announced today the appointment of Dr. Christine Brennan as Chief Business Officer. ...
2010 June " Silico Research Vitae Pharmaceuticals has announced that it has earned a $14 million ... GW Pharmaceuticals has announced that it has signed a three year extension to ...
Vitae Pharmaceuticals, Inc. (formerly Concurrent ... Vitae Pharmaceuticals, Inc. (formerly Concurrent Pharmaceuticals)-Detailed Product Pipeline Vitae Pharmaceuticals, Inc. (formerly Concurrent Pharmaceuticals) ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Vitae Pharmaceuticals is new name of Concurrent ... Vitae Pharmaceuticals is new name of Concurrent. Philadelphia Business Journal ... Vitae has raised a total of $75 million in equity capital to date. ...
VITAE INITIATES CLINICAL TRIALS FOR PSORIASIS AND CANCER ... Vitae Pharmaceuticals has initiated Phase II clinical studies with VTP-201227 for the treatment of psoriasis and VTP-195183 to enhance immune cell ...
Martin Freed - LinkedIn Principal at Pharmaceutical/Biotech Development Consulting ... Chief Medical Officer at Vitae Pharmaceuticals. Vice President, Clinical Development at ...
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... TradingMarkets News for Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced the company’s novel, clinical-stage renin inhi
German drugmaker Boehringer to partner with Vitae to develop ... TRENTON, N.J. — German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... announce GMP manufacturing agreement , : Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing ...
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Vitae Pharmaceuticals | Neurology Sites: CardiologyOncologyRespiratoryEndocrineNeurologyGastroenterology featured_supplier: not featured supplierSupplier Type: Pharmaceutical ...
Second Collaboration With Boehringer Provides Extended Cash ... Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae on The Pink Sheet DAILY, Jun-15-2009
Venrock Vitae Pharmaceuticals. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient ...
GLAXOSMITHKLINE AND VITAE ESTABLISH STRATEGIC ALLIANCE GlaxoSmithKline and Vitae Pharmaceuticals have formed an exclusive worldwide strategic alliance to develop and commercialize novel drug compounds for ...
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Vertex Pharmaceuticals Incorporated (VRTX.O) People | Reuters.com Business news & Financial news from Reuters.com. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Oligopeptides - Data on oligopeptides described by ... Data on oligopeptides described by researchers at Vitae Pharmaceuticals ... For additional information, contact G. Wu, Vitae Pharmaceuticals, 502 West Office Center Drive, Fort ...
Vitae Pharmaceuticals And Boehringer Ingelheim Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
vitae pharma | Lowongan kerja | Bursa cari pekerjaan vitae pharma ... The Scene called all of them to discuss their relationships with pharmaceutical companies and the potential ... Executive secretary for a Pharmaceutical ...
Business Directory | Gastroenterology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies. W L ...
Vitae Pharma Names New Chief Business Officer - News - Drug ... Vitae Pharmaceuticals has appointed Christine Brennan as a new chief business officer. Earlier, she served as an executive director and head of strategy ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
Vitae earns $14M milestone payment from Boehringer Ingelheim Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone ...
Business Directory | Neurology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Pipeline - Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the discovery and development of ... Vitae is uniquely able to discover innovative compounds by ...
Vitae Pharmaceuticals - Company Profile | LinkedIn View the Vitae Pharmaceuticals company profile on LinkedIn. See recent hires and promotions, competitors and how you're connected to Vitae Pharmaceuticals.
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer FORT WASHINGTON, Pa., Jul 14, 2010 (BUSINESS WIRE) -- Vitae Pharmaceuticals, Inc. ...
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
Atlas Venture News Vitae Pharmaceuticals is a development-stage biopharmaceutical company building a ... Vitae Pharmaceuticals is financed by leading corporate and venture ...
Pennsylvania Bio - Vitae Pharmaceuticals Secures $13 Million ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
Vitae Pharmaceuticals related content - Philadelphia Business ... Topic Result: News articles and analysis about Vitae Pharmaceuticals from bizjournals and from around the web < sign in to watch Vitae Pharmaceuticals ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... Vitae Pharmaceuticals Receives $14 Million Milestone Payment as Boehringer Ingelheim Advances Lead Compound into Phase I Clinical Trials
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... Program Targets 11beta-HSD-1 for the Treatment of Diabetes and Other Metabolic Syndrome Disorders FORT WASHINGTON, Pa.--(Business Wire)-- Vitae Pharmaceuticals, Inc. ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... Vitae Pharmaceuticals Appoints Richard Gregg, M.D. as Chief Scientific Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ... Vitae Pharmaceuticals is an emerging pharmaceutical company with a ...
Boehringer Ingelheim and Vitae Pharmaceuticals Announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have entered into a significant worldwide collaboration to research an
Vitae's Debt Financing: Crucial Lifeline in a Tightening ... Start-Up -- Roughly one week after GlaxoSmithKline gave Vitae Pharmaceuticals back rights to its renin inhibitor, the biotech signed a $13 million ...
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
Vitae earns $14M milestone payment from Boehringer Ingelheim Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone ...
Home Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis ... Nunc euismod velit vitae mi. Suspendisse ac tellus. In et augue in nisl placerat cursus. ...
Vitae Pharmaceuticals Appoints Richard Gregg, M.D. as Chief ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... FORT WASHINGTON, Pa. - (Business Wire) Vitae Pharmaceuticals, Inc., announced today the appointment of Dr. Christine Brennan as Chief Business Officer. ...
2010 June " Silico Research Vitae Pharmaceuticals has announced that it has earned a $14 million ... GW Pharmaceuticals has announced that it has signed a three year extension to ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Related Business News - Boehringer, Vitae partner on ... German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the potential to slow or even ...
VITAE INITIATES CLINICAL TRIALS FOR PSORIASIS AND CANCER ... Vitae Pharmaceuticals has initiated Phase II clinical studies with VTP-201227 for the treatment of psoriasis and VTP-195183 to enhance immune cell ...
Diabetes Johnson & Johnson Pharmaceutical Research & Develo... Novo Nordisk : ... Vitae Pharmaceuticals Receives $14 Million Milesto... Servier : Launch of IMIDIA, an ...
Martin Freed - LinkedIn Principal at Pharmaceutical/Biotech Development Consulting ... Chief Medical Officer at Vitae Pharmaceuticals. Vice President, Clinical Development at ...
Vitae Pharmaceuticals Inc related content - Philadelphia ... Bizjournals is one of the leading sources of comprehensive business news and in-depth analysis. ... Jeff Hatfield has been the president and CEO of Vitae Pharmaceuticals Inc. ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... TradingMarkets News for Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Vitae Pharmaceuticals, Inc. (formerly Concurrent ... Vitae Pharmaceuticals, Inc. (formerly Concurrent Pharmaceuticals)-Detailed Product Pipeline Vitae Pharmaceuticals, Inc. (formerly Concurrent Pharmaceuticals) ...
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... announce GMP manufacturing agreement , : Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing ...
Vitae Pharmaceuticals | Neurology Sites: CardiologyOncologyRespiratoryEndocrineNeurologyGastroenterology featured_supplier: not featured supplierSupplier Type: Pharmaceutical ...
Second Collaboration With Boehringer Provides Extended Cash ... Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae on The Pink Sheet DAILY, Jun-15-2009
Venrock Vitae Pharmaceuticals. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced the company’s novel, clinical-stage renin inhi
GLAXOSMITHKLINE AND VITAE ESTABLISH STRATEGIC ALLIANCE GlaxoSmithKline and Vitae Pharmaceuticals have formed an exclusive worldwide strategic alliance to develop and commercialize novel drug compounds for ...
Pharmaceuticals Vitae - Pay less with Antag Pharmaceuticals: Vitae Vitae Chlorella Plus (Intestinal transit) 120 tablets. ... Pharmaceuticals: Vitae Vitae Chlorella Plus (Intestinal transit) 300 tablets. ...
Vertex Pharmaceuticals Incorporated (VRTX.O) People | Reuters.com Business news & Financial news from Reuters.com. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Business & Technology | Boehringer, Vitae partner on ... German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop ... to Vitae, a small, development-stage pharmaceutical company based ...
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Oxford Finance Corporation - Archived Press Releases Titan Pharmaceuticals to Receive $3 Million Loan Additional $1 Million in Equity Raised ... Vitae Pharmaceuticals Secures $13 Million in Debt Financing ...
Vitae Pharma Names New Chief Business Officer - News - Drug ... Vitae Pharmaceuticals has appointed Christine Brennan as a new chief business officer. Earlier, she served as an executive director and head of strategy ...
Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Careers - Job Opportunities at Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the discovery and development of ... Vitae is uniquely able to discover innovative compounds by ...
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Vitae Pharmaceuticals related content - Philadelphia Business ... Topic Result: News articles and analysis about Vitae Pharmaceuticals from bizjournals and from around the web < sign in to watch Vitae Pharmaceuticals ...
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... Vitae Pharmaceuticals Appoints Richard Gregg, M.D. as Chief Scientific Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Portfolio Company News Vitae will have the right to develop products independently for certain other indications. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Pharmaceuticals, Inc., an integrated discovery and development company, announced that it has initiated a Phase 1 clinical trial of its novel ...
New blood pressure meds available Vitae, based in Fort Washington, Pa. and formerly known as Concurrent Pharmaceuticals, ... Vitae will also receive committed funding to support research activities conducted by ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Vitae Pharmaceuticals And Boehringer Ingelheim Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ... Vitae Pharmaceuticals is an emerging pharmaceutical company with a ...
Vitae Pharmaceuticals Appoints Richard Gregg, M.D. as Chief ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
VITAE INITIATES CLINICAL TRIALS FOR PSORIASIS AND CANCER ... Vitae Pharmaceuticals has initiated Phase II clinical studies with VTP-201227 for the treatment of psoriasis and VTP-195183 to enhance immune cell ...
Vitae Pharmaceuticals: Another Obesity Player " Personal ... Vitae Pharmaceuticals: Another Obesity Player. Posted on June 23, 2007. ... under: biotech, obesity | Vitae Pharmaceuticals. Make a Comment. Make ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... Vitae Pharmaceuticals Appoints Industry Veteran, Donald Hayden, as Chairman (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Committee Composition, Vertex Pharmaceuticals | vrtx.com Extensive and easy-to-navigate financial information on Vertex. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
vitae pharma | Lowongan kerja | Bursa cari pekerjaan (BUSINESS WIRE)--Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million ...
2010 June " Silico Research Vitae Pharmaceuticals has announced that it has earned a $14 million ... GW Pharmaceuticals has announced that it has signed a three year extension to ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
Second Collaboration With Boehringer Provides Extended Cash ... Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae on The Pink Sheet DAILY, Jun-15-2009
VITAE - Vitae Vitae pharmaceuticals, inc. is a private company and located in PA, United States. Address: 502 w office center dr, PA, 190343260, Fort washington United States ...
Vitae Pharmaceuticals Inc related content - Philadelphia ... Bizjournals is one of the leading sources of comprehensive business news and in-depth analysis. ... Jeff Hatfield has been the president and CEO of Vitae Pharmaceuticals Inc. ...
Vitae to Receive $42M from Boehringer Ingelheim in ... Vitae to Receive $42M from Boehringer Ingelheim in Alzheimer's Agreement ... Vitae Pharmaceuticals and Boehringer Ingelheim signed an agreement to develop beta ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Business Directory | Gastroenterology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies. W L ...
Boehringer, Vitae ink $242 mln Alzheimer's deal | Reuters Boehringer, Vitae ink $242 mln Alzheimer's deal. Tweet This. Share on LinkedIn. Share on ... biotech company Vitae Pharmaceuticals to research and develop new ...
Custom Chemical Synthesis, nutraceuticals - Lawrence ... Lawrence Pharmaceuticals is an advanced contract research and manufacturing ...
Yuri Bukhtiyarov - LinkedIn Research Fellow. Vitae Pharmaceuticals (Privately Held; Pharmaceuticals industry) ... (Public Company; 1001-5000 employees; Pharmaceuticals industry) ...
Vitae Pharmaceuticals links up with Boehringer Ingelheim for ... The small Fort Washington drug developer will receive $42 million up front from the large German pharmaceutical maker.
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
GLAXOSMITHKLINE AND VITAE ESTABLISH STRATEGIC ALLIANCE GlaxoSmithKline and Vitae Pharmaceuticals have formed an exclusive worldwide strategic alliance to develop and commercialize novel drug compounds for ...
NURX PHARMACEUTICALS INC (NUXP:US): Stock Quote & Company ... It has a license agreement with Vitae Pharmaceuticals, Inc. ... NuRx Pharmaceuticals, Inc expected to report Fiscal Year 2010 results on December 28, ...
Venrock Vitae Pharmaceuticals. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient ...
View Online Source PETER TU, ESQ. Vitae Pharmaceuticals, Inc. ( Fort Washington, PA) ...
A Place for Discovery in Biotech--in Which Discovery Knows ... A Place for Discovery in Biotech--in Which Discovery Knows Its Place on Start-Up, Jul-01-2005 ... Novartis AG Speedel Group Roche Sanofi-Aventis Vitae Pharmaceuticals Inc. ...
Pauline Javorski - LinkedIn Human Resources at Vitae Pharmaceuticals, Inc. HR Generalist at Wyeth ... (Public Company; 10,001 or more employees; WYE; Pharmaceuticals industry) ...
Vertex Pharmaceuticals Incorporated (VRTX.O) People | Reuters.com Business news & Financial news from Reuters.com. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Bio Investor Forum Virdante Pharmaceuticals. Vitae Pharmaceuticals. Highlights. New Updates ... CEO's of Alimera, Constellation, Fate, Nuon, Syndax, Tobira, Vitae and Virdante. ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... announce GMP manufacturing agreement , : Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing ...
Twitter / TVG: Come see these presenters ... Come see these presenters at BioPartnering Europe next wk: Spherix, TransPharma Medical, Vitae Pharmaceuticals - http://bit.ly/9DftI2 #bpe10
BioScience Industry Partnership | Pennsylvania Bio TetraLogic Pharmaceutical Corp. Thomas Medical Products. ViroPharma ... Vitae Pharmaceuticals, Inc.* Yaupon Therapeutics, Inc. *indicates member of the Steering ...
Peter Barrett, PhD - Autism Consortium The Autism Consortium is an innovative collaboration of scientific and clinical leaders working with families to change the research paradigm and accelerate the ...
Chronic Kidney Disease, Diabetes, Atherosclerosis ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market ...
Careers - Job Opportunities at Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the discovery and development of ... Vitae is uniquely able to discover innovative compounds by ...
Richard Gregg, M.D., Chief Scientific Officer - Vitae ... Vitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address ...
Vitae Pharmaceuticals related content - Philadelphia Business ... Topic Result: News articles and analysis about Vitae Pharmaceuticals from bizjournals and from around the web < sign in to watch Vitae Pharmaceuticals ...
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
Boehringer Ingelheim and Vitae Pharmaceuticals Announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have ... Vitae Pharmaceuticals is financed by leading corporate and venture ...
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Healthcare Sales & Marketing Network: Vitae Pharmaceuticals ... Vitae Pharmaceuticals Appoints Richard Gregg, M.D. as Chief Scientific Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Pharmaceuticals, Inc., an integrated discovery and development company, announced that it has initiated a Phase 1 clinical trial of its novel ...
Portfolio Company News Vitae Pharmaceuticals Secures $13 Million in Debt Financing ... Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the discovery ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ... Vitae Pharmaceuticals is an emerging pharmaceutical company with a ...
Vitae Pharmaceuticals: Another Obesity Player " Personal ... Vitae Pharmaceuticals: Another Obesity Player. Posted on June 23, 2007. ... under: biotech, obesity | Vitae Pharmaceuticals. Make a Comment. Make ...
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Vitae Pharmaceuticals And Boehringer Ingelheim Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
vitae pharma | Lowongan kerja | Bursa cari pekerjaan (BUSINESS WIRE)--Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million ...
VITAE Vitae, Pharmaceuticals, VITAE - Company Profile, Phone number and address Vitae Pharmaceuticals
Healthcare Sales & Marketing Network - HSMN NewsFeed: Vitae ... Vitae Pharmaceuticals Appoints Industry Veteran, Donald Hayden, as Chairman (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Business Directory | Oncology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Vitae Pharmaceuticals Appoints Richard Gregg, M.D. as Chief ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
VITAE INITIATES CLINICAL TRIALS FOR PSORIASIS AND CANCER ... Vitae Pharmaceuticals has initiated Phase II clinical studies with VTP-201227 for the treatment of psoriasis and VTP-195183 to enhance immune cell ...
Pauline Javorski - LinkedIn Human Resources at Vitae Pharmaceuticals, Inc. HR Generalist at Wyeth ... (Public Company; 10,001 or more employees; WYE; Pharmaceuticals industry) ...
Second Collaboration With Boehringer Provides Extended Cash ... Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae on The Pink Sheet DAILY, Jun-15-2009
GSK, Vitae form alliance - Philadelphia Business Journal GlaxoSmithKline and Vitae Pharmaceuticals Inc. announced on Monday ... Vitae will also receive funding to support research activities and further ...
Boehringer, Vitae ink $242 mln Alzheimer's deal | Reuters Boehringer, Vitae ink $242 mln Alzheimer's deal. Tweet This. Share on LinkedIn. Share on ... biotech company Vitae Pharmaceuticals to research and develop new ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Isis Pharmaceuticals adds ISIS-APOCIIIRx to its development ... Isis Pharmaceuticals, Inc. announced today that it has added a new drug, ISIS-APOCIIIRx, to its development pipeline. ISIS-APOCIIIRx provides a novel ...
Vitae to Receive $42M from Boehringer Ingelheim in ... Vitae to Receive $42M from Boehringer Ingelheim in Alzheimer's Agreement ... Vitae Pharmaceuticals and Boehringer Ingelheim signed an agreement to develop beta ...
Diabetes Vitae Pharmaceuticals Receives $14 Million Milestone Payment as ... Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of diabetes and metabolic ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
Custom Chemical Synthesis, nutraceuticals - Lawrence ... Lawrence Pharmaceuticals is an advanced contract research and manufacturing ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
Yuri Bukhtiyarov - LinkedIn Research Fellow. Vitae Pharmaceuticals (Privately Held; Pharmaceuticals industry) ... (Public Company; 1001-5000 employees; Pharmaceuticals industry) ...
NURX PHARMACEUTICALS INC (NUXP:US): Stock Quote & Company ... It has a license agreement with Vitae Pharmaceuticals, Inc. ... NuRx Pharmaceuticals, Inc expected to report Fiscal Year 2010 results on December 28, ...
GLAXOSMITHKLINE AND VITAE ESTABLISH STRATEGIC ALLIANCE GlaxoSmithKline and Vitae Pharmaceuticals have formed an exclusive worldwide strategic alliance to develop and commercialize novel drug compounds for ...
Novartis' Christine Brennan joins Vitae | InPharm US biopharmaceutical company Vitae Pharmaceuticals has appointed Christine Brennan chief business officer. ... Vitae's chief executive Jeffrey Hatfield commented: "We are very ...
Vertex Pharmaceuticals Incorporated (VRTX.O) People | Reuters.com Business & Financial news from Reuters.com. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
View Online Source PETER TU, ESQ. Vitae Pharmaceuticals, Inc. ( Fort Washington, PA) ...
A Place for Discovery in Biotech--in Which Discovery Knows ... A Place for Discovery in Biotech--in Which Discovery Knows Its Place on Start-Up, Jul-01-2005 ... Novartis AG Speedel Group Roche Sanofi-Aventis Vitae Pharmaceuticals Inc. ...
Business Directory | Gastroenterology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies. W L ...
Peter Barrett, PhD - Autism Consortium The Autism Consortium is an innovative collaboration of scientific and clinical leaders working with families to change the research paradigm and accelerate the ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... announce GMP manufacturing agreement , : Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing ...
Bio-IT Briefs - Bio-IT World GlaxoSmithKline responds to tsunami disaster with donation of antibiotics, vaccines, cashConcurrent Pharmaceuticals changes name to Vitae Pharmaceuticals and ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a leader ... Vitae's first and lead program is in renin inhibition, an industry ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an entrepreneurial, vibrant and growing pharmaceutical company ... Vitae Pharmaceuticals offers a competitive compensation and benefits ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Vitae Pharmaceuticals Vitae's accomplished team has significant experience discovering, developing and ... Prior to joining VITAE PHARMACEUTICALS, Ms. Fiumenero spent 13 years at Bristol ...
Healthcare Sales & Marketing Network - HSMN NewsFeed: Vitae ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... Vitae Pharmaceuticals Receives $14 Million Milestone Payment as Boehringer Ingelheim Advances Lead Compound into Phase I Clinical Trials. Tue Jun 29, 7:31 AM ...
PharmaLive: Vitae Pharmaceuticals Receives $14 Million ... Vitae Pharmaceuticals Receives $14 Million Milestone Payment as ... Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of diabetes and metabolic ...
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor - Vitae Pharmaceuticals, Inc.
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the discovery and development of ... Vitae is uniquely able to discover innovative compounds by ...
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
World Pharma News - Boehringer Ingelheim and Vitae ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration ... Vitae Pharmaceuticals is an emerging pharmaceutical company building ...
Vitae Pharmaceuticals related content - Philadelphia Business ... Topic Result: News articles and analysis about Vitae Pharmaceuticals from bizjournals and from around the web < sign in to watch Vitae Pharmaceuticals ...
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Company Profile: Vitae Pharmaceuticals, Inc - Portfolio.com Vitae Pharmaceuticals is an emerging pharmaceutical company with a unique and powerful ... Vitae was founded with the goal to create a paradigm breakthrough in ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... FORT WASHINGTON, Pa.--(EON: Enhanced Online News)--Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that ...
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... Vitae Pharmaceuticals, Inc., announced today the appointment of Dr. Christine Brennan as Chief Business Officer. Dr. Brennan has over 10 years experience ...
BioSpace - Vitae Pharmaceuticals, Inc. News, Search Jobs, Events Boehringer Ingelheim Corporation And Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference
Vitae Pharmaceuticals gets $13M in financing - Philadelphia ... Vitae Pharmaceuticals Inc. entered into a $13 million loan agreement ... Vitae is looking at developing renin-ihibitors for new drugs to treat hypertension, ...
vitae pharma | Lowongan kerja | Bursa cari pekerjaan Dr. Beart brings to this doctrine an impressive curriculum vitae in medical innovation and leadership as well in; ?OTC Pharmaceuticals in South Korea? ...
Un equipo líder en su clase con demostrada trayectoria en ... Before joining moksha8, Mr. Howarth was Chief Business Officer at Vitae Pharmaceuticals leading commercial, business development and legal. ...
Healthcare Sales & Marketing Network - HSMN NewsFeed: Vitae ... Vitae Pharmaceuticals Appoints Industry Veteran, Donald Hayden, as Chairman (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Boehringer, Vitae Partner On Alzheimer's Drugs German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals say they are partnering to develop enzyme-inhibiting drugs with the potential to slow or even halt ...
Portfolio Company News Vitae Pharmaceuticals Secures $13 Million in Debt Financing ... Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the discovery ...
Vitae Pharma borrows $13M for heart, Alzheimer drug projects ... Vitae Pharmaceuticals, Ft. Washington, borrows $13 million from Silicon Valley Bank and Oxford Finance Corp. for work on high blood pressure and Alzheimer's ...
News Headlines Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer ... "We are very pleased to welcome Christine to Vitae at this stage of our growth. ...
Pharmaceuticals Companies in Irvine, California (CA) 77 Pharmaceuticals Companies in Irvine, California. Search or browse our list of pharmaceuticals companies in Irvine, CA by category.
Novartis' Christine Brennan joins Vitae | InPharm US biopharmaceutical company Vitae Pharmaceuticals has appointed Christine Brennan chief business officer. ... Vitae's chief executive Jeffrey Hatfield commented: "We are very ...
Eurand Names Former Solvay Executive Jean-Louis Anspach ... A 25-year veteran of the specialty pharmaceutical and chemical industries ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer ...
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... TradingMarkets News for Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer ... Vitae Pharmaceuticals is a development-stage biopharmaceutical company building ...
Three Rivers Pharmaceuticals Announces FDA Approval Of ... Home > Off the Wire > Three Rivers Pharmaceuticals Announces FDA Approval Of Expanded Labeling of INFERGEN® ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ...
Vitae receives $14M in diabetes project | Philadelphia ... Vitae Pharmaceuticals Inc., Fort Washington, said today that it received a $14 million "milestone" payment from its partner in developing ...
VITAE INITIATES CLINICAL TRIALS FOR PSORIASIS AND CANCER ... Vitae Pharmaceuticals has initiated Phase II clinical studies with VTP-201227 for the treatment of psoriasis and VTP-195183 to enhance immune cell ...
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... announce GMP manufacturing agreement , : Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing ...
Clinical Trials News - Pharmaceutical Industry Today Clinical Trials News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about pharmaceuticals.
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Vitae Regains Rights to Preclinical Renin Inhibitor Program ... Vitae Regains Rights to Preclinical Renin Inhibitor Program from GSK ... Vitae Pharmaceuticals has reacquired full rights to its renin inhibitor program from GlaxoSmithKline. ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... Vitae Pharmaceuticals Receives $14 Million Milestone Payment as Boehringer Ingelheim ... Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the ...
Boehringer hopes cash injection will turbocharge diabetes and ... Boehringer Ingelheim has witnessed Vitae Pharmaceuticals attack the same diabetes and obesity target as itself, only faster, and has decided to splash out for a piece ...
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer ... Vitae has built a strong pipeline of programs in a variety of therapeutic ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone payment from ...
Second Collaboration With Boehringer Provides Extended Cash ... Second Collaboration With Boehringer Provides Extended Cash Runway For Vitae on The Pink Sheet DAILY, Jun-15-2009
Boehringer and Vitae collaborate on Alzheimer's treatment Boehringer Ingelheim and Vitae Pharmaceuticals have entered into a ... Vitae will also receive commercial performance payments and royalties from Beohringer ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a leader ... Vitae's first and lead program is in renin inhibition, an industry ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an entrepreneurial, vibrant and growing pharmaceutical company ... Vitae Pharmaceuticals offers a competitive compensation and benefits ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Vitae Pharmaceuticals Vitae's accomplished team has significant experience discovering, developing and ... Prior to joining VITAE PHARMACEUTICALS, Ms. Fiumenero spent 13 years at Bristol ...
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer ... Vitae has built a strong pipeline of programs in a variety of therapeutic categories with ...
Healthcare Sales & Marketing Network - HSMN NewsFeed: Vitae ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer ... Vitae has built a strong pipeline of programs in a variety of ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer ... Vitae Pharmaceuticals is a development-stage biopharmaceutical company building ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... FORT WASHINGTON, Pa. --(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc. , an integrated discovery and development company, today announced that it has ...
World Pharma News - Boehringer Ingelheim and Vitae ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration ... Vitae Pharmaceuticals is an emerging pharmaceutical company building ...
Vitae Pharmaceuticals, Inc. Receives $14 Million Milestone ... Vitae Pharmaceuticals, Inc. Receives $14 Million Milestone Payment as Boehringer Ingelheim Corporation Advances Lead Compound into Phase I Clinical Trials ...
PharmaLive: Vitae Pharmaceuticals Receives $14 Million ... Vitae Pharmaceuticals Receives $14 Million Milestone Payment as ... Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of diabetes and metabolic ...
Vitae Pharmaceuticals News - FierceBiotech Read the latest Vitae Pharmaceuticals news and developments from FierceBiotech. Also, feel free to sign up for the Vitae Pharmaceuticals news RSS feed.
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor - Vitae Pharmaceuticals, Inc.
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the discovery and development of ... Vitae is uniquely able to discover innovative compounds by ...
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... Vitae Pharmaceuticals, Inc., announced today the appointment of Dr. Christine Brennan as Chief Business Officer. Dr. Brennan has over 10 years experience ...
Citybizlist Philadelphia - Vitae Pharmaceuticals Appoints ... <p>FORT WASHINGTON, Pa.--<strong> Vitae Pharmaceuticals, Inc</strong>
Vitae Pharmaceuticals related content - Philadelphia Business ... Topic Result: News articles and analysis about Vitae Pharmaceuticals from bizjournals and from around the web < sign in to watch Vitae Pharmaceuticals ...
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
Company Profile: Vitae Pharmaceuticals, Inc - Portfolio.com Vitae Pharmaceuticals is an emerging pharmaceutical company with a unique and powerful ... Vitae was founded with the goal to create a paradigm breakthrough in ...
BioSpace - Vitae Pharmaceuticals, Inc. News, Search Jobs, Events Boehringer Ingelheim Corporation And Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... Vitae Pharmaceuticals Receives $14 Million Milestone Payment as Boehringer Ingelheim Advances Lead Compound into Phase I Clinical Trials. Tue Jun 29, 7:31 AM ...
Vitae earns $14M milestone payment from Boehringer Ingelheim Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone ...
Vitae to get at least $42M in Boehringer Ingelheim ... Vitae to get at least $42M in Boehringer Ingelheim collaboration ... Vitae Pharmaceuticals will receive $42 million in upfront and near-term payments ...
Columbia Laboratories Enters into Purchase and Collaboration ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer. Radient Pharmaceuticals Launches New Corporate Video and Website ...
Healthcare Sales & Marketing Network - HSMN NewsFeed: Vitae ... Vitae Pharmaceuticals Appoints Industry Veteran, Donald Hayden, as Chairman (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Un equipo líder en su clase con demostrada trayectoria en ... Before joining moksha8, Mr. Howarth was Chief Business Officer at Vitae Pharmaceuticals leading commercial, business development and legal. ...
Eugene Cordes: Executive Profile & Biography - BusinessWeek Read the full executive profile of Eugene Cordes. Find Eugene Cordes's salary, education, stock options, ... He served as a Director of Vitae Pharmaceuticals, Inc. ...
EvaluatePharma - Boehringer Ingelheim - Worldwide - Overview Vitae Pharmaceuticals (June 28, 2010) Marinomed Signs Collaboration with Boehringer Ingelheim for Anti-Viral Nasal Spray Against Common Cold ...
Portfolio Company News Vitae Pharmaceuticals Secures $13 Million in Debt Financing ... Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the discovery ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Boehringer, Vitae Partner On Alzheimer's Drugs German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals say they are partnering to develop enzyme-inhibiting drugs with the potential to slow or even halt ...
VITAE INITIATES CLINICAL TRIALS FOR PSORIASIS AND CANCER ... Vitae Pharmaceuticals has initiated Phase II clinical studies with VTP-201227 for the treatment of psoriasis and VTP-195183 to enhance immune cell ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned ...
Pennsylvania Bio Life Sciences Career Alliance Bio-pharmaceutical Industry Human Capital Infrastructure Final Report. Live News ... Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
compound risk definition Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of diabetes and metabolic ... Vitae Pharmaceuticals Receives $14 Million Milestone Payment as ...
BioPortfolio - vitae Vitae Pharmaceuticals Receives $14 Million Milestone Payment as Boehringer ... Vitae Pharmaceuticals research - Entry on Bioportfolio's Biocorporate Database. ...
Vitae Regains Rights to Preclinical Renin Inhibitor Program ... Vitae Regains Rights to Preclinical Renin Inhibitor Program from GSK ... Vitae Pharmaceuticals has reacquired full rights to its renin inhibitor program from GlaxoSmithKline. ...
Vitae Pharma borrows $13M for heart, Alzheimer drug projects ... Vitae Pharmaceuticals, Ft. Washington, borrows $13 million from Silicon Valley Bank and Oxford Finance Corp. for work on high blood pressure and Alzheimer's ...
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief ... TradingMarkets News for Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Scripintelligence - Pharmaceutical drug news The Spanish pharmaceutical industry is calling for a new strategic ... New appointment at Vitae Pharmaceuticals Vitae Pharmaceuticals, a US-based development ...
Clinical Trials News - Pharmaceutical Industry Today Clinical Trials News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about pharmaceuticals.
Diabetes Vitae Pharmaceuticals Receives $14 Million Milestone Payment as ... Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of diabetes and metabolic ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... announce GMP manufacturing agreement , : Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing ...
A best-in-class team with proven track record in emerging ... moksha8 provides the highest quality products and services to patients and clinicians in emerging markets. Our goal is to become the leading pharmaceutical company ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a leader ... Vitae's first and lead program is in renin inhibition, an industry ...
Vitae Pharmaceuticals The Service is owned and operated by Vitae Pharmaceuticals, Inc. ... Vitae may refuse to offer the Service to any person or entity and may change its ...
Vitae Pharmaceuticals Vitae's accomplished team has significant experience discovering, developing and ... Prior to joining VITAE PHARMACEUTICALS, Ms. Fiumenero spent 13 years at Bristol ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor - Vitae Pharmaceuticals, Inc.
Company Profile: Vitae Pharmaceuticals, Inc - Portfolio.com Vitae Pharmaceuticals is an emerging pharmaceutical company with a unique and powerful ... Vitae was founded with the goal to create a paradigm breakthrough in ...
VITAE PHARMACEUTICALS INC - Corporate Information Vitae Pharmaceuticals (formerly Concurrent Pharmaceuticals) is an ... Vitae's goal is to discover, develop and commercialize innovative new medicines that will ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... Vitae Pharmaceuticals Receives $14 Million Milestone Payment as Boehringer Ingelheim Advances Lead Compound into Phase I Clinical Trials. Tue Jun 29, 7:31 AM ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone payment from ...
Vitae Pharmaceuticals links up with Boehringer Ingelheim for ... The small Fort Washington drug developer will receive $42 million up front from the large German pharmaceutical maker.
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... Program Targets 11beta-HSD-1 for the Treatment of Diabetes and Other Metabolic Syndrome Disorders FORT WASHINGTON, Pa.--(BUSINESS WIRE)-- Vitae Pharmaceuticals, Inc. ...
Acceso.com - boehringer ingelheim y vitae pharmaceuticals ... notas de prensa - boehringer ingelheim y vitae pharmaceuticals desarrollaran conjuntamente nuevos farmacos contra el alzheimer
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the discovery and development of ... Vitae is uniquely able to discover innovative compounds by ...
PipelineReview.com - Biotech News & Online Store - Vitae ... Vitae Pharmaceuticals Receives $14 Million Milestone Payment as Boehringer Ingelheim Advances Lead Compound into Phase I Clinical Trials. 29 Jun 2010 ...
Boehringer, Vitae Partner To Develop Alzheimer Drugs German drugmaker and Vitae Pharmaceuticals said they are partnering to develop enzyme-inhibiting drugs with potential to slow or even halt progression ...
Vitae related content - The Business Journal of Milwaukee Vitae Pharmaceuticals Inc. initiated a phase-I clinical trial Monday of its experimental... Vitae Pharmaceuticals will receive $42 million in upfront and near ...
Vitae Pharmaceuticals related content - Philadelphia Business ... Topic Result: News articles and analysis about Vitae Pharmaceuticals from bizjournals and from around the web < sign in to watch Vitae Pharmaceuticals ...
Vitae Pharmaceuticals And Boehringer Ingelheim Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... EuroInvestor News story - Vitae Pharmaceuticals Receives $14 Million Milestone Payment As Boehringer Ingelheim Advances Lead Compound Into Phase I...
Healthcare Sales & Marketing Network - HSMN NewsFeed: Vitae ... Vitae Pharmaceuticals Appoints Industry Veteran, Donald Hayden, as Chairman (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... announce GMP manufacturing agreement , : Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
Boehringer Ingelheim and Vitae Pharmaceuticals announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to research and develop novel treatments for Alzheimer`s disease ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... Vitae Pharmaceuticals Receives $14 Million Milestone Payment as Boehringer Ingelheim ... Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... FORT WASHINGTON, Pa.--(EON: Enhanced Online News)--Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that ...
PharmaLive: Vitae Pharmaceuticals Receives $14 Million ... Vitae Pharmaceuticals Receives $14 Million Milestone Payment as ... Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of diabetes and metabolic ...
Database of career stories - www.vitae.ac.uk/policy-practice Vitae is committed to enhancing the quality and output of the research base in the United Kingdom, through supporting the ... Science and pharmaceuticals ...
Pennsylvania Pharmaceuticals News - Pharmaceutical Industry Today Pennsylvania Pharmaceuticals News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about Pennsylvania Pharmaceuticals.
BioSpace - Vitae Pharmaceuticals, Inc. News, Search Jobs, Events Boehringer Ingelheim Corporation And Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... Vitae Pharmaceuticals Receives $14 Million Milestone Payment as Boehringer Ingelheim Advances Lead Compound into Phase I Clinical Trials
World Pharma News - Boehringer Ingelheim and Vitae ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration ... Vitae Pharmaceuticals is an emerging pharmaceutical company building ...
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
BioTech Career Center drug discovery (computational drug design and medicinal chemistry) ... Vitae Pharmaceuticals changed their name from Concurrent Pharmaceuticals in ...
pharmaceuticals without a prior prescription. Lowest prices ... tap pharmaceuticals lawsuit settlement ucb pharmaceuticals ... japan pharmaceuticals lawsuit ww ii. bradmer pharmaceuticals. vitae pharmaceuticals. abbott ...
vitae pharma | Lowongan kerja | Bursa cari pekerjaan Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they be dressed established a primary collaboration to develop and commercialize ...
VITAE PHARMACEUTICALS SECURES $15 MILLION IN FINANCING Vitae Pharmaceuticals today announced that its recent licensing and development agreement with GlaxoSmithKline (GSK) has met its closing conditions, ...
Newsvine - Boehringer, Vitae partner on Alzheimer's drugs TRENTON — German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with ...
Portfolio Company News Vitae Pharmaceuticals Secures $13 Million in Debt Financing ... Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the discovery ...
Industry News: Vitae Pharmaceuticals Receives $14 Million ... Vitae Pharmaceuticals Receives $14 Million Milestone Payment as Boehringer Ingelheim ... find out more about the company visit Vitae Pharmaceuticals profile. ...
Vitae Pharmaceuticals Receives $14 Million Milestone Payment ... Vitae Pharmaceuticals Receives $14 Million Milestone Payment as ... Vitae's 11beta-hydroxysteroid dehydrogenase (HSD)-1 is targeted for the treatment of ...
Vitae earns $14M milestone payment from Boehringer Ingelheim Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned a $14 million clinical milestone ...
PharmaDeals: Press Release Pharmaceutical strategic business consultancy involved in partnering, licensing, ... Vitae Pharmaceuticals is financed by leading corporate and venture capital investors; its ...
Boehringer Ingelheim und Vitae Pharmaceuticals erforschen und ... Boehringer Ingelheim und Vitae Pharmaceuticals erforschen und entwickeln gemeinsam neuartige Alzheimer-Therapien, : Boehringer Ingelheim und Vitae ...
BioSpectrum - Pharma - Vitae, Boehringer collaborate on novel ... Boehringer Ingelheim and Vitae Pharmaceuticals have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
Summary of NURX PHARMACEUTICALS, INC. - Yahoo! Finance On February 10, 2010, we served notice of our intent to terminate the Vitae license as well as the underlying license to Allergan Pharmaceuticals, Inc. ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a leader ... Vitae's first and lead program is in renin inhibition, an industry ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an entrepreneurial, vibrant and growing pharmaceutical company ... Vitae Pharmaceuticals offers a competitive compensation and benefits ...
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Vitae Pharmaceuticals related content - Philadelphia Business ... Topic Result: News articles and analysis about Vitae Pharmaceuticals from bizjournals and from around the web < sign in to watch Vitae Pharmaceuticals ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the discovery and development of ... Vitae is uniquely able to discover innovative compounds by ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... announce GMP manufacturing agreement , : Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing ...
Vitae Pharmaceuticals, Inc. Receives $8 Million Payment from ... Vitae Pharmaceuticals, Inc. Receives $8 Million Payment from Boehringer Ingelheim ... Vitae Pharmaceuticals is an integrated discovery and development ...
Healthcare Sales & Marketing Network - HSMN NewsFeed: Vitae ... Vitae Pharmaceuticals Appoints Industry Veteran, Donald Hayden, as Chairman (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics)
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Portfolio Company News Vitae Pharmaceuticals President John J. Baldwin Inducted into American Chemical ... Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the ...
PHARMACEUTICALS, - VITAE PHARMACEUTICALS TO PRESENT AT ... Pharmaceuticals, - Vitae Pharmaceuticals to Present at Windhoverâ€™s Annual Therapeutic Area Partnerships Conference Vitae Pharmaceuticals, Inc. ...
Boehringer Ingelheim and Vitae Pharmaceuticals announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to research and develop novel treatments for Alzheimer`s disease ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
Boehringer, Vitae Partner To Develop Alzheimer Drugs German drugmaker and Vitae Pharmaceuticals said they are partnering to develop enzyme-inhibiting drugs with potential to slow or even halt progression ...
Vitae Pharmaceuticals Inc related content - Philadelphia ... Bizjournals is one of the leading sources of comprehensive business news and in-depth analysis.
Vitae Pharmaceuticals to Present at Windhover's Annual ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced the company’ ...
VITAE PHARMACEUTICALS SECURES $15 MILLION IN FINANCING Vitae Pharmaceuticals today announced that its recent licensing and development agreement with GlaxoSmithKline (GSK) has met its closing conditions, ...
FarmaIndustrial [F+I] - Supplier business journal of the ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ...
Solvias - Your Reliable Partner | Solvias - The name is also ... With our services, products and technologies in the field of analytical, chemical and biopharmaceutical development, we provide integrated solutions to enhance the ...
15 October 2007 Vitae Pharmaceuticals and Boehringer Ingelheim announce a major collaboration to ... Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
15 June 2009 Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Vitae Pharmaceuticals And Boehringer Ingelheim Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
Vitae Receives $8 Million Payment from Boehringer Ingelheim ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned ...
Vitae closes $34mm venture round - Deal Vitae closes $34mm venture round on Strategic Transactions, Jan-01-2005 ... Vitae Pharmaceuticals (focused on cancer, cardiovascular, and dermatology therapeutics) ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Pharmaceuticals, Inc., an integrated discovery and development company, announced that it has initiated a Phase 1 clinical trial of its novel ...
2010 BIO International Convention - Business Forum - List of ... Alexion Pharmaceuticals, Inc. Alexza Pharmaceuticals, Inc. Algenics. AlgiPharma AS ... Vitae Pharmaceuticals, Inc. Viva Biotech. Vivalis. Vivia Biotech S.L ...
pharmaceuticals without a prior prescription. Lowest prices ... tap pharmaceuticals lawsuit settlement ucb pharmaceuticals ... japan pharmaceuticals lawsuit ww ii. bradmer pharmaceuticals. vitae pharmaceuticals. abbott ...
The IN VIVO Blog: Vitae and Boehringer Get on BACE Vitae Pharmaceuticals and Boehringer Ingelheim will announce today ... Vitae will get $42 million up-front in combined cash, equity payments and research funding, and will be ...
Venrock Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, ...
Eugene Cordes: Executive Profile & Biography - BusinessWeek Read the full executive profile of Eugene Cordes. Find Eugene Cordes's salary, education, stock options, ... He served as a Director of Vitae Pharmaceuticals, Inc. ...
PRMinds - Vitae Pharmaceuticals, Inc. (formerly Concurrent ... PRMinds is a press release distribution services for European IT & Telecoms news, business development. ... Aarkstore announce a new report"Vitae Pharmaceuticals, Inc. ...
PRMinds Online Press Release Distribution Service Vital Pharmaceutical Holdings Limited (formerly Vital BioTech Holdings Limited) ... Vitae Pharmaceuticals, Inc. ( formerly Concurrent Pharmaceuticals) ...
IndustryPro :: Merger and Acquisition Advisory Services International investment banking firm facilitating business mergers, acquisitions, ... Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a ...
New blood pressure meds available Vitae, based in Fort Washington, Pa. and formerly known as Concurrent Pharmaceuticals, ... Vitae will also receive committed funding to support research activities conducted by ...
Yuri Bukhtiyarov - LinkedIn Vitae Pharmaceuticals (Privately Held; 11-50 employees; Pharmaceuticals industry) ... (Public Company; 1001-5000 employees; Pharmaceuticals industry) ...
Pharmaceutical & Biotechnology - philly.com Thatâ€™s what makes yesterdayâ€™s announcement by Fort Washingtonâ€™s Vitae Pharmaceuticals Inc. and Germanyâ€™s Boehringer Ingelheim so interesting. ...
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Newsvine - Boehringer, Vitae partner on Alzheimer's drugs TRENTON — German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Um time diferenciado com comprovadas experiências nos ... Before joining moksha8, Mr. Howarth was Chief Business Officer at Vitae Pharmaceuticals leading commercial, business development and legal. ...
Header News Item Boehringer Ingelheim struck an agreement with Vitae Pharmaceuticals to develop beta-secretase inhibitors, a class of Alzheimer's disease drugs. ...
Vitae Pharma borrows $13M for heart, Alzheimer drug projects ... Vitae Pharmaceuticals, Ft. Washington, borrows $13 million from Silicon Valley Bank and Oxford Finance Corp. for work on high blood pressure and Alzheimer's ...
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
Member Listing | Pennsylvania Bio PhaseBio Pharmaceuticals, Inc. Philadelphia Convention & Visitors Bureau. Philadelphia ... Vitae Pharmaceuticals, Inc. ViviSource Laboratories, Inc. Vox Medica, ...
BioSpectrum - Pharma - Vitae, Boehringer collaborate on novel ... Boehringer Ingelheim and Vitae Pharmaceuticals have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
Custom Chemical Synthesis, nutraceuticals - Lawrence ... Lawrence Pharmaceuticals is an advanced contract research and manufacturing ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a leader ... Vitae's first and lead program is in renin inhibition, an industry ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an entrepreneurial, vibrant and growing pharmaceutical company ... Vitae Pharmaceuticals offers a competitive compensation and benefits ...
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor - Vitae Pharmaceuticals, Inc.
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Vitae Pharmaceuticals, Inc. Receives $8 Million Payment from ... Vitae Pharmaceuticals, Inc. Receives $8 Million Payment from Boehringer Ingelheim ... Vitae Pharmaceuticals is an integrated discovery and development ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Vitae Pharmaceuticals to Present at Windhover's Annual ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced the company’ ...
Vitae Pharmaceuticals to Reacquire Full Rights to Renin ... Expects renin program to enter clinic in 2009 FORT WASHINGTON, Pa. -- Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and ...
World Pharma News - Boehringer Ingelheim and Vitae ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration ... Vitae Pharmaceuticals is an emerging pharmaceutical company building ...
PHARMACEUTICALS, - VITAE PHARMACEUTICALS TO PRESENT AT ... Pharmaceuticals, - Vitae Pharmaceuticals to Present at Windhoverâ€™s Annual Therapeutic Area Partnerships Conference Vitae Pharmaceuticals, Inc. ...
Portfolio Company News Vitae Pharmaceuticals Appoints Richard Gregg, M.D. as Chief Scientific Officer ... Vitae Pharmaceuticals is financed by leading corporate and venture capital ...
Philadelphia Business Journal: Vitae Pharmaceuticals Inc ... Bizjournals is one of the leading sources of comprehensive business news and in-depth analysis. ... Vitae Pharmaceuticals Inc articles from bizjournals ...
Newsvine - Boehringer, Vitae partner on Alzheimer's drugs German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the potential to slow or even ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
Boehringer, Vitae Partner To Develop Alzheimer Drugs German drugmaker and Vitae Pharmaceuticals said they are partnering to develop enzyme-inhibiting drugs with potential to slow or even halt progression ...
Boehringer Ingelheim and Vitae Pharmaceuticals announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to research and develop novel treatments for Alzheimer`s disease ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
Boehringer Ingelheim And Vitae Pharmaceuticals Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have entered into a significant worldwide collaboration to research and develop beta ...
Vitae Pharmaceuticals and Boehringer Ingelheim announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have established a major collaboration to develop and commercialize 11beta-HSD1 ...
Vitae Pharmaceuticals And Boehringer Ingelheim Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
News: Vitae Pharmaceuticals and Boehringer Ingelheim Announce ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have established a major collaboration to develop and commercialize 11beta-HSD1 ...
Curriculum Vitae - Larisa Soloviova | Balkan pharmaceuticals _ Work experience 2008 - to present day - Pharmaceutical factory BALKAN PHARMACEUTICALS LTD, chief of the department of quality. 2006 - to present day - National ...
Vitae Receives $8 Million Payment from Boehringer Ingelheim ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned ...
15 June 2009 Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
15 October 2007 Vitae Pharmaceuticals and Boehringer Ingelheim announce a major collaboration to ... Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the ...
The IN VIVO Blog: Vitae and Boehringer Get on BACE Vitae Pharmaceuticals and Boehringer Ingelheim will announce today ... Vitae will get $42 million up-front in combined cash, equity payments and research funding, and will be ...
NEA ... Pharmos, Sensors for Medicine & Science, Supernus Pharmaceuticals, TargetRx, and Vitae Pharmaceuticals. His prior board memberships include AMERIGROUP, ...
Attendees | Sofinnova Biopharma Partnering Conference 2009 VentiRx Pharmaceuticals. Vitae Pharmaceuticals. 2009 Attending Companies. Abbott Japan ... Vitae Pharmaceuticals. 2008 Attending Japanese Companies. Ajinomoto ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Vitae Pharma borrows $13M for heart, Alzheimer drug projects ... Vitae Pharmaceuticals, Ft. Washington, borrows $13 million from Silicon Valley Bank and Oxford Finance Corp. for work on high blood pressure and Alzheimer's ...
Vitae Pharmaceuticals, Inc. (formerly Concurrent ... Vitae Pharmaceuticals, Inc. (formerly Concurrent Pharmaceuticals)-Company Report - new market report released. News from Directories
Portfolio Company News Sep 21, 2009 Vitae Initiates Phase 1 Trial of Novel Renin Inhibitor ... Oct 22, 2008 Vitae Pharmaceuticals to Reacquire Full Rights to Renin Inhibitor Program for Hypertension ...
在新兴市场和全球合作中拥有出色记录的一流团队 Before joining moksha8, Mr. Howarth was Chief Business Officer at Vitae Pharmaceuticals leading commercial, business development and legal. ...
Pharmaceutical & Biotechnology - philly.com Thatâ€™s what makes yesterdayâ€™s announcement by Fort Washingtonâ€™s Vitae Pharmaceuticals Inc. and Germanyâ€™s Boehringer Ingelheim so interesting. ...
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
IndustryPro :: Merger and Acquisition Advisory Services International investment banking firm facilitating business mergers, acquisitions, ... Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a ...
NuRx Pharmaceuticals, Inc: Private Company Information ... Get NuRx Pharmaceuticals, Inc company research & investing information. Find executive management and the ... It has a license agreement with Vitae Pharmaceuticals, Inc. ...
Unfounded claims for Baycol, FDA says | Pharmaceuticals ... Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic ... Vitae's Novel Renin Inhibitor Program Recognized as a Top 10 Project to Watch ...
The Business Journal of Milwaukee: Vitae related content Vitae Pharmaceuticals Inc. initiated a phase-I clinical trial Monday of its experimental... Vitae Pharmaceuticals will receive $42 million in upfront and near ...
Paul Noto - LinkedIn Pharmaceuticals. Paul Noto's Experience. Research Associate III. Vitae Pharmaceuticals ... (Public Company; 10,001 or more employees; WYE; Pharmaceuticals industry) ...
Header News Item Boehringer Ingelheim struck an agreement with Vitae Pharmaceuticals to develop beta-secretase inhibitors, a class of Alzheimer's disease drugs. ...
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
Summary of NURX PHARMACEUTICALS, INC. - Yahoo! Finance Vitae"), pursuant to which we acquired an exclusive, worldwide ... payments made pursuant to the license Agreement with Vitae Pharmaceuticals, Inc. ...
Boehringer and Vitae collaborate on Alzheimer's treatment Boehringer Ingelheim and Vitae Pharmaceuticals have entered into a ... Vitae will also receive commercial performance payments and royalties from Beohringer ...
Wall Street Ideas Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a ... Vitae and GlaxoSmithKline formed one of 2005's largest preclinical partnerships ...
The IN VIVO Blog: Deals of the Week 3G S Watson/Arrow: On June 17, Watson Pharmaceuticals announced a $1.75 billion cash and stock ... Vitae Pharmaceuticals/Boehringer Ingelheim: Vitae says it has ...
Custom Chemical Synthesis, nutraceuticals - Lawrence ... Lawrence Pharmaceuticals is an advanced contract research and manufacturing ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a leader ... Vitae's first and lead program is in renin inhibition, an industry ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an entrepreneurial, vibrant and growing pharmaceutical company ... Vitae Pharmaceuticals offers a competitive compensation and benefits ...
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor - Vitae Pharmaceuticals, Inc.
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Vitae Pharmaceuticals, Inc. Receives $8 Million Payment from ... Vitae Pharmaceuticals, Inc. Receives $8 Million Payment from Boehringer Ingelheim ... Vitae Pharmaceuticals is an integrated discovery and development ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... announce GMP manufacturing agreement , : Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the manufacturing ...
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced the company’ ...
World Pharma News - Boehringer Ingelheim and Vitae ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration ... Vitae Pharmaceuticals is an emerging pharmaceutical company building ...
Vitae Pharmaceuticals Appoints Richard Gregg, M.D. as Chief ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
PHARMACEUTICALS, - VITAE PHARMACEUTICALS TO PRESENT AT ... Pharmaceuticals, - Vitae Pharmaceuticals to Present at Windhoverâ€™s Annual Therapeutic Area Partnerships Conference Vitae Pharmaceuticals, Inc. ...
Portfolio Company News Vitae Pharmaceuticals Appoints Richard Gregg, M.D. as Chief Scientific Officer ... Vitae Pharmaceuticals is financed by leading corporate and venture capital ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
Philadelphia Business Journal: Vitae Pharmaceuticals Inc ... Bizjournals is one of the leading sources of comprehensive business news and in-depth analysis. ... Vitae Pharmaceuticals Inc articles from bizjournals ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Boehringer, Vitae Partner To Develop Alzheimer Drugs German drugmaker and Vitae Pharmaceuticals said they are partnering to develop enzyme-inhibiting drugs with potential to slow or even halt progression ...
Portfolio Company News Vitae will have the right to develop products independently for certain other indications. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Boehringer Ingelheim and Vitae Pharmaceuticals announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to research and develop novel treatments for Alzheimer`s disease ...
Newsvine - Boehringer, Vitae partner on Alzheimer's drugs German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the potential to slow or even ...
News: Vitae Pharmaceuticals and Boehringer Ingelheim Announce ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have established a major collaboration to develop and commercialize 11beta-HSD1 ...
Vitae Pharmaceuticals And Boehringer Ingelheim Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
Curriculum Vitae - Eugen Mihai Diug | Balkan pharmaceuticals _ Professional experience: 2007 – up to present – Consultant at SC Balkan Pharmaceuticals SRL 2006 – member of the Contest Commission of the Department of Medicine of ...
Vitae Pharmaceuticals and Boehringer Ingelheim announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have established a major collaboration to develop and commercialize 11beta-HSD1 ...
Curriculum Vitae - Larisa Soloviova | Balkan pharmaceuticals _ Work experience 2008 - to present day - Pharmaceutical factory BALKAN PHARMACEUTICALS LTD, chief of the department of quality. 2006 - to present day - National ...
15 October 2007 Vitae Pharmaceuticals and Boehringer Ingelheim announce a major collaboration to ... Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the ...
Vitae Receives $8 Million Payment from Boehringer Ingelheim ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned ...
Boehringer, Vitae partner on Alzheimer's drugs - Worldnews.com TRENTON, N.J. - German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the potential ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Pharmaceuticals, Inc., an integrated discovery and development company, announced that it has initiated a Phase 1 clinical trial of its novel ...
The IN VIVO Blog: Vitae and Boehringer Get on BACE Vitae Pharmaceuticals and Boehringer Ingelheim will announce today ... Vitae will get $42 million up-front in combined cash, equity payments and research funding, and will be ...
Yuri Bukhtiyarov - LinkedIn Vitae Pharmaceuticals (Privately Held; 11-50 employees; Pharmaceuticals industry) ... (Public Company; 1001-5000 employees; Pharmaceuticals industry) ...
NEA ... Pharmos, Sensors for Medicine & Science, Supernus Pharmaceuticals, TargetRx, and Vitae Pharmaceuticals. His prior board memberships include AMERIGROUP, ...
Attendees | Sofinnova Biopharma Partnering Conference 2009 VentiRx Pharmaceuticals. Vitae Pharmaceuticals. 2009 Attending Companies. Abbott Japan ... Vitae Pharmaceuticals. 2008 Attending Japanese Companies. Ajinomoto ...
Vitae Pharmaceuticals, Inc. (formerly Concurrent ... Vitae Pharmaceuticals, Inc. (formerly Concurrent Pharmaceuticals)-Company Report - new market report released. News from Directories
Vitae Pharma borrows $13M for heart, Alzheimer drug projects ... Vitae Pharmaceuticals, Ft. Washington, borrows $13 million from Silicon Valley Bank and Oxford Finance Corp. for work on high blood pressure and Alzheimer's ...
在新兴市场和全球合作中拥有出色记录的一流团队 Before joining moksha8, Mr. Howarth was Chief Business Officer at Vitae Pharmaceuticals leading commercial, business development and legal. ...
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
NuRx Pharmaceuticals, Inc: Private Company Information ... Get NuRx Pharmaceuticals, Inc company research & investing information. Find executive management and the ... It has a license agreement with Vitae Pharmaceuticals, Inc. ...
Pharmaceutical & Biotechnology - philly.com Thatâ€™s what makes yesterdayâ€™s announcement by Fort Washingtonâ€™s Vitae Pharmaceuticals Inc. and Germanyâ€™s Boehringer Ingelheim so interesting. ...
Header News Item Boehringer Ingelheim struck an agreement with Vitae Pharmaceuticals to develop beta-secretase inhibitors, a class of Alzheimer's disease drugs. ...
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
The Business Journal of Milwaukee: Vitae related content Vitae Pharmaceuticals Inc. initiated a phase-I clinical trial Monday of its experimental... Vitae Pharmaceuticals will receive $42 million in upfront and near ...
Summary of NURX PHARMACEUTICALS, INC. - Yahoo! Finance Vitae"), pursuant to which we acquired an exclusive, worldwide ... payments made pursuant to the license Agreement with Vitae Pharmaceuticals, Inc. ...
Boehringer and Vitae collaborate on Alzheimer's treatment Boehringer Ingelheim and Vitae Pharmaceuticals have entered into a ... Vitae will also receive commercial performance payments and royalties from Beohringer ...
Wall Street Ideas Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a ... Vitae and GlaxoSmithKline formed one of 2005's largest preclinical partnerships ...
The IN VIVO Blog: Deals of the Week 3G S Watson/Arrow: On June 17, Watson Pharmaceuticals announced a $1.75 billion cash and stock ... Vitae Pharmaceuticals/Boehringer Ingelheim: Vitae says it has ...
Custom Chemical Synthesis, nutraceuticals - Lawrence ... Lawrence Pharmaceuticals is an advanced contract research and manufacturing ...
James B. Tananbaum | Silicon Valley Association of Startup ... Jim is a Managing Director of Prospect Venture Partners. Jim co-founded Prospect Venture Partners II and III, ... Vanda Pharmaceuticals (NASDAQ: VNDA) and Vitae Pharmaceuticals. ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a leader ... Vitae's first and lead program is in renin inhibition, an industry ...
Vitae Pharmaceuticals Vitae is committed to creating superior products for important medical needs. ... Vitae & Vitae Pharmaceuticals are trademarks of Vitae Pharmaceuticals, Inc. ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Philadelphia Business Journal: Vitae Pharmaceuticals Inc ... Bizjournals is one of the leading sources of comprehensive business news and in-depth analysis. ... Vitae Pharmaceuticals Inc articles from bizjournals ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced the company’ ...
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.654.1262. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Vitae scores $242M Alzheimer's pact with Boehringer ... Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. ...
The Business Journal of Milwaukee: Vitae related content Vitae Pharmaceuticals Inc. initiated a phase-I clinical trial Monday of its experimental... Vitae Pharmaceuticals will receive $42 million in upfront and near ...
Vitae Pharmaceuticals and Boehringer Ingelheim announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have established a major collaboration to develop and commercialize 11beta-HSD1 ...
Boehringer Ingelheim and Vitae Pharmaceuticals Announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals Announce a Major Collaboration to Research and Develop Novel Treatments for Alzheimer s Disease
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its ...
Vitae Pharmaceuticals, Inc. Initiates Phase 1 Trial of Novel ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has ...
Newsvine - Boehringer, Vitae partner on Alzheimer's drugs German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the potential to slow or even ...
Solvias AG and Vitae Pharmaceuticals, Inc. announce GMP ... Vitae Pharmaceuticals is a valuable customer for Solvias and to be awarded this ... Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a ...
Boehringer Ingelheim and Vitae Pharmaceuticals announce a ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to research and develop novel treatments for Alzheimer`s disease ...
Vitae Pharmaceuticals And Boehringer Ingelheim Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
BioPortfolio - vitae Vitae Pharmaceuticals is an emerging pharmaceutical company with two ... Solvias AG and Vitae Pharmaceuticals announced the companies have entered into an agreement for the ...
Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc ... Boehringer Ingelheim Corporation, Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Pharmaceuticals, Inc., an integrated discovery and development company, announced that it has initiated a Phase 1 clinical trial of its novel ...
Database of career stories - www.vitae.ac.uk/policy-practice Vitae is committed to enhancing the quality and output of the research base in the United ... Science and pharmaceuticals. Research subject: Biochemistry, Molecular Biology and ...
Portfolio Company News Vitae Pharmaceuticals Secures $13 Million in Debt Financing ... Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the discovery ...
NEA NEA.com, The NEA Team ... Medicine & Science, Supernus Pharmaceuticals, TargetRx, Trine Pharmaceuticals, and Vitae Pharmaceuticals. His prior board ...
Vitae Receives $8 Million Payment from Boehringer Ingelheim ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned ...
Digizyme - Web & Multimedia Design for the Sciences These range from individual research laboratory sites, to pharmaceutical & large corporate intranet sites. ... Synta Pharmaceuticals. Vitae Pharmaceuticals. Biotechnology ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference
Peter Barrett Peter Barrett is a Partner in the Life Sciences group and joined Atlas Venture in 2002. ... Pharmaceuticals, Sirion Therapeutics, Stromedix, Vitae Pharmaceuticals and Zafgen. ...
Un equipo líder en su clase con demostrada trayectoria en ... Before joining moksha8, Mr. Howarth was Chief Business Officer at Vitae Pharmaceuticals leading commercial, business development and legal. ...
15 June 2009 Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Venrock Vitae Pharmaceuticals, Inc. Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, ...
News: Boehringer Ingelheim and Vitae Partner on Compounds to ... Boehringer Ingelheim and Vitae Pharmaceuticals are collaborating to develop and commercialize compounds against a particular target to treat diabetes and metabolic syndro
IndustryPro :: Merger and Acquisition Advisory Services International investment banking firm facilitating business mergers, acquisitions, ... Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a ...
Vitae Pharma borrows $13M for heart, Alzheimer drug projects ... Vitae Pharmaceuticals, Ft. Washington, borrows $13 million from Silicon Valley Bank and Oxford Finance Corp. for work on high blood pressure and Alzheimer's ...
Vitae Pharmaceuticals, Inc. (formerly Concurrent ... Vitae Pharmaceuticals, Inc. (formerly Concurrent Pharmaceuticals)-Company Report - new market report released. News from Directories
Digizyme - Web & Multimedia Design for the Sciences Merrimack Pharmaceuticals. Novartis Pharmaceuticals. Ohmx Corporation ... Tempo Pharmaceuticals. Vitae Pharmaceuticals. Biotechnology. ActivBiotics. AdipoGenix ...
15 October 2007 Vitae Pharmaceuticals and Boehringer Ingelheim announce a major collaboration to ... Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the ...
Summary of NURX PHARMACEUTICALS, INC. - Yahoo! Finance On May 11, 2007, we entered into a license agreement with Vitae Pharmaceuticals, Inc. (" Vitae"), pursuant to which we acquired an exclusive, worldwide ...
Curriculum Vitae - Eugen Mihai Diug | Balkan pharmaceuticals _ Professional experience: 2007 – up to present – Consultant at SC Balkan Pharmaceuticals SRL 2006 – member of the Contest Commission of the Department of Medicine of ...
Vitae Pharmaceuticals Appoints Richard Gregg, M.D. as Chief ... Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development of innovative small molecule medicines, ...
Oxford Finance :: News :: Recent Press Releases Titan Pharmaceuticals to Receive $3 Million Loan Additional $1 Million in Equity Raised ... Vitae Pharmaceuticals Secures $13 Million in Debt Financing ...
Pauline Javorski - LinkedIn Human Resources at Vitae Pharmaceuticals, Inc. HR Generalist at Wyeth ... (Public Company; 10,001 or more employees; WYE; Pharmaceuticals industry) ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
World Pharma News - Boehringer Ingelheim and Vitae ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration ... Vitae Pharmaceuticals is an emerging pharmaceutical company building ...
Boehringer Ingelheim: Privacy Has its Virtues - IN VIVO BI and Vitae partner on 11beta-HSD1 inhibitors for diabetes, Deal 10/1/2007 ... European Pharmaceutical Companies Patent Expirations Pharmaceutical Profits R&D ...
Business & Financial News, Breaking US & International News ... Quantrx Biomedical Corp. To Acquire NuRx Pharmaceuticals Inc ... that it has entered into a license agreement with Vitae Pharmaceuticals, Inc. ...
News: Vitae Regains Rights to Preclinical Renin Inhibitor ... Vitae Pharmaceuticals has reacquired full rights to its renin inhibitor program from GlaxoSmithKline. The companies inked a deal in June 2005 vaued ...
Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor Vitae Initiates Phase 1 Trial Of Novel Renin Inhibitor - Vitae Pharmaceuticals, Inc.
Attendees | Sofinnova Biopharma Partnering Conference 2009 VentiRx Pharmaceuticals. Vitae Pharmaceuticals. 2009 Attending Companies. Abbott Japan ... Vitae Pharmaceuticals. 2008 Attending Japanese Companies. Ajinomoto ...
Pharmaceutical & Biotechnology - philly.com Thatâ€™s what makes yesterdayâ€™s announcement by Fort Washingtonâ€™s Vitae Pharmaceuticals Inc. and Germanyâ€™s Boehringer Ingelheim so interesting. ...
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
Quest Group International, Inc. Raises $20 Million, Acquires ... Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a ... Vitae and GlaxoSmithKline formed one of 2005's largest preclinical partnerships ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a leader ... Vitae's first and lead program is in renin inhibition, an industry ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an entrepreneurial, vibrant and growing pharmaceutical company ... Vitae Pharmaceuticals offers a competitive compensation and benefits ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.461.2000. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Vitae Pharmaceuticals And Boehringer Ingelheim Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
The Business Journal of Milwaukee: Vitae related content Vitae Pharmaceuticals Inc. initiated a phase-I clinical trial Monday of its experimental... Vitae Pharmaceuticals will receive $42 million in upfront and near ...
Vitae Pharmaceuticals to Reacquire Full Rights to Renin ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc., an emerging pharmaceutical company dedicated to the discovery and development ...
Heart Attack - Vitae Initiates Phase 1 Trial of Novel Renin ... 2009 OCT 5 - (NewsRx.com) -- Vitae Pharmaceuticals, Inc., an integrated discovery and ... Vitae Pharmaceuticals Vitae Pharmaceuticals is an integrated discovery and development ...
Vitae Pharmaceuticals gets $13M in financing - Philadelphia ... Vitae Pharmaceuticals gets $13M in financing ... Vitae is looking at developing renin-ihibitors for new drugs to treat hypertension, diabetic nephropathy, congestive heart ...
Company Profile: Vitae Pharmaceuticals, Inc - Portfolio.com Vitae Pharmaceuticals is an emerging pharmaceutical company with a unique and powerful ... Vitae's approach to value generation begins with a unique discovery ...
NEA - Team Member Display NEA.com, Team Member Display ... Medicine & Science, Supernus Pharmaceuticals, TargetRx, Trine Pharmaceuticals, and Vitae Pharmaceuticals. His prior board ...
Database of career stories - www.vitae.ac.uk/policy-practice Vitae is committed to enhancing the quality and output of the research base in the United ... Regulatory affairs consultant, freelance consultant for pharmaceutical companies ...
Peter Barrett Peter Barrett is a Partner in the Life Sciences group and joined Atlas Venture in 2002. ... InfaCare Pharmaceuticals, Stromedix, Vitae Pharmaceuticals and Zafgen. ...
15 June 2009 Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to ... Vitae Pharmaceuticals is an emerging pharmaceutical company building a clinical ...
Digizyme - Web & Multimedia Design for the Sciences These range from individual research laboratory sites, to pharmaceutical & large corporate intranet sites. ... Synta Pharmaceuticals. Vitae Pharmaceuticals. Biotechnology ...
Un equipo líder en su clase con demostrada trayectoria en ... Before joining moksha8, Mr. Howarth was Chief Business Officer at Vitae Pharmaceuticals leading commercial, business development and legal. ...
Vitae Receives $8 Million Payment from Boehringer Ingelheim ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned ...
Send to a Friend Atlas has been a spectacular partner for all these years, always constructive in ... Send to a Friend. Vitae Pharmaceuticals. Required fields indicated by ...
BioWorld Today Talk about making the pulse race: Privately held Vitae Pharmaceuticals Inc. ... privately held Vitae changed its name and raised $34 million in equity financing ...
Vitae Pharma borrows $13M for heart, Alzheimer drug projects ... Vitae Pharmaceuticals, Ft. Washington, borrows $13 million from Silicon Valley Bank and Oxford Finance Corp. for work on high blood pressure and Alzheimer's ...
Oxford Finance :: News :: Recent Press Releases Titan Pharmaceuticals to Receive $3 Million Loan Additional $1 Million in Equity Raised ... Vitae Pharmaceuticals Secures $13 Million in Debt Financing ...
News: Vitae Regains Rights to Preclinical Renin Inhibitor ... Vitae Pharmaceuticals has reacquired full rights to its renin inhibitor program from GlaxoSmithKline. The companies inked a deal in June 2005 vaued ...
Summary of NURX PHARMACEUTICALS, INC. - Yahoo! Finance Vitae"), pursuant to which we acquired an exclusive, worldwide ... payments made pursuant to the license Agreement with Vitae Pharmaceuticals, Inc. ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Digizyme - Web & Multimedia Design for the Sciences Merrimack Pharmaceuticals. Novartis Pharmaceuticals. Ohmx Corporation ... Tempo Pharmaceuticals. Vitae Pharmaceuticals. Biotechnology. ActivBiotics. AdipoGenix ...
Quest Group International, Inc. Raises $20 Million, Acquires ... Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a ... Vitae and GlaxoSmithKline formed one of 2005's largest preclinical partnerships ...
Business Directory | Gastroenterology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Vitae Pharmaceuticals Appoints Industry Veteran, Donald ... Vitae Pharmaceuticals Appoints Industry Veteran, Donald Hayden, as Chairman ... an emerging pharmaceutical company dedicated to the discovery and development of ...
Attendees | Sofinnova Biopharma Partnering Conference 2009 VentiRx Pharmaceuticals. Vitae Pharmaceuticals. 2009 Attending Companies. Abbott Japan ... Vitae Pharmaceuticals. 2008 Attending Japanese Companies. Ajinomoto ...
Business & Financial News, Breaking US & International News ... Quantrx Biomedical Corp. To Acquire NuRx Pharmaceuticals Inc ... that it has entered into a license agreement with Vitae Pharmaceuticals, Inc. ...
Pharmaceutical & Biotechnology - philly.com Thatâ€™s what makes yesterdayâ€™s announcement by Fort Washingtonâ€™s Vitae Pharmaceuticals Inc. and Germanyâ€™s Boehringer Ingelheim so interesting. ...
BioSpace - Vitae Pharmaceuticals, Inc. News, Search Jobs, Events Boehringer Ingelheim Corporation And Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals, Inc. to Reacquire Full Rights to Renin Inhibitor Program for ...
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
New blood pressure meds available Vitae, based in Fort Washington, Pa. and formerly known as Concurrent Pharmaceuticals, ... Vitae will also receive committed funding to support research activities conducted by ...
Yuri Bukhtiyarov - LinkedIn Vitae Pharmaceuticals (Privately Held; 11-50 employees; Pharmaceuticals industry) ... (Public Company; 1001-5000 employees; Pharmaceuticals industry) ...
View Online Source PETER TU, ESQ. Vitae Pharmaceuticals, Inc. ( Fort Washington, PA) ...
Summary of NURX PHARMACEUTICALS, INC. - Yahoo! Finance On May 11, 2007, we entered into a license agreement with Vitae Pharmaceuticals, Inc. (" Vitae"), pursuant to which we acquired an exclusive, worldwide ...
Boehringer Ingelheim: Privacy Has its Virtues - IN VIVO BI and Vitae partner on 11beta-HSD1 inhibitors for diabetes, Deal 10/2007 ... European Pharmaceutical Companies Patent Expirations Pharmaceutical Profits R&D ...
Vitae Pharmaceuticals, Inc. Secures $13 Million in Debt ... Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to the ... Vitae Pharmaceuticals is financed by leading venture capital and ...
Prospect Venture Partners :: James B. Tananbaum, M.D. Jim co-founded Prospect Venture Partners II and III, as dedicated ... Infinity Pharmaceuticals (NASDAQ:INFI), Vitae Pharmaceuticals, and Amira Pharmaceuticals. ...
Pauline Javorski - LinkedIn Human Resources at Vitae Pharmaceuticals, Inc. HR Generalist at Wyeth ... (Public Company; 10,001 or more employees; WYE; Pharmaceuticals industry) ...
Jan. 5, 2005 Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, has announced its ... Nereus Pharmaceuticals, a pioneer in drug discovery and development from marine ...
Industrial Workshops Abbott, Acadia Pharmaceuticals, Active BioTech, Aerospace Corporation, Air ... Vernalis, ViroPharma, Vitae Pharmaceuticals, Waters Corporation, ...
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Oxford Finance :: Portfolio :: Clients CardioFocus. Catalyst Biosciences. Celator Pharmaceuticals. Celleration. Cellomics ... Verus Pharmaceuticals. Vical. VisualSonics. Vitae Pharmaceuticals. VLST ...
What is the name of the new renin inhibitor compound from ... Vitae Pharma is going to be going into clinical trials this year with a new renin inhibitor compound for hypertension. I need to find out the name of this compound. ...
Clients Stromedix. Vitae Pharmaceuticals. Xenome. Marketed Pharmaceuticals. Access Pharmaceuticals ... Idenix Pharmaceuticals. Millennium The Takeda Oncology Company. Mutual ...
Venrock Previously, Steve served on the boards of Vitae Pharmaceuticals (a Venrock-backed company), Ilypsa (acquired by Amgen), Affymax (acquired by GSK) ...
Sapphire Energy - Board of Directors Sapphire Energy has built a revolutionary platform that uses photosynthetic microorganisms to produce a renewable, high-value replacement for fossil fuel petroleum.
BioScan : V BioWorld Online is the news service of record for the biotechnology industry and is updated every business morning. ... Vitae Pharmaceuticals Inc. ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a ... Vitae was founded with the goal to create a paradigm breakthrough in the field ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an entrepreneurial, vibrant and growing pharmaceutical ... Vitae Pharmaceuticals offers a competitive compensation and benefits ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.461.2000. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference
Vitae Pharmaceuticals to Reacquire Full Rights to Renin ... Vitae Pharmaceuticals to Reacquire Full Rights to Renin Inhibitor Program for ... an emerging pharmaceutical company dedicated to the discovery and development of ...
The Business Journal of Milwaukee: Vitae related content Vitae Pharmaceuticals Inc. initiated a phase-I clinical trial Monday of its experimental... Vitae Pharmaceuticals will receive $42 million in upfront and near ...
Heart Attack - Vitae Initiates Phase 1 Trial of Novel Renin ... Vitae Pharmaceuticals Vitae Pharmaceuticals is an integrated ... Vitae Pharmaceuticals is financed by leading corporate and venture capital investors, ...
Vitae Pharmaceuticals And Boehringer Ingelheim Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
Vitae Pharmaceuticals gets $13M in financing - Philadelphia ... Vitae Pharmaceuticals gets $13M in financing ... Vitae Pharmaceuticals Inc. entered into a $13 million loan agreement Tuesday with Silicon Valley Bank and Oxford Finance Corp. ...
Vitae Receives $8 Million Payment from Boehringer Ingelheim ... Vitae Receives $8 Million Payment from Boehringer Ingelheim for ... Vitae Pharmaceuticals is financed by leading corporate and venture capital investors, ...
Peter Barrett Peter Barrett is a Partner in the Life Sciences group and joined Atlas Venture in 2002. ... InfaCare Pharmaceuticals, Stromedix, Vitae Pharmaceuticals and Zafgen. ...
NEA - Team Member Display ... Pharmaceuticals, TargetRx, Trine Pharmaceuticals, and Vitae ... PatientKeeper, Russ Pharmaceuticals, Scandipharm, Sepracor, Surgical Health, and Zymark Corporation. ...
Database of career stories - www.vitae.ac.uk/policy-practice Vitae is committed to enhancing the quality and output of the research base in ... Regulatory affairs consultant, freelance consultant for pharmaceutical companies ...
在新兴市场和全球合作中拥有出色记录的一流团队 Before joining moksha8, Mr. Howarth was Chief Business Officer at Vitae Pharmaceuticals leading commercial, business development and legal. ...
Venrock Vitae Pharmaceuticals is a drug discovery company bringing together the basic ... sciences to form a powerful, efficient and effective platform for drug design and development. ...
15 June 2009 Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to ... Vitae Pharmaceuticals is an emerging pharmaceutical company building aclinical ...
Digizyme - Web & Multimedia Design for the Sciences These range from individual research laboratory sites, to pharmaceutical & large corporate intranet sites. ... Synta Pharmaceuticals. Vitae Pharmaceuticals. Biotechnology ...
Vitae Pharma borrows $13M for heart, Alzheimer drug projects ... Vitae Pharmaceuticals, Ft. Washington, borrows $13 million from Silicon Valley ...
Quest Group International, Inc. Raises $20 Million, Acquires ... Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a ... Vitae and GlaxoSmithKline formed one of 2005's largest preclinical partnerships ...
BioWorld Today Talk about making the pulse race: Privately held Vitae Pharmaceuticals Inc. ... privately held Vitae changed its name and raised $34 million in equity financing ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Summary of NURX PHARMACEUTICALS, INC. - Yahoo! Finance Vitae"), pursuant to which we acquired an exclusive, worldwide ... payments made pursuant to the license Agreement with Vitae Pharmaceuticals, Inc. ...
BioSpace - Send News Article From Email: News Headline. Vitae Pharmaceuticals, Inc. to Present at Windhover Information Inc.'s Annual Therapeutic Area Partnerships Conference. Your Message ...
Portfolio Company News Vitae Pharmaceuticals Appoints Richard Gregg, M.D. as Chief Scientific Officer ... Vitae Pharmaceuticals is an emerging pharmaceutical company with a unique and ...
News: Vitae Regains Rights to Preclinical Renin Inhibitor ... Vitae Pharmaceuticals has reacquired full rights to its renin inhibitor program from GlaxoSmithKline. ...
Oxford Finance :: News :: Recent Press Releases Titan Pharmaceuticals to Receive $3 Million Loan Additional $1 Million in Equity Raised ... Vitae Pharmaceuticals Secures $13 Million in Debt Financing ...
Digizyme - Web & Multimedia Design for the Sciences Merrimack Pharmaceuticals. Novartis Pharmaceuticals. Ohmx Corporation ... Tempo Pharmaceuticals. Vitae Pharmaceuticals. Biotechnology. ActivBiotics. AdipoGenix ...
Vitae Pharmaceuticals Appoints Industry Veteran, Donald ... Vitae Pharmaceuticals Appoints Industry Veteran, Donald Hayden, as Chairman ... an emerging pharmaceutical company dedicated to the discovery and development of ...
Attendees | Sofinnova Biopharma Partnering Conference 2009 VentiRx Pharmaceuticals. Vitae Pharmaceuticals. 2009 Attending Companies. Abbott Japan ... Vitae Pharmaceuticals. 2008 Attending Japanese Companies. Ajinomoto ...
Pauline Javorski - LinkedIn Human Resources at Vitae Pharmaceuticals, Inc. HR Generalist at Wyeth ... (Public Company; 10,001 or more employees; WYE; Pharmaceuticals industry) ...
New blood pressure meds available GlaxoSmithKline plc and Vitae Pharmaceuticals Inc. will jointly develop and market blood ... Vitae will also receive committed funding to support research ...
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
Comtex News Network - Research and Markets: Strategies for ... Pharmaceutical companies are seeking new ways to build early-stage pipelines. ... Vitae Pharmaceuticals. GlaxoSmithKline/Concert Pharmaceuticals. Sanofi ...
Business Directory | Gastroenterology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
Summary of NURX PHARMACEUTICALS, INC. - Yahoo! Finance ... we entered into a license agreement with Vitae Pharmaceuticals, Inc. ... The Company paid Vitae an upfront licensing fee of $2,100,000 and $50,000 for its ...
BioSpace - Vitae Pharmaceuticals, Inc. News, Search Jobs, Events Vitae Pharmaceuticals, Inc. Initiates Phase 1 Trial of Novel Renin Inhibitor 9/21/2009 9: ... Boehringer Ingelheim Corporation And Vitae Pharmaceuticals, Inc. ...
Pharmaceutical & Biotechnology - philly.com Thatâ€™s what makes yesterdayâ€™s announcement by Fort Washingtonâ€™s Vitae Pharmaceuticals Inc. and Germanyâ€™s Boehringer Ingelheim so interesting. ...
Boehringer Ingelheim and Vitae Pharmaceuticals Join Forces ... Boehringer Ingelheim and Vitae Pharmaceuticals Join Forces Against Alzheimer's ... a German company, and Vitae Pharmaceuticals of Fort Washington, Pa. announced ...
Yuri Bukhtiyarov - LinkedIn Vitae Pharmaceuticals (Privately Held; 11-50 employees; Pharmaceuticals industry) ... (Public Company; 1001-5000 employees; Pharmaceuticals industry) ...
Oxford Finance :: Portfolio :: Clients CardioFocus. Catalyst Biosciences. Celator Pharmaceuticals. Celleration. Cellomics ... Verus Pharmaceuticals. Vical. VisualSonics. Vitae Pharmaceuticals. VLST ...
Prospect Venture Partners :: James B. Tananbaum, M.D. Jim co-founded Prospect Venture Partners II and III, as dedicated ... Infinity Pharmaceuticals (NASDAQ:INFI), Vitae Pharmaceuticals, and Amira Pharmaceuticals. ...
BioTech Career Center The Biotech Career Center is a portal for scientists seeking career advancement with hundreds of up to date job listings as well as a job search agent. In addition, ...
View Online Source PETER TU, ESQ. Vitae Pharmaceuticals, Inc. ( Fort Washington, PA) ...
Boehringer teams up with Vitae on BACE project for ... Boehringer teams up with Vitae on BACE project for Alzheimer's ... Pharmaceuticals to research and develop beta-secretase (BACE) inhibitors for the ...
Jan. 5, 2005 Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, has announced its ... Nereus Pharmaceuticals, a pioneer in drug discovery and development from marine ...
Industrial Workshops Abbott, Acadia Pharmaceuticals, Active BioTech, Aerospace Corporation, Air ... Vernalis, ViroPharma, Vitae Pharmaceuticals, Waters Corporation, ...
Corporate Governance Board of Directors, Vertex ... Find information on Vertex Pharmaceuticals board of directors. ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy at the University of Michigan. ...
Clients Stromedix. Vitae Pharmaceuticals. Xenome. Marketed Pharmaceuticals. Access Pharmaceuticals ... Idenix Pharmaceuticals. Millennium The Takeda Oncology Company. Mutual ...
What is the name of the new renin inhibitor compound from ... Vitae Pharma is going to be going into clinical trials this year with a new renin inhibitor compound for hypertension. I need to find out the name of this compound. ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a ... Vitae was founded with the goal to create a paradigm breakthrough in the field ...
Vitae Pharmaceuticals Vitae Pharmaceuticals is an entrepreneurial, vibrant and growing pharmaceutical ... Vitae Pharmaceuticals offers a competitive compensation and benefits ...
Vitae Pharmaceuticals Vitae Pharmaceuticals and Boehringer Ingelheim Announce a Major Collaboration to Develop and Commercialize Novel Treatments for Diabetes and Metabolic Diseases ...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.461.2000. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Vitae Pharmaceuticals gets $13M in financing - Philadelphia ... Vitae Pharmaceuticals gets $13M in financing ... Vitae Pharmaceuticals Inc. entered into a $13 million loan agreement Tuesday with Silicon Valley Bank and Oxford Finance Corp. ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference
Portfolio Company News Vitae Pharmaceuticals to Reacquire Full Rights to Renin Inhibitor Program for ... Vitae Pharmaceuticals is financed by leading corporate and venture capital ...
Vitae Pharmaceuticals links up with Boehringer Ingelheim for ... The small Fort Washington drug developer will receive $42 million up front from the large German pharmaceutical maker.
The Business Journal of Milwaukee: Vitae related content Vitae Pharmaceuticals Inc. initiated a phase-I clinical trial Monday of its experimental... Vitae Pharmaceuticals will receive $42 million in upfront and near ...
Boehringer Ingelheim and Vitae Pharmaceuticals Join Forces ... Boehringer Ingelheim and Vitae Pharmaceuticals Join Forces Against Alzheimer's ... a German company, and Vitae Pharmaceuticals of Fort Washington, Pa. announced ...
Company Profile: Vitae Pharmaceuticals, Inc - Portfolio.com Vitae Pharmaceuticals is an emerging pharmaceutical company with a unique and ... Vitae's goal is to discover, develop and commercialize innovative new medicines, ...
PrimarySearch_ki Vitae Pharmaceuticals. Bioorg Med Chem Lett. 19: 3541-5 (2009) Renin. Homo sapiens (human) ... Vitae Pharmaceuticals. Bioorg Med Chem Lett. 19: 3541-5 (2009) Renin ...
Vitae Pharmaceuticals And Boehringer Ingelheim Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
Peter Barrett Peter Barrett is a Partner in the Life Sciences group and joined Atlas Venture in 2002. ... InfaCare Pharmaceuticals, Stromedix, Vitae Pharmaceuticals and Zafgen. ...
Vitae Receives $8 Million Payment from Boehringer Ingelheim ... Vitae Receives $8 Million Payment from Boehringer Ingelheim for ... Vitae Pharmaceuticals is financed by leading corporate and venture capital investors, ...
NEA - Team Member Display ... Pharmaceuticals, TargetRx, Trine Pharmaceuticals, and Vitae ... PatientKeeper, Russ Pharmaceuticals, Scandipharm, Sepracor, Surgical Health, and Zymark Corporation. ...
Venrock Vitae Pharmaceuticals is a drug discovery company bringing together the basic ... sciences to form a powerful, efficient and effective platform for drug design and development. ...
15 June 2009 Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to ... Vitae Pharmaceuticals is an emerging pharmaceutical company building aclinical ...
A best-in-class team with proven track record in emerging ... Before joining moksha8, Mr. Howarth was Chief Business Officer at Vitae Pharmaceuticals leading commercial, business development and legal. ...
Digizyme - Web & Multimedia Design for the Sciences These range from individual research laboratory sites, to pharmaceutical & large corporate intranet sites. ... Synta Pharmaceuticals. Vitae Pharmaceuticals. Biotechnology ...
Quest Group International, Inc. Raises $20 Million, Acquires ... Vitae Pharmaceuticals is an emerging pharmaceutical company dedicated to being a ... Vitae and GlaxoSmithKline formed one of 2005's largest preclinical partnerships ...
BioWorld Today Talk about making the pulse race: Privately held Vitae Pharmaceuticals Inc. ... privately held Vitae changed its name and raised $34 million in equity financing ...
Vitae receives 11Beta-HSD-1 program milestone payment from ... Vitae and Boehringer Ingelheim initiated their strategic alliance in October of 2007. ... payment from Boehringer Ingelheim Vitae Pharmaceuticals, Inc. ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and our management team. ... Formerly Chairman of Vitae Pharmaceuticals, Inc. ...
Pharmacy Choice - Pharmaceutical News - Vitae Pharmaceuticals ... Pharmacy Choice - online community for the pharmacist, pharmacy technician and pharmacy student, offering pharmacy jobs, continuing education, pharmaceutical news and ...
Vitae Pharma borrows $13M for heart, Alzheimer drug projects ... Vitae Pharmaceuticals, Ft. Washington, borrows $13 million from Silicon Valley ...
Summary of NURX PHARMACEUTICALS, INC. - Yahoo! Finance Vitae"), pursuant to which we acquired an exclusive, worldwide ... payments made pursuant to the license Agreement with Vitae Pharmaceuticals, Inc. ...
BioSpace - Send News Article From Email: News Headline. Vitae Pharmaceuticals, Inc. to Present at Windhover Information Inc.'s Annual Therapeutic Area Partnerships Conference. Your Message ...
Oxford Finance :: News :: Recent Press Releases Titan Pharmaceuticals to Receive $3 Million Loan Additional $1 Million in Equity Raised ... Vitae Pharmaceuticals Secures $13 Million in Debt Financing ...
News: Vitae Regains Rights to Preclinical Renin Inhibitor ... Vitae Pharmaceuticals has reacquired full rights to its renin inhibitor program from GlaxoSmithKline. ...
Digizyme - Web & Multimedia Design for the Sciences Merrimack Pharmaceuticals. Novartis Pharmaceuticals. Ohmx Corporation ... Tempo Pharmaceuticals. Vitae Pharmaceuticals. Biotechnology. ActivBiotics. AdipoGenix ...
Vitae Pharmaceuticals Appoints Industry Veteran, Donald ... Vitae Pharmaceuticals Appoints Industry Veteran, Donald Hayden, as Chairman ... an emerging pharmaceutical company dedicated to the discovery and development of ...
Healthcare Sales & Marketing Network News: Bristol Myers-Squibb Bristol Myers-Squibb: News, Information, Networking and Market Research for sales and marketing professionals in medical devices, pharmaceuticals and biotechnology.
Attendees | Sofinnova Biopharma Partnering Conference 2009 VentiRx Pharmaceuticals. Vitae Pharmaceuticals. 2009 Attending Companies. Abbott Japan ... Vitae Pharmaceuticals. 2008 Attending Japanese Companies. Ajinomoto ...
Pauline Javorski - LinkedIn Human Resources at Vitae Pharmaceuticals, Inc. HR Generalist at Wyeth ... (Public Company; 10,001 or more employees; WYE; Pharmaceuticals industry) ...
Business Directory | Gastroenterology Classification: Pharmaceutical Companies, Pharmaceuticals - Therapeutic ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
New blood pressure meds available GlaxoSmithKline plc and Vitae Pharmaceuticals Inc. will jointly develop and market blood ... Vitae will also receive committed funding to support research ...
Prospect Venture Partners :: Portfolio Amira Pharmaceuticals, Inc. San Diego, CA. Developing a new generation of nucleic acid ... Vitae Pharmaceuticals, Inc. Fort Washington, PA. Developing novel approaches to the ...
Comtex News Network - Research and Markets: Strategies for ... Pharmaceutical companies are seeking new ways to build early-stage pipelines. ... Vitae Pharmaceuticals. GlaxoSmithKline/Concert Pharmaceuticals. Sanofi ...
Summary of NURX PHARMACEUTICALS, INC. - Yahoo! Finance ... we entered into a license agreement with Vitae Pharmaceuticals, Inc. ... The Company paid Vitae an upfront licensing fee of $2,100,000 and $50,000 for its ...
BioSpace - Vitae Pharmaceuticals, Inc. News, Search Jobs, Events Vitae Pharmaceuticals, Inc. Initiates Phase 1 Trial of Novel Renin Inhibitor 9/21/2009 9: ... Boehringer Ingelheim Corporation And Vitae Pharmaceuticals, Inc. ...
Yuri Bukhtiyarov - LinkedIn Vitae Pharmaceuticals (Privately Held; 11-50 employees; Pharmaceuticals industry) ... (Public Company; 1001-5000 employees; Pharmaceuticals industry) ...
Oxford Finance :: Portfolio :: Clients CardioFocus. Catalyst Biosciences. Celator Pharmaceuticals. Celleration. Cellomics ... Verus Pharmaceuticals. Vical. VisualSonics. Vitae Pharmaceuticals. VLST ...
Prospect Venture Partners :: James B. Tananbaum, M.D. Jim co-founded Prospect Venture Partners II and III, as dedicated ... Infinity Pharmaceuticals (NASDAQ:INFI), Vitae Pharmaceuticals, and Amira Pharmaceuticals. ...
BioTech Career Center The Biotech Career Center is a portal for scientists seeking career advancement with hundreds of up to date job listings as well as a job search agent. In addition, ...
View Online Source PETER TU, ESQ. Vitae Pharmaceuticals, Inc. ( Fort Washington, PA) ...
Jan. 5, 2005 Vitae Pharmaceuticals, formerly Concurrent Pharmaceuticals, has announced its ... Nereus Pharmaceuticals, a pioneer in drug discovery and development from marine ...
hireBio Offers job listings, resumes, and resources for employers and candidates in the pharmaceutical and biotechnology fields.
Industrial Workshops Abbott, Acadia Pharmaceuticals, Active BioTech, Aerospace Corporation, Air ... Vernalis, ViroPharma, Vitae Pharmaceuticals, Waters Corporation, ...
Vitae Pharmaceuticals Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to ...
Vitae Pharmaceuticals Vitae Pharmaceuticals offers a competitive compensation and benefits package ... Vitae Pharmaceuticals is an equal opportunity employer. ...
Vitae Pharmaceuticals - Fort Washington, PA @ YELLOWPAGES.COM Vitae Pharmaceuticals - Health & Beauty - Pharmaceutical Retail in Fort Washington, PA. Get contact info, directions and more at YELLOWPAGES.COM
Vitae Pharmaceuticals - Irvine, CA: Citysearch.com Get details on Vitae Pharmaceuticals - Irvine, CA, at Citysearch - over 1 million user reviews & editorials about local businesses.
Vitae Pharmaceuticals Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference ... Ingelheim and Vitae Pharmaceuticals announce a major ...
21-FEB-05 | Vitae Pharmaceuticals Price: $4.95 | Vitae Pharmaceuticals, Fort Washington, Pennsylvania, has ... Vitae Pharmaceuticals. Chemistry and Industry Vitae Pharmaceuticals. ...
Article: Vitae Pharmaceuticals.(Manufacturers) Register today for a free trial, credit card req'd. Find Medical Marketing & Media articles plus many other academic journal articles, magazine articles & newspaper a...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.461.2000. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Vitae Pharmaceuticals gets $13M in financing - Philadelphia ... Vitae Pharmaceuticals gets $13M in financing. Philadelphia Business Journal ... Vitae Pharma moves ahead with GSK and $15M deals ... Vitae Pharmaceuticals Inc. ...
Portfolio Company News Fort Washington, PA, September 21, 2009 - Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is financed by leading corporate and venture capital ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference ... Vitae Pharmaceuticals is an integrated discovery and ...
Vitae Pharmaceuticals, Inc. to Present at Windhover ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals, Inc. • Windhover Information Inc. • Biotech/Pharma - Events ...
Portfolio Company News Vitae Pharmaceuticals to Reacquire Full Rights to Renin Inhibitor Program for Hypertension. FORT WASHINGTON, Pa.--(BUSINESS WIRE) - Vitae Pharmaceuticals, Inc. ...
The Business Journal of Milwaukee: Vitae related content Bizjournals is one of the leading sources of comprehensive business news ... Vitae Pharmaceuticals will receive $42 million in upfront and near-term payments ...
Boehringer Ingelheim and Vitae Pharmaceuticals Join Forces ... Boehringer Ingelheim and Vitae Pharmaceuticals Join Forces Against Alzheimer's ... a German company, and Vitae Pharmaceuticals of Fort Washington, Pa. announced ...
Vitae Pharmaceuticals - Irvine, California (CA) | Company Reports Vitae Pharmaceuticals - Irvine, California (CA) company information. Find contact info, annual sales, number of employees & premium business reports at Manta.com.
Boehringer and Vitae Partner on Alzheimer's Drugs German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the potential to slow or even ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... BusinessWire - Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an integrated discovery and development company with a ...
Vitae Pharmaceuticals initiates Phase 1 clinical trial of its ... Vitae ... Vitae Pharmaceuticals initiates Phase 1 clinical trial of its novel ... Additionally, Vitae will evaluate pharmacodynamic markers of ...
Vitae Pharma borrows $13M for heart, Alzheimer drug projects ... Vitae Pharmaceuticals, Ft. Washington, borrows $13 million ... Vitae Pharma borrows $13M for heart, Alzheimer drug projects. Vitae ... Vitae's management ...
Vitae Receives $8 Million Payment from Boehringer Ingelheim ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is financed by leading corporate and venture capital ...
Vitae Pharmaceuticals And Boehringer Ingelheim Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
NEA - Team Member Display NEA.com, Team Member Display ... Pharmaceuticals, TargetRx, Trine Pharmaceuticals, and Vitae Pharmaceuticals. ... Vitae Pharmaceuticals, Inc. Active Investments ...
Venrock Venrock, a premier venture capital firm originally established as the venture capital arm of the Rockefeller family, continues a seven-decade tradition of funding ...
15 June 2009 Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to ... Pharmaceuticals is an emerging pharmaceutical ... Vitae Pharmaceuticals ...
Digizyme - Web & Multimedia Design for the Sciences Pharmaceutical / Medical Device. Acceleron Pharmaceuticals ... Synta Pharmaceuticals. Vitae Pharmaceuticals. Biotechnology. ActivBiotics. Beyond Genomics ...
BioWorld Today Talk about making the pulse race: Privately held Vitae Pharmaceuticals Inc. ... Under the terms, Vitae gets an up-front payment comprised of cash and an equity ...
Vitae receives 11Beta-HSD-1 program milestone payment from ... Vitae ... Vitae and Boehringer Ingelheim initiated their strategic alliance in ... payment from Boehringer Ingelheim Vitae Pharmaceuticals, Inc. ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy ...
Oxford Finance :: News :: Recent Press Releases Vitae Pharmaceuticals Secures $13 Million in Debt Financing. 9/16/08 ... Somaxon Pharmaceuticals Secures up to $65 Million in Financing. 5/7/08 ...
Pharmacy Choice - Pharmaceutical News - Vitae Pharmaceuticals ... Pharmacy Choice - online community for the pharmacist, pharmacy technician and pharmacy student, offering pharmacy jobs, continuing education, pharmaceutical news and ...
Quest Group International, Inc. Raises $20 Million, Acquires ... Quest Group International, Inc. Raises $20 Million, Acquires Extensive New Generation Oncology Portfolio and Announces ... About Vitae Pharmaceuticals, Inc. ...
Summary of NURX PHARMACEUTICALS, INC. - Yahoo! Finance ... 11, 2007, we entered into a license agreement with Vitae Pharmaceuticals, Inc. ... payments made pursuant to the license Agreement with Vitae Pharmaceuticals, Inc. ...
BioSpace - Send News Article SEND NEWS ARTICLE TO FRIEND. To Email: From Email: News Headline. Vitae Pharmaceuticals, Inc. ... to Present at Windhover Information Inc.'s Annual Therapeutic ...
News: Vitae Regains Rights to Preclinical Renin Inhibitor ... Vitae Pharmaceuticals has reacquired full rights to its renin inhibitor program ... Vitae and GSK began discussions in spring to faciliate a smooth transition of ...
Digizyme - Web & Multimedia Design for the Sciences Novartis Pharmaceuticals. Ohmx Corporation. Pervasis Therapeutics ... Tempo Pharmaceuticals. Vitae Pharmaceuticals. Biotechnology. ActivBiotics. AdipoGenix ...
Vitae Pharmaceuticals Appoints Industry Veteran, Donald ... FORT WASHINGTON, Pa., April 6 /PRNewswire/ -- Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is financed by leading corporate and venture capital ...
Healthcare Sales & Marketing Network News: Bristol Myers-Squibb ... and Market Research for sales and marketing professionals in medical devices, pharmaceuticals and biotechnology. ... Vitae Pharmaceuticals Appoints ...
Pauline Javorski - LinkedIn View Pauline Javorski's professional profile on LinkedIn. LinkedIn is the world's largest business network, ... Resources at Vitae Pharmaceuticals, Inc. HR ...
Pharmaceutical & Biotechnology - philly.com Welcome to Philly.com's Job Search Site, powered by Monster, the biggest and most comprehensive Internet Job Search Engine ... Vitae Pharmaceuticals links up ...
Business Directory | Gastroenterology Valeant Pharmaceuticals International. Country: United States of America ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
New blood pressure meds available GlaxoSmithKline plc and Vitae Pharmaceuticals Inc. ... Vitae will also receive committed funding to support research activities ...
Prospect Venture Partners :: Portfolio Vitae. Zelos Inc. Developing and commercializing therapeutics for the treatment of Celiac Sprue ... Vitae Pharmaceuticals, Inc. Fort Washington, PA ...
Business Directory | Cardiology Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ... Invasive Monitoring and Testing, Pharmaceuticals - Diagnostic, Technology, ...
Comtex News Network - Research and Markets: Strategies for ... Boehringer Ingelheim/Vitae Pharmaceuticals. GlaxoSmithKline/Concert Pharmaceuticals ... Pharmaceuticals. Roche. Takeda Pharmaceuticals. Vitae Pharmaceuticals ...
Summary of NURX PHARMACEUTICALS, INC. - Yahoo! Finance ... 11, 2007, we entered into a license agreement with Vitae Pharmaceuticals, Inc. (" Vitae"), pursuant to which we acquired an exclusive, worldwide sublicense, with ...
The 7th Annual BIO Asia Partnering Conference - 2010 Attendees Tioga Pharmaceuticals. Valetta Health. Vectura Group Plc. Vitae Pharmaceuticals, Inc. XOMA Ltd. Zobio *As of 12/18/09. ACRONET Corporation ...
Yuri Bukhtiyarov - LinkedIn View Yuri Bukhtiyarov's professional profile on LinkedIn. LinkedIn is the world's largest business network, ... at Vitae Pharmaceuticals. Past. Senior ...
Oxford Finance :: Portfolio :: Clients 3-Dimensional Pharmaceuticals. Acceleron Pharma. Achillion. Advanced ... VisualSonics. Vitae Pharmaceuticals. VLST Corporation. Zogenix. ZONARE Medical Systems ...
Vitae Pharmaceuticals Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to ...
Vitae Pharmaceuticals Vitae Pharmaceuticals offers a competitive compensation and benefits package ... Vitae Pharmaceuticals is an equal opportunity employer. ...
Vitae Pharmaceuticals - Fort Washington, PA @ YELLOWPAGES.COM Vitae Pharmaceuticals - Health & Beauty - Pharmaceutical Retail in Fort Washington, PA. Get contact info, directions and more at YELLOWPAGES.COM
Vitae Pharmaceuticals - Irvine, CA: Citysearch.com Get details on Vitae Pharmaceuticals - Irvine, CA, at Citysearch - over 1 million user reviews & editorials about local businesses.
Vitae Pharmaceuticals Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference ... Ingelheim and Vitae Pharmaceuticals announce a major ...
21-FEB-05 | Vitae Pharmaceuticals Price: $4.95 | Vitae Pharmaceuticals, Fort Washington, Pennsylvania, has ... Vitae Pharmaceuticals. Chemistry and Industry Vitae Pharmaceuticals. ...
Article: Vitae Pharmaceuticals.(Manufacturers) Register today for a free trial, credit card req'd. Find Medical Marketing & Media articles plus many other academic journal articles, magazine articles & newspaper a...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.461.2000. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Vitae Pharmaceuticals Prior to joining VITAE PHARMACEUTICALS, Inc. ... Prior to joining VITAE PHARMACEUTICALS, Ms. Fiumenero spent 13 years at Bristol ... © 2007 Vitae Pharmaceuticals, Inc. ...
Portfolio Company News Fort Washington, PA, September 21, 2009 - Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is financed by leading corporate and venture capital ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference ... Vitae Pharmaceuticals is an integrated discovery and ...
Vitae Pharmaceuticals, Inc. to Present at Windhover ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals, Inc. • Windhover Information Inc. • Biotech/Pharma - Events ...
Portfolio Company News Vitae Pharmaceuticals to Reacquire Full Rights to Renin Inhibitor Program for Hypertension. FORT WASHINGTON, Pa.--(BUSINESS WIRE) - Vitae Pharmaceuticals, Inc. ...
Vitae Pharmaceuticals to Reacquire Full Rights to Renin ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is financed by leading corporate and venture capital ...
The Business Journal of Milwaukee: Vitae related content Bizjournals is one of the leading sources of comprehensive business news ... Vitae Pharmaceuticals will receive $42 million in upfront and near-term payments ...
Boehringer Ingelheim and Vitae Pharmaceuticals Join Forces ... Boehringer Ingelheim and Vitae Pharmaceuticals Join Forces Against Alzheimer's ... a German company, and Vitae Pharmaceuticals of Fort Washington, Pa. announced ...
Vitae Pharmaceuticals - Irvine, California (CA) | Company Reports Vitae Pharmaceuticals - Irvine, California (CA) company information. Find contact info, annual sales, number of employees & premium business reports at Manta.com.
BI gets BACE1 inhibitors from Vitae in their second alliance ... BI gets BACE1 inhibitors from Vitae in their second alliance on Strategic ... for metabolic diseases, Vitae Pharmaceuticals (small-molecule drug discovery) ...
Boehringer and Vitae Partner on Alzheimer's Drugs German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the potential to slow or even ...
VITA LIFE SCIENCES LIMITED Information | Business.com Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference ... BusinessWire - Vitae Pharmaceuticals, Inc. ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an integrated discovery and development company with a ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... BusinessWire - Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an integrated discovery and development company with a ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Where do you ... Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area ... Vitae Pharmaceuticals is an integrated discovery and ...
Vitae Pharmaceuticals, Inc Company Profile | Company Information Vitae Pharmaceuticals, Inc Company Profile - View Vitae Pharmaceuticals, Inc Company Information. Financial information, key executives, company news and more.
NEA - Team Member Display NEA.com, Team Member Display ... Pharmaceuticals, TargetRx, Trine Pharmaceuticals, and Vitae Pharmaceuticals. ... Vitae Pharmaceuticals, Inc. Active Investments ...
Venrock Venrock, a premier venture capital firm originally established as the venture capital arm of the Rockefeller family, continues a seven-decade tradition of funding ...
Vitae Pharmaceuticals And Boehringer Ingelheim Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy ...
15 June 2009 Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to ... Pharmaceuticals is an emerging pharmaceutical ... Vitae Pharmaceuticals ...
A best-in-class team with proven track record in emerging ... ... Business Officer at Vitae Pharmaceuticals leading commercial, business development and legal. ... of Intellectual Property at Vitae Pharmaceuticals, Inc. ...
Digizyme - Web & Multimedia Design for the Sciences Pharmaceutical / Medical Device. Acceleron Pharmaceuticals ... Synta Pharmaceuticals. Vitae Pharmaceuticals. Biotechnology. ActivBiotics. Beyond Genomics ...
Vitae Pharma borrows $13M for heart, Alzheimer drug projects ... Vitae Pharmaceuticals, Ft. Washington, borrows $13 million ... Vitae Pharma borrows $13M for heart, Alzheimer drug projects. Vitae ... Vitae's management ...
Quest Group International, Inc. Raises $20 Million, Acquires ... Quest Group International, Inc. Raises $20 Million, Acquires Extensive New Generation Oncology Portfolio and Announces ... About Vitae Pharmaceuticals, Inc. ...
BioWorld Today Talk about making the pulse race: Privately held Vitae Pharmaceuticals Inc. ... Under the terms, Vitae gets an up-front payment comprised of cash and an equity ...
Oxford Finance :: News :: Recent Press Releases Vitae Pharmaceuticals Secures $13 Million in Debt Financing. 9/16/08 ... Somaxon Pharmaceuticals Secures up to $65 Million in Financing. 5/7/08 ...
Pharmacy Choice - Pharmaceutical News - Vitae Pharmaceuticals ... Pharmacy Choice - online community for the pharmacist, pharmacy technician and pharmacy student, offering pharmacy jobs, continuing education, pharmaceutical news and ...
Summary of NURX PHARMACEUTICALS, INC. - Yahoo! Finance ... 11, 2007, we entered into a license agreement with Vitae Pharmaceuticals, Inc. ... payments made pursuant to the license Agreement with Vitae Pharmaceuticals, Inc. ...
BioSpace - Send News Article SEND NEWS ARTICLE TO FRIEND. To Email: From Email: News Headline. Vitae Pharmaceuticals, Inc. ... to Present at Windhover Information Inc.'s Annual Therapeutic ...
Digizyme - Web & Multimedia Design for the Sciences Novartis Pharmaceuticals. Ohmx Corporation. Pervasis Therapeutics ... Tempo Pharmaceuticals. Vitae Pharmaceuticals. Biotechnology. ActivBiotics. AdipoGenix ...
Vitae Pharmaceuticals Appoints Industry Veteran, Donald ... FORT WASHINGTON, Pa., April 6 /PRNewswire/ -- Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is financed by leading corporate and venture capital ...
Healthcare Sales & Marketing Network News: Bristol Myers-Squibb ... and Market Research for sales and marketing professionals in medical devices, pharmaceuticals and biotechnology. ... Vitae Pharmaceuticals Appoints ...
News: Vitae Regains Rights to Preclinical Renin Inhibitor ... Vitae Pharmaceuticals has reacquired full rights to its renin inhibitor program ... Vitae and GSK began discussions in spring to faciliate a smooth transition of ...
Business Directory | Gastroenterology Valeant Pharmaceuticals International. Country: United States of America ... Vitae Pharmaceuticals. Country: North America. Classification: Pharmaceutical Companies ...
New blood pressure meds available GlaxoSmithKline plc and Vitae Pharmaceuticals Inc. ... Vitae will also receive committed funding to support research activities ...
Prospect Venture Partners :: Portfolio Vitae. Zelos Inc. Developing and commercializing therapeutics for the treatment of Celiac Sprue ... Vitae Pharmaceuticals, Inc. Fort Washington, PA ...
Comtex News Network - Research and Markets: Strategies for ... Boehringer Ingelheim/Vitae Pharmaceuticals. GlaxoSmithKline/Concert Pharmaceuticals ... Pharmaceuticals. Roche. Takeda Pharmaceuticals. Vitae Pharmaceuticals ...
Summary of NURX PHARMACEUTICALS, INC. - Yahoo! Finance ... 11, 2007, we entered into a license agreement with Vitae Pharmaceuticals, Inc. (" Vitae"), pursuant to which we acquired an exclusive, worldwide sublicense, with ...
Oxford Finance :: Portfolio :: Clients 3-Dimensional Pharmaceuticals. Acceleron Pharma. Achillion. Advanced ... VisualSonics. Vitae Pharmaceuticals. VLST Corporation. Zogenix. ZONARE Medical Systems ...
Prospect Venture Partners :: James B. Tananbaum, M.D. ... Pharmaceuticals (NASDAQ:INFI), Vitae Pharmaceuticals, and Amira Pharmaceuticals. ... investments in a number of specialty pharmaceutical companies including ...
Vitae Pharmaceuticals Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area ... Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration to ...
Vitae Pharmaceuticals Vitae Pharmaceuticals offers a competitive compensation and benefits package ... Vitae Pharmaceuticals is an equal opportunity employer. ...
Vitae Pharmaceuticals - Fort Washington, PA @ YELLOWPAGES.COM Vitae Pharmaceuticals - Health & Beauty - Pharmaceutical Retail in Fort Washington, PA. Get contact info, directions and more at YELLOWPAGES.COM
Vitae Pharmaceuticals - Irvine, CA: Citysearch.com Get details on Vitae Pharmaceuticals - Irvine, CA, at Citysearch - over 1 million user reviews & editorials about local businesses.
Vitae Pharmaceuticals Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference ... Ingelheim and Vitae Pharmaceuticals announce a major ...
21-FEB-05 | Vitae Pharmaceuticals Price: $4.95 | Vitae Pharmaceuticals, Fort Washington, Pennsylvania, has ... Vitae Pharmaceuticals. Chemistry and Industry Vitae Pharmaceuticals. ...
Article: Vitae Pharmaceuticals.(Manufacturers) Register today for a free trial, credit card req'd. Find Medical Marketing & Media articles plus many other academic journal articles, magazine articles & newspaper a...
Vitae Pharmaceuticals, Inc.: Private Company Information ... Get Vitae Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments.
Vitae Pharmaceuticals Incorporated, Fort Washington, PA ... Vitae Pharmaceuticals Incorporated, Fort Washington, PA : Reviews and maps - Yahoo! Local, 215.461.2000. Get Ratings, Reviews, Photos and more on Yahoo! Local.
Portfolio Company News Fort Washington, PA, September 21, 2009 - Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is financed by leading corporate and venture capital ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference ... Vitae Pharmaceuticals is an integrated discovery and ...
Vitae Pharmaceuticals, Inc. to Present at Windhover ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals, Inc. • Windhover Information Inc. • Biotech/Pharma - Events ...
Portfolio Company News Vitae Pharmaceuticals to Reacquire Full Rights to Renin Inhibitor Program for Hypertension. FORT WASHINGTON, Pa.--(BUSINESS WIRE) - Vitae Pharmaceuticals, Inc. ...
Vitae Pharmaceuticals to Reacquire Full Rights to Renin ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is financed by leading corporate and venture capital ...
The Business Journal of Milwaukee: Vitae related content Bizjournals is one of the leading sources of comprehensive business news ... Vitae Pharmaceuticals will receive $42 million in upfront and near-term payments ...
Vitae Pharma gets $8M milestone payment | Philadelphia ... Vitae Pharmaceuticals Inc. said it had earned an $8 million milestone payment from Boehringer Ingelheim its work on a diabetes drug.
Boehringer Ingelheim and Vitae Pharmaceuticals Join Forces ... Boehringer Ingelheim and Vitae Pharmaceuticals Join Forces Against Alzheimer's ... a German company, and Vitae Pharmaceuticals of Fort Washington, Pa. announced ...
Vitae Pharmaceuticals - Irvine, California (CA) | Company Reports Vitae Pharmaceuticals - Irvine, California (CA) company information. Find contact info, annual sales, number of employees & premium business reports at Manta.com.
Vitae Pharmaceuticals to Present at Windhover's Annual ... FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an integrated discovery and development company with a ...
Vitae Pharmaceuticals | Neurology Sites: CardiologyOncologyRespiratoryEndocrineNeurologyGastroenterology featured_supplier: not featured supplierSupplier Type: Pharmaceutical ...
Boehringer and Vitae Partner on Alzheimer's Drugs German drugmaker Boehringer Ingelheim and Vitae Pharmaceuticals said Monday they are partnering to develop enzyme-inhibiting drugs with the potential to slow or even ...
VITA LIFE SCIENCES LIMITED Information | Business.com Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference ... BusinessWire - Vitae Pharmaceuticals, Inc. ...
Vitae Pharmaceuticals to Present at Windhover's Annual ... BusinessWire - Vitae Pharmaceuticals, Inc. ... Vitae Pharmaceuticals is an integrated discovery and development company with a ...
Vitae Pharmaceuticals, Inc Company Profile | Company Information Vitae Pharmaceuticals, Inc Company Profile - View Vitae Pharmaceuticals, Inc Company Information. Financial information, key executives, company news and more.
NEA - Team Member Display NEA.com, Team Member Display ... Pharmaceuticals, TargetRx, Trine Pharmaceuticals, and Vitae Pharmaceuticals. ... Vitae Pharmaceuticals, Inc. Active Investments ...
Vitae Pharmaceuticals And Boehringer Ingelheim Announce A ... Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced that they have established a major collaboration to develop and commercialize 11beta-HSD1 inhibitors. ...
Eugene Cordes, Vertex Pharmaceuticals | vrtx.com Information about Vertex: our company, our business strategy, our history and ... Prior to joining Vitae Pharmaceuticals, Dr. Cordes was a professor of pharmacy ...
Boehringer Ingelheim News - 15 October 2007 – Boehringer Ingelheim and Vitae Pharmaceuticals, Inc. ... About Vitae Pharmaceuticals ... Vitae Pharmaceuticals is financed by leading ...